Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KRTAP2-2	KAP2.2	ENSG00000214518	"Keratin associated protein 2-2"	Q9BYT5	17	41054498-41055230	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	305	"skin 1: 30.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: AB_2683947"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP19-3	KAP19.3	ENSG00000244025	"Keratin associated protein 19-3"	Q7Z4W3	21	30491464-30491985	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	279	"skeletal muscle: 39.3;skin 1: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP9-9	"KAP9.5, KAP9.9, KRTAP9-5"	ENSG00000198083	"Keratin associated protein 9-9"	Q9BYP9	17	41255384-41256364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	208	"skin 1: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP1-3	KAP1.3	ENSG00000221880	"Keratin associated protein 1-3"	Q8IUG1	17	41033884-41034855	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	88	"skin 1: 40.7"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP10-8	"KAP10.8, KRTAP18-8, KRTAP18.8"	ENSG00000187766	"Keratin associated protein 10-8"	P60410	21	44612079-44612954	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	79	"skin 1: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830519-54858393	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	75	"breast: 283.5;salivary gland: 277.2;skin 1: 99.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 2.1;hTCEpi: 2.3;MCF7: 3.8;SK-BR-3: 9.7"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											HPA039093	Enhanced				"Secreted in other tissues"					"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	2.9	0.0	0.1	0.1	0.1	0.0	283.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	277.2	0.1	0.2	99.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell line enriched"	"Detected in single"	844	"SK-MEL-30: 84.3"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: , HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
KRTAP9-3	KAP9.3	ENSG00000204873	"Keratin associated protein 9-3"	Q9BYQ3	17	41232463-41233454	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	69	"skin 1: 29.4"	"Cell line enriched"	"Detected in single"	14	"SCLC-21H: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	150000	150000																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-2	KAP4.2	ENSG00000244537	"Keratin associated protein 4-2"	Q9BYR5	17	41177446-41178208	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"skin 1: 20.1"	"Cell line enriched"	"Detected in single"	12	"HDLM-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	1200000	1200000																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-9	KAP4.9	ENSG00000212722	"Keratin associated protein 4-9"	Q9BYQ8	17	41105332-41106488	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"skin 1: 28.2"	"Cell line enhanced"	"Detected in some"		"BJ: 1.9;BJ hTERT+ SV40 Large T+: 1.4;U-138 MG: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP2-1	KAP2.1A	ENSG00000212725	"Keratin associated protein 2-1"	Q9BYU5	17	41046541-41047316	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	62	"skin 1: 34.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;SCLC-21H: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: AB_2683947"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 75.0"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4
KRTAP26-1		ENSG00000197683	"Keratin associated protein 26-1"	Q6PEX3	21	30319124-30320316	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"placenta: 59.4;skin 1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP2-4	KAP2.4	ENSG00000213417	"Keratin associated protein 2-4"	Q9BYR9	17	41065116-41065879	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	55	"skin 1: 27.4"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: AB_2683947"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AL354761.1		ENSG00000236543			9	135604345-135618952	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	52	"skin 1: 20.8"	"Cell line enriched"	"Detected in single"	16	"BEWO: 13.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.3		0.0		0.0	0.0		0.0	0.4	0.0	20.8	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP4-7	KAP4.7	ENSG00000240871	"Keratin associated protein 4-7"	Q9BYR0	17	41084150-41085141	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	52	"skin 1: 30.9"	"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 3.0;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP9-4	KAP9.4	ENSG00000241595	"Keratin associated protein 9-4"	Q9BYQ2	17	41249687-41250653	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"skin 1: 26.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP10-11	"KAP10.11, KAP18.11, KRTAP18-11, KRTAP18.11"	ENSG00000243489	"Keratin associated protein 10-11"	P60412	21	44646414-44647650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"skin 1: 12.2"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP9-7	"KAP9.7, KRTAP9L1"	ENSG00000180386	"Keratin associated protein 9-7"	A8MTY7	17	41275659-41276697	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	47	"skin 1: 11.8"	"Cell line enriched"	"Detected in single"	7	"HDLM-2: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP21-2	KAP21.2	ENSG00000187026	"Keratin associated protein 21-2"	Q3LI59	21	30746794-30747233	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	45	"skin 1: 3.4;testis: 5.7"	"Cell line enriched"	"Detected in single"	10	"HEK 293: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	0.1	0.1	0.0	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP10-9	"KAP10.9, KAP18.9, KRTAP18-9"	ENSG00000221837	"Keratin associated protein 10-9"	P60411	21	44627123-44628293	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	41	"skin 1: 13.4"	"Cell line enriched"	"Detected in single"	13	"SCLC-21H: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP10-3	"KAP10.3, KAP18.3, KRTAP18-3"	ENSG00000212935	"Keratin associated protein 10-3"	P60369	21	44557790-44558760	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	38	"skin 1: 19.5"	"Cell line enriched"	"Detected in single"	4	"SCLC-21H: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	34	"cerebellum: 1.8"	HPA059196	Uncertain									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP10-5	"KAP10.5, KAP18.5, KRTAP18-5"	ENSG00000241123	"Keratin associated protein 10-5"	P60370	21	44579455-44580604	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	31	"skin 1: 16.6"	"Cell line enriched"	"Detected in single"	4	"SCLC-21H: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP10-10	"KAP10.10, KAP18.10, KRTAP18-10"	ENSG00000221859	"Keratin associated protein 10-10"	P60014	21	44637356-44638455	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"skin 1: 18.0"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3			0.5		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0										
KRTAP19-5	KAP19.5	ENSG00000186977	"Keratin associated protein 19-5"	Q3LI72	21	30501657-30502117	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"skin 1: 23.5"	"Cell line enriched"	"Detected in some"	6	"HEK 293: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	2100000	2100000																					0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP3-3	KAP3.3	ENSG00000212899	"Keratin associated protein 3-3"	Q9BYR6	17	40993430-40994133	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	25	"skin 1: 50.5;tongue: 29.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Supported									"HPA042992: AB_2678258"																		0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.0	0.3	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SPRR2G		ENSG00000159516	"Small proline rich protein 2G"	Q9BYE4	1	153149582-153150869	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"skin 1: 128.3;tongue: 274.6"	"Cell line enriched"	"Detected in single"	17	"hTCEpi: 8.8"	"Group enriched"	"Detected in many"	15	"head and neck cancer: 256.0;melanoma: 131.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"																					"unprognostic (3.93e-1)"				"unprognostic (1.90e-1)"		"unprognostic (3.25e-1)"	"unprognostic (2.44e-1)"								"unprognostic (1.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	5.4	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	128.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	274.6	9.3	0.1	5.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
KRTAP20-1	KAP20.1	ENSG00000244624	"Keratin associated protein 20-1"	Q3LI63	21	30616425-30616699	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	21	"skin 1: 2.7;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP3-2	KAP3.2	ENSG00000212900	"Keratin associated protein 3-2"	Q9BYR7	17	40999193-40999894	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"esophagus: 22.1;skin 1: 42.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.2;HeLa: 2.2;SCLC-21H: 1.1;U-2197: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Approved									"HPA042992: AB_2678258"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0
LCE1F	LEP6	ENSG00000240386	"Late cornified envelope 1F"	Q5T754	1	152776372-152776728	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	21	"skin 1: 69.5"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 11.4;hTERT-HME1: 5.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 5.5;melanoma: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (2.21e-1)"			"unprognostic (8.43e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	69.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822595	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	20	"skin 1: 1236.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 129.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000132, HPA012014"	Enhanced				"Intracellular and membrane"	34000000000	34000000000			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	4.1	4.4	5.3	3.7	6.0	3.9	41.4	7.2	6.4	37.3	3.7	1.4	8.2	4.0	14.9	5.4	7.4	3.0	3.7	9.3	6.4	2.9	5.9	7.6	3.0	5.3	5.2	3.2	3.3	9.2	2.6	8.1	5.7	4.9	5.6	2.9	2.4	17.4	8.3	12.2	1236.8	4.9	3.0	4.0	3.7	4.3	9.6	6.1	11.6	5.5	21.7	5.8	3.3	62.7	17.5	15.4	21.7	5.7	13.2	13.4	3.4	17.5	22.4	6.6	7.0	8.1	7.3	6.1	15.8	9.8	6.6	6.0	8.5	6.6	4.9	23.9	7.0	35.4	2.7	6.0	8.4	11.6	17.6	4.6	29.2	15.5	9.4	9.7	13.6	5.6	129.0	4.3	9.4	4.5	24.8	9.3	7.6	13.2	12.7	9.5	8.4	14.3	9.5	9.5	10.4	6.7	19.1	5.7	6.7	11.3	27.1	20.6	21.1	13.3	5.1	11.1	16.3	13.6	19.6	0.2	11.8	13.8	15.0	6.4	13.7	21.7	4.7	19.1	9.8	4.2	11.1	17.5	10.8	13.4	7.7	10.1	12.1	11.8	1.6	13.2	5.7	15.4	10.3	3.4	5.3	6.0	7.2	6.4	6.4	2.9	5.2	3.2	4.9	6.1
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063967	Enhanced				"Secreted in other tissues"	370000000	370000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.5	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.3	0.7	0.4	0.0	0.0	0.4	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DGAT2L6	"DC3, FLJ25989"	ENSG00000184210	"Diacylglycerol O-acyltransferase 2 like 6"	Q6ZPD8	X	70177483-70205545	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"breast: 6.9;skin 1: 10.1"	"Cell line enriched"	"Detected in single"	6	"NB-4: 4.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.90e-2)"				"unprognostic (3.08e-1)"							"unprognostic (1.43e-3)"	"unprognostic (3.47e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP9-2	KAP9.2	ENSG00000239886	"Keratin associated protein 9-2"	Q9BYQ4	17	41226648-41227652	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	19	"skin 1: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP10-12	"KAP10.12, KRTAP18-12, KRTAP18.12"	ENSG00000189169	"Keratin associated protein 10-12"	P60413	21	44697172-44698044	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	18	"skin 1: 13.2"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	13.2	0.7	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP11-1	KAP11.1	ENSG00000182591	"Keratin associated protein 11-1"	Q8IUC1	21	30880644-30881555	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skin 1: 60.7;tongue: 18.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 1.3;urothelial cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.3"	HPA054008	Enhanced					3800000	3800000			"HPA054008: AB_2682341"																		1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.3	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT39	KA35	ENSG00000196859	"Keratin 39"	Q6A163	17	40958417-40966892	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"skin 1: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									270000	270000				"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.85e-1)"		"unprognostic (9.03e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.00e-2)"		"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.42e-10)"	"unprognostic (3.95e-1)"			"unprognostic (3.04e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT32	"Ha-2, KRTHA2"	ENSG00000108759	"Keratin 32"	Q14532	17	41459811-41467429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"esophagus: 12.8;skin 1: 18.0"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;HaCaT: 1.5;MCF7: 1.6;PC-3: 2.5;U-2197: 1.3;U-87 MG: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									230000000	230000000				"unprognostic (1.39e-2)"	"unprognostic (3.29e-1)"		"unprognostic (1.88e-1)"		"unprognostic (2.71e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"		"unprognostic (2.32e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.72e-9)"		"unprognostic (1.31e-2)"		"unprognostic (1.77e-1)"	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0			0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP4-5	KAP4.5	ENSG00000198271	"Keratin associated protein 4-5"	Q9BYR2	17	41148924-41149802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 14.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-6	"KAP4.15, KAP4.6, KRTAP4-15"	ENSG00000198090	"Keratin associated protein 4-6"	Q9BYQ5	17	41139433-41140487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 24.2"	"Group enriched"	"Detected in some"	13	"CACO-2: 1.1;HaCaT: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.5"																																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"skin 1: 6.1"	"Group enriched"	"Detected in some"	4	"A-431: 1.1;BEWO: 1.6;PC-3: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.2;hippocampal formation: 1.1"	CAB022336	Uncertain					9000	9000			"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WFDC3	"dJ447F3.3, WAP14"	ENSG00000124116	"WAP four-disulfide core domain 3"	Q8IUB2	20	45747944-45791932	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	16	"skin 1: 14.9;testis: 45.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.9;HUVEC TERT2: 1.0;PC-3: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.0"														"Secreted in male reproductive system"						"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.75e-2)"	"unprognostic (9.30e-4)"	"unprognostic (6.63e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.36e-8)"	"unprognostic (8.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.27e-3)"	"unprognostic (3.03e-2)"	0.4	0.1	0.2	0.3	1.1	0.0	1.8	0.2	1.0	0.1	0.2	1.4	1.3	0.5	0.2	1.1	0.1	0.9	0.1	0.3	0.5	0.2	0.1	0.1	0.2	0.0	0.5	0.4	0.1	0.2	0.0	1.1	0.1	0.6	0.2	0.2	0.0	0.0	0.6	0.1	14.9	0.1	1.2	0.5	0.1	0.1	45.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	4.9	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.2	1.0	0.5	0.2	0.5	0.4	0.6	0.4
KPRP	C1orf45	ENSG00000203786	"Keratinocyte proline rich protein"	Q5T749	1	152759561-152762052	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 72.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0;hTEC/SVTERT24-B: 5.7;LHCN-M2: 1.9;U-2197: 3.4;U-87 MG: 2.4"	"Group enriched"	"Detected in some"	22	"head and neck cancer: 6.9;melanoma: 13.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031988, HPA031990"	Enhanced					2700000	2700000			"HPA031988: AB_10671582, HPA031990: AB_2674102"		"unprognostic (1.03e-1)"				"unprognostic (2.67e-2)"			"unprognostic (1.22e-1)"								"unprognostic (1.03e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.2	0.0			0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.3	72.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.7	0.9	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652164	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 289.9"	"Group enriched"	"Detected in some"	6	"HEL: 6.5;HMC-1: 2.8"	"Group enriched"	"Detected in some"	35	"head and neck cancer: 4.7;melanoma: 23.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Group enriched"	"Detected in some"	6	"amygdala: 1.8;hippocampal formation: 2.9"	"Low region specificity"	"Detected in single"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		14000000000	14000000000	"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"CAB037321: , HPA006299: "	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0.0	2.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	6.8	0.1	19.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 33.1"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									270000000	270000000																					1.8	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	33.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP12-1	"KAP12.1, KRTAP12.1"	ENSG00000187175	"Keratin associated protein 12-1"	P59990	21	44681576-44682163	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skin 1: 20.4"	"Cell line enriched"	"Detected in single"	35	"SCLC-21H: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (4.04e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.4	0.0	0.1		0.0	0.2		0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.4	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP19-4	KAP19.4	ENSG00000186967	"Keratin associated protein 19-4"	Q3LI73	21	30496824-30497133	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	15	"skin 1: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP8-1	KAP8.1	ENSG00000183640	"Keratin associated protein 8-1"	Q8IUC2	21	30812697-30813252	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skin 1: 33.2"	"Cell line enriched"	"Detected in single"	17	"U-937: 1.6"	"Cancer enriched"	"Detected in single"	21	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 123.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 6.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									61000	61000					"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	123.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;CACO-2: 3.9;HBF TERT88: 1.3;HUVEC TERT2: 1.4;LHCN-M2: 1.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.6	0.5	0.1	0.0	3.9	0.0	0.4	0.2	0.3	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0
KRTAP12-3	KRTAP12.3	ENSG00000205439	"Keratin associated protein 12-3"	P60328	21	44657932-44658341	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	14	"blood: 3.3;skin 1: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.3"																																					0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.5	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0										
KRTAP9-8	KAP9.8	ENSG00000187272	"Keratin associated protein 9-8"	Q9BYQ0	17	41238045-41239004	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"skin 1: 26.2"	"Cell line enriched"	"Detected in single"	59	"HDLM-2: 5.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0
LIPM	"bA304I5.1, LIPL3"	ENSG00000173239	"Lipase family member M"	Q5VYY2	10	88802730-88820546	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"skin 1: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 2.2;CAPAN-2: 7.2;HaCaT: 2.0;HL-60: 4.0;NB-4: 3.4;RT4: 3.0;T-47d: 3.5;U-937: 3.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (7.72e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.23e-4)"	"unprognostic (6.70e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.75e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.05e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.02e-2)"	"unprognostic (9.70e-6)"	0.0	0.0	0.0	0.8	0.0	0.2	1.9	0.0	0.0	0.0	0.1			0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	30.1	0.0	0.0	0.0	0.1	2.2	0.0			0.0		0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	0.1	0.1	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1										
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell line enriched"	"Detected in single"	38	"RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain									"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skin 1: 57.5;tongue: 16.1"	"Cell line enriched"	"Detected in some"	5	"A549: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA049778	Supported					160000000	160000000			"HPA049778: AB_2680877"	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		2.1	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.3	0.1	0.0	0.1	0.1	0.4	0.2	57.5	0.1	0.1	0.1	0.1	0.0	2.9	0.1	0.3	1.1	16.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	1.3	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
KRTAP4-8	KAP4.8	ENSG00000204880	"Keratin associated protein 4-8"	Q9BYQ9	17	41096981-41098141	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 20.7"	"Cell line enhanced"	"Detected in some"		"BJ: 2.1;BJ hTERT+ SV40 Large T+: 1.2;HBF TERT88: 4.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
CCL27	"ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine"	ENSG00000213927	"C-C motif chemokine ligand 27"	Q9Y4X3	9	34661880-34664048	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 96.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.0;T-cells: 2.0"					"Not detected"	"Not detected"			HPA073848	Enhanced				"Secreted to blood"					"HPA073848: AB_2732243"																		0.1	0.0	0.1	0.1	0.1	0.1	5.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	96.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	8.0	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	5.5	1.8	1.6	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.1	0.0	2.1	3.5	0.0	2.4	2.1	0.0	0.0	1.8	0.8	0.7	0.0	0.0	3.0	1.9	0.6	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.4	1.6	0.0	0.0	0.2	1.6	0.0	0.0	2.5	2.0	2.0	0.0	0.3	1.0	0.1	0.9	0.4	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium voltage-gated channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"lymphoid tissue: 3.5;skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enhanced"	"Detected in many"		"cerebellum: 75.1"	HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	8.1	0.0	0.0		0.0	0.0	0.3			0.0		3.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703463	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 77.7"	"Cell line enriched"	"Detected in single"	90	"HaCaT: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3"	"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		2100000000	2100000000	"Nuclear membrane, Plasma membrane"	"Nuclear membrane, Plasma membrane"	"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	77.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP10-1	"KAP10.1, KAP18.1, KRTAP18-1"	ENSG00000215455	"Keratin associated protein 10-1"	P60331	21	44538981-44540195	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 13.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.0	13.1	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP12-2	"KAP12.2, KRTAP12.2"	ENSG00000221864	"Keratin associated protein 12-2"	P59991	21	44666189-44666927	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 19.8"	"Cell line enhanced"	"Detected in single"		"T-47d: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371391-30372257	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"intestine: 5.9;skin 1: 14.9;tongue: 19.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	1300000	1300000												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP20-2	KAP20.2	ENSG00000184032	"Keratin associated protein 20-2"	Q3LI61	21	30635236-30635619	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	12	"skin 1: 5.1"	"Group enriched"	"Detected in some"	22	"ASC diff: 3.2;U-2 OS: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE6A	C1orf44	ENSG00000235942	"Late cornified envelope 6A"	A0A183	1	152842868-152843983	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 77.1"	"Cell line enriched"	"Detected in single"	15	"RPMI-8226: 1.5"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046376	Enhanced									"HPA046376: AB_10965998"						"unprognostic (4.25e-2)"			"unprognostic (8.73e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.2	0.0	0.1	0.1	0.1	0.2	77.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.8	0.1	6.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LIPK	"bA186O14.2, LIPL2"	ENSG00000204021	"Lipase family member K"	Q5VXJ0	10	88724544-88752786	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"skin 1: 27.1"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 7.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (7.65e-2)"	"unprognostic (8.64e-2)"				"unprognostic (3.57e-2)"		"unprognostic (3.19e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.13e-1)"						"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.1		0.0	0.0		0.1	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdTCR: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA023120: , HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.5	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	0.4	0.9	10.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.8	0.1	14.8	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	4.7	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240627	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 3.8;skin 1: 6.1"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063412	Enhanced									"HPA063412: AB_2685009"	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 40.1;SiHa: 9.0;U-2 OS: 26.2;U-251 MG: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058999			Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"			"Nuclear speckles"	"Nuclear speckles"	"HPA058999: "	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.1	0.0	0.0	0.0	4.7	26.2	0.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2
KRTAP24-1	KAP24.1	ENSG00000188694	"Keratin associated protein 24-1"	Q3LI83	21	30281309-30282958	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"skin 1: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017604	Enhanced									"HPA017604: AB_2669625"																		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-3	KAP4.3	ENSG00000196156	"Keratin associated protein 4-3"	Q9BYR4	17	41167231-41168194	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 17.3"	"Cell line enriched"	"Detected in single"	51	"HDLM-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"															390000	390000																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP5-3	"KRTAP5-9, KRTAP5.3"	ENSG00000196224	"Keratin associated protein 5-3"	Q6L8H2	11	1607565-1608463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"skin 1: 11.4"	"Cell line enriched"	"Detected in single"	5	"RT4: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		1.0	0.0	0.0	11.4	0.0	0.1	0.0	0.0	0.0	0.3			0.0		0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-6	KRTAP5.6	ENSG00000205864	"Keratin associated protein 5-6"	Q6L8G9	11	1697195-1697755	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"liver: 6.7;placenta: 2.6;skin 1: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;SK-BR-3: 1.9"	"Cancer enriched"	"Detected in single"	21	"liver cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"prognostic favourable (6.04e-5)"			"unprognostic (3.70e-1)"					"unprognostic (2.93e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0		0.0	0.0	0.0	0.0	2.6		0.0	0.0		0.2	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.1	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.0	1.9	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;HMC-1: 3.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"					"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.2	0.1	0.6	0.5	6.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LCE1C	LEP3	ENSG00000197084	"Late cornified envelope 1C"	Q5T751	1	152804835-152806628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"skin 1: 100.1"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 2.5;HBEC3-KT: 5.1;hTEC/SVTERT24-B: 2.7;hTERT-HME1: 6.9"	"Cancer enriched"	"Detected in some"	6	"melanoma: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.35e-2)"			"unprognostic (5.95e-2)"	"unprognostic (3.46e-2)"			"unprognostic (3.35e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	8.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.7	100.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	8.8	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"breast: 5.7;skin 1: 14.0"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 2.3;PC-3: 2.6;SK-BR-3: 1.1"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062748	Approved									"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT9	"CK-9, EPPK, K9"	ENSG00000171403	"Keratin 9"	P35527	17	41565841-41572058	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"lymphoid tissue: 25.7;skin 1: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.6;HaCaT: 18.0;U-2197: 3.2;U-937: 5.6"	"Cancer enriched"	"Detected in some"	6	"melanoma: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA007261, CAB037322"	Supported					42000000000	42000000000			"CAB037322: , HPA007261: AB_1079182"	"unprognostic (2.13e-2)"	"unprognostic (5.08e-2)"		"unprognostic (4.97e-2)"		"unprognostic (3.65e-2)"		"unprognostic (2.89e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.92e-7)"	"unprognostic (1.28e-1)"		"unprognostic (3.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (4.15e-2)"	0.1	1.7	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.9	0.1	7.6	0.5	0.2	0.1	0.1	0.0	0.7	0.1	25.7	0.1	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP1-1	"HB2A, KAP1.1, KAP1.1A, KAP1.1B"	ENSG00000188581	"Keratin associated protein 1-1"	Q07627	17	41040559-41041461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 38.7"	"Cell line enhanced"	"Detected in some"		"BJ: 2.3;fHDF/TERT166: 1.9;LHCN-M2: 2.3;U-2197: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																																"unprognostic (2.90e-1)"							0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP10-2	"KAP10.2, KAP18.2, KRTAP18-2"	ENSG00000205445	"Keratin associated protein 10-2"	P60368	21	44550357-44551505	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 16.0"	"Cell line enriched"	"Detected in single"	6	"U-266/84: 3.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"																													"unprognostic (1.26e-1)"								0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	16.0	0.3	0.0	0.0	0.2	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0										
KRTAP5-4	KRTAP5.4	ENSG00000241598	"Keratin associated protein 5-4"		11	1620958-1622138	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"skeletal muscle: 2.4;skin 1: 8.7"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (6.52e-2)"	"unprognostic (4.04e-4)"						"unprognostic (1.80e-1)"	"unprognostic (7.83e-2)"			"unprognostic (2.00e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	2.4	8.7	0.0	0.0	0.0	0.1	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE1A	LEP1	ENSG00000186844	"Late cornified envelope 1A"	Q5T7P2	1	152827473-152827894	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 97.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"melanoma: 14.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (3.82e-2)"			"unprognostic (1.70e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	97.7	0.0	0.0	0.1	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE2B	"LEP10, SPRL1B, XP5"	ENSG00000159455	"Late cornified envelope 2B"	O14633	1	152686123-152687401	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 101.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+: 2.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 11.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (3.04e-2)"			"unprognostic (1.36e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.0	101.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE2C	LEP11	ENSG00000187180	"Late cornified envelope 2C"	Q5TA81	1	152675295-152676574	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 75.3"	"Cell line enhanced"	"Detected in some"		"BJ: 1.0;CACO-2: 1.9"	"Group enriched"	"Detected in some"	30	"head and neck cancer: 2.0;melanoma: 9.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (1.47e-2)"			"unprognostic (7.00e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.9	75.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"lymphoid tissue: 7.7;skin 1: 3.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.2;CAPAN-2: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.2			0.0		7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 81.9"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 6.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.8;melanoma: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 0.2"						"Secreted in other tissues"	570000	570000				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	81.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell line enriched"	"Detected in some"	21	"A-431: 92.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		75000000	75000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favourable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CLEC2A	"INPE5792, KACL, PILAR, UNQ5792"	ENSG00000188393	"C-type lectin domain family 2 member A"	Q6UVW9	12	9898673-9932381	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skin 1: 37.0"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 13.2;U-937: 32.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048530, HPA072407"	Approved		Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA048530: AB_2680429, HPA072407: AB_2686518"		"unprognostic (3.10e-1)"							"unprognostic (5.29e-2)"						"unprognostic (2.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
DLX3		ENSG00000064195	"Distal-less homeobox 3"	O60479	17	49990005-49995224	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"placenta: 47.6;skin 1: 32.4;tongue: 11.9"	"Group enriched"	"Detected in some"	5	"BEWO: 53.5;SK-BR-3: 17.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.44e-5)"	"unprognostic (3.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	0.5	0.2	0.1	0.0	0.1	0.0	1.5	0.0	0.2	2.2	0.3	0.1	0.0	0.0	0.1	0.6	2.8	0.1	0.2	0.1	0.1	0.1	0.5	0.0	0.4	0.0	0.0	0.0	1.4	0.8	0.0	0.2	47.6	0.3	0.7	0.0	0.5	1.1	1.1	0.1	32.4	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.4	3.6	11.9	3.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	1.0	0.3	0.2	53.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.6	6.6	2.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.2	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.7	5.9	0.0	0.6	17.2	0.0	6.8	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0
IL1F10	"FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833"	ENSG00000136697	"Interleukin 1 family member 10"	Q8WWZ1	2	113067970-113075850	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 5.9;skin 1: 14.8"	"Group enriched"	"Detected in some"	7	"BEWO: 3.3;HaCaT: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"							"unprognostic (3.89e-1)"				"unprognostic (6.25e-2)"		"unprognostic (1.48e-1)"	"unprognostic (1.18e-1)"			"unprognostic (2.42e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT26	KRT25B	ENSG00000186393	"Keratin 26"	Q7Z3Y9	17	40766238-40772162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"blood: 7.1;skin 1: 10.7;testis: 3.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	17	"basophil: 2.8;neutrophil: 7.1"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.1"									HPA026890	Enhanced									"HPA026890: AB_2672042"																		0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.2		0.0	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.5	0.3	0.0	0.7	0.0	0.0	0.7	0.4	2.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.2	0.0	0.0	0.0	0.0										
KRT82	"Hb-2, KRTHB2"	ENSG00000161850	"Keratin 82"	Q9NSB4	12	52393931-52406355	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 14.9"	"Cell line enriched"	"Detected in single"	5	"U-87 MG: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058715, HPA067230"	Enhanced					20000000	20000000			"HPA058715: AB_2683798, HPA067230: AB_2685807"		"unprognostic (3.04e-1)"				"unprognostic (3.59e-3)"												0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.6		0.0	0.0		0.3	0.0	0.0	14.9	0.0	0.0	0.0	0.2	0.0	0.7			0.0		0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP17-1	KAP17.1	ENSG00000186860	"Keratin associated protein 17-1"	Q9BYP8	17	41314917-41315695	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	9	"skin 1: 20.6"	"Group enriched"	"Detected in some"	48	"HDLM-2: 12.6;SCLC-21H: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-4	"KAP4.13, KAP4.4, KRTAP4-13"	ENSG00000171396	"Keratin associated protein 4-4"	Q9BYR3	17	41159651-41160731	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	1300000	1300000																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP9-6	"KAP9.6, KRTAP9L2"	ENSG00000212659	"Keratin associated protein 9-6"	A8MVA2	17	41265339-41266641	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	9	"skin 1: 6.9"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0		0.1	0.0	0.0	0.0	0.1		0.2	0.4		0.0	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.2	0.0			0.0		0.1	0.0	0.0	0.4	0.2	0.7	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.4	0.1	0.3	0.3	0.4	0.5	0.7	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.5	0.2	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0										
LCE1B	"LEP2, SPRL2A"	ENSG00000196734	"Late cornified envelope 1B"	Q5T7P3	1	152811971-152813109	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skin 1: 59.7"	"Group enriched"	"Detected in some"	8	"HBEC3-KT: 1.7;hTCEpi: 6.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.79e-1)"				"unprognostic (1.24e-2)"			"unprognostic (6.43e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	59.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE2D	"LEP12, SPRL1A"	ENSG00000187223	"Late cornified envelope 2D"	Q5TA82	1	152663396-152664659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skin 1: 52.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.4;U-2197: 1.0"	"Group enriched"	"Detected in some"	42	"head and neck cancer: 1.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (3.94e-2)"			"unprognostic (5.63e-2)"									0.1	0.0	0.1	0.1	0.1	0.0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	52.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721845	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HaCaT: 1.9;MCF7: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	1.9	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.4	0.1	5.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.5	0.0	0.1	0.1	0.0	2.4	0.1	0.2	89.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	1.8	0.1	56.1	24.8	0.1	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.8	0.4	0.1	0.0	0.1	1.9	0.0	0.2	0.1	0.0	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 3.8;hTCEpi: 4.8;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC004233.2		ENSG00000270168			16	2988256-3002016	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	8	"skin 1: 8.9"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;CAPAN-2: 3.5;HaCaT: 7.5;hTCEpi: 5.6;MCF7: 3.9;SCLC-21H: 5.7;T-47d: 3.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.61e-1)"		"unprognostic (1.97e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.21e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1		0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.6	0.1	0.1	1.1	0.1	0.1	8.9	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.6	0.4	0.1	0.2	0.5	0.2	3.5	0.0	0.2	0.0	7.5	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.1	5.6	0.2	0.0	0.0	0.6	0.3	0.0	3.9	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.2	5.7	0.2	0.5	2.4	0.1	3.0	0.1	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0										
AC093762.1		ENSG00000284635			2	227745845-227746681	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	8	"skin 1: 2.5"	"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	2.5	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23754627-23758951	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 105.8;skin 1: 36.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.2;NB-4: 10.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB072806	Approved									"CAB072806: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.3	0.0	0.3	8.8	0.5	0.0	0.5	0.4	0.7	2.3	37.4	0.7	0.8	54.8	0.4	0.6	0.4	0.1	0.3	0.3	0.3	0.1	0.5	0.3	0.5	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.8	0.8	1.4	26.2	0.4	0.6	0.5	0.3	36.8	105.8	0.9	0.9	0.3	0.0	2.9	0.6	0.5	0.3	0.5	0.4	6.2	1.4	1.5	1.3	2.5	0.9	0.4	0.9	0.1	1.2	2.7	0.9	0.8	1.7	1.7	1.6	3.6	1.4	0.6	1.3	0.8	2.9	0.6	1.2	3.1	1.8	0.6	3.5	0.8	0.8	0.3	0.6	5.1	2.1	2.1	0.5	0.9	1.2	1.1	3.2	9.2	1.5	1.5	1.3	1.6	0.2	0.1	10.6	0.5	2.6	0.3	0.2	1.7	1.4	1.5	0.8	1.0	1.1	0.3	0.1	0.3	0.2	1.6	0.7	1.0	1.0	0.2	0.6	0.2	0.3	0.0	0.7	0.7	1.2	0.9	0.2	0.9	0.5	0.5	0.7	0.6	0.7	0.4	1.5	0.9	0.8	2.5	0.4	0.5	1.3	0.3	0.1	0.3	0.5	0.4	0.7	0.3	0.1	1.2	0.3	0.8	0.6
IGFL3	UNQ483	ENSG00000188624	"IGF like family member 3"	Q6UXB1	19	46120071-46124674	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 22.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.1;CACO-2: 2.1;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"											HPA062776	Uncertain				"Secreted in other tissues"					"HPA062776: AB_2684866"	"unprognostic (8.61e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.69e-1)"		"unprognostic (4.78e-2)"	"unprognostic (7.45e-3)"		"unprognostic (2.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-4)"			"unprognostic (2.86e-2)"	"unprognostic (1.90e-1)"		"unprognostic (3.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	22.4	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.9	0.1	2.7	0.1	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.6	0.5	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.1	1.1	0.5	2.8	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.1	0.6	0.0	0.2	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.6	0.6	0.1	0.2	0.2	1.5	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782534	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 37.4"	"Group enriched"	"Detected in some"	6	"EFO-21: 5.5;SK-BR-3: 1.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 104.2"	HPA055114	Enhanced									"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.1	0.0	0.1	0.1	1.2	0.0	4.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	37.4	0.2	0.1	0.1	0.1	0.0	1.0	0.1	2.8	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553147	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"epididymis: 10.8;skin 1: 42.7"	"Cell line enriched"	"Detected in single"	14	"CACO-2: 11.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049404	Enhanced					180000000	180000000			"HPA049404: AB_2680748"	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573825	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"epididymis: 11.9;skin 1: 17.2"	"Cell line enriched"	"Detected in single"	6	"HaCaT: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"					"Low region specificity"	"Detected in some"			HPA048596	Enhanced									"HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	11.9	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	17.2	0.1	0.1	0.4	0.1	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP10-6	"KAP10.6, KAP18.6, KRTAP18-6, KRTAP18.6"	ENSG00000188155	"Keratin associated protein 10-6"	P60371	21	44591268-44592505	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"skin 1: 7.5"	"Cell line enriched"	"Detected in single"	26	"SCLC-21H: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	7.5	0.5	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0										
KRTAP13-1	KAP13.1	ENSG00000198390	"Keratin associated protein 13-1"	Q8IUC0	21	30396074-30396822	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"skin 1: 13.0;tongue: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	2000000	2000000																					0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP19-1	KAP19.1	ENSG00000184351	"Keratin associated protein 19-1"	Q8IUB9	21	30479699-30480344	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 17.6"	"Cell line enriched"	"Detected in some"	12	"HEK 293: 21.7"	"Cancer enriched"	"Detected in some"	19	"melanoma: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (2.36e-2)"			"unprognostic (8.67e-2)"									0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP5-8	"KRTAP5-2, KRTAP5.8, UHSKerB"	ENSG00000241233	"Keratin associated protein 5-8"	O75690	11	71538025-71539207	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;RT4: 4.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (9.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.92e-2)"		"unprognostic (2.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.14e-1)"		"unprognostic (3.62e-2)"	"unprognostic (2.21e-3)"	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.3	0.4	0.0	0.2			0.3	0.0	3.4	0.0	0.1	0.2	0.0	0.2	0.3	7.1	0.1	0.2	0.1	0.2		0.0	0.0	0.1	0.0	0.0		0.0	0.2		0.1	0.2	0.4	8.7	0.4	0.0	0.1	0.1	0.0	2.7			0.1		0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
LCE1E	LEP5	ENSG00000186226	"Late cornified envelope 1E"	Q5T753	1	152786214-152788426	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 39.5"	"Cell line enriched"	"Detected in some"	4	"HaCaT: 14.5"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enriched"	"Detected in single"	15	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (9.92e-2)"				"unprognostic (9.50e-2)"			"unprognostic (2.30e-2)"								"unprognostic (2.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.3	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	2.6	0.0	0.0	14.5	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE2A	LEP9	ENSG00000187173	"Late cornified envelope 2A"	Q5TA79	1	152698364-152699442	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skin 1: 54.2;tongue: 14.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.8;SK-MEL-30: 3.8;U-138 MG: 1.9;U-2197: 2.7;U-87 MG: 1.3"	"Cancer enriched"	"Detected in some"	5	"melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (3.45e-2)"			"unprognostic (6.77e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	54.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 19.9"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.4;HaCaT: 2.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041105	Enhanced									"HPA041105: AB_2677300"	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0			0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPRR5		ENSG00000283227	"Small proline rich protein 5"	A0A1B0GTR4	1	152947154-152949258	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"skin 1: 30.7;tongue: 32.7"	"Group enriched"	"Detected in some"	8	"HaCaT: 4.0;hTCEpi: 10.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TINCR	"FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2"	ENSG00000223573	"TINCR ubiquitin domain containing"		19	5558167-5578349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"placenta: 50.0;skin 1: 45.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.5;HaCaT: 18.2;SK-BR-3: 28.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"																		"unprognostic (4.75e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.32e-2)"	0.0	0.4	1.0	0.0	0.7	0.6	1.7	0.0	1.0	1.7	0.4	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.0	0.0	0.0		0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	1.8	50.0	0.6	1.5	0.6	0.1	0.2	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	5.3	3.8	0.3	0.4	2.4	3.0	5.7	1.1	1.6	1.3	0.3	1.0	0.8	0.1	0.2	0.2	0.5	27.5	0.1	0.0	0.0	0.1	0.4	3.2	0.1	0.2	0.1	18.2	0.3	0.2	0.2	0.3	0.6	0.2	1.0	0.2	0.1	0.3	0.2	0.2	6.0	0.1	0.1	0.0	0.1	0.5	0.0	7.3	0.1	0.4	0.5	1.3	0.5	0.2	0.6	0.0	1.9	0.4	0.1	2.0	28.8	2.8	3.5	0.2	0.0	0.3	0.2	0.5	0.0	0.7	0.2	0.5	0.1	0.3	0.6	5.0	1.1	1.2	1.0	0.7	0.7	1.9	0.9	0.9	0.3	2.4	1.0	1.3	5.7	1.6	0.9	3.0	1.0	0.3										
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 31.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.3	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.8	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 75.3"	"Cell line enhanced"	"Detected in many"		"REH: 8.8"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"					"Cell type enriched"	"Detected in some"	6	"neutrophil: 11.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced					83000	83000			"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	0.2	0.2	0.5	0.1	0.6	0.0	5.5	0.8	0.4	0.3	0.0			0.3	0.3	0.6	0.0	0.4	0.1	0.1	0.6	0.7	0.2	0.0	0.1	0.1	0.7		0.9	0.0	0.0	0.5	0.1		0.1	0.0		0.0	0.2	1.0	75.3	0.2	0.2	1.0	0.4	0.1	0.4			0.0		0.1	0.0	0.6	0.1	1.2	11.2	0.1	0.3	0.9	0.5	0.1	0.7	1.8	3.5	2.3	0.8	0.5	0.4	0.7	0.4	0.3	1.2	0.1	1.3	0.3	0.3	0.5	1.6	0.2	0.4	2.4	4.6	2.7	0.4	1.2	0.9	2.3	2.0	1.1	0.7	0.4	0.7	0.4	1.0	3.6	0.4	0.5	1.9	5.2	1.8	0.4	8.8	1.0	0.5	0.1	0.1	2.0	0.5	0.2	1.4	1.4	0.1	1.0	0.2	0.1	1.8	0.1	0.3	3.9	2.3	2.7	0.2	1.6	2.0	0.0	0.1	1.9	0.7	0.1	0.7	0.0	0.3	0.6	0.1	0.1	0.2	0.6	11.2	0.3	0.1	1.2	0.9	0.5										
CDX4		ENSG00000131264	"Caudal type homeobox 4"	O14627	X	73447254-73455245	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"skin 1: 5.3;testis: 3.3"	"Cell line enriched"	"Detected in single"	8	"HEK 293: 2.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056528	Uncertain									"HPA056528: AB_2683166"															"unprognostic (1.97e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"retina: 18.2;skin 1: 6.8;testis: 10.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;HeLa: 4.0;RPMI-8226: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain									"HPA060314: AB_2684250"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.7	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	18.2	0.7	0.1	0.1	6.8	1.6	0.1	0.1	0.2	0.4	10.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.8	0.8	0.9	1.2	0.0	1.0	0.1	1.5	0.7	2.7	1.5	0.1	0.0	1.0	0.5	0.0	0.0	0.0	0.7	3.2	1.5	0.5	0.0	4.8	0.0	0.0	0.0	1.2	0.4	0.4	4.0	0.3	0.0	1.1	0.6	0.0	0.2	0.0	0.0	0.0	1.1	2.3	0.0	1.0	0.0	0.3	0.2	2.2	0.0	1.1	5.4	0.0	0.8	0.9	1.8	0.6	1.8	0.2	3.4	0.1	0.0	0.3	0.2	0.8	0.4	0.9	0.8	0.3	0.7	1.6	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8	0.4	0.2	0.3	0.0	1.0	0.2	0.2	0.0	1.2	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.6;RH-30: 26.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	0.4	2.1	0.3	0.4	0.0	1.8	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.1	0.0	0.0	11.6	0.0	0.1	0.8	0.0	0.0	0.1	0.5	1.7	0.0	26.5	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.6	0.1	0.0	0.0	3.5	0.0	2.0	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995355-47999791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 18.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.0	0.0		0.0		0.0	5.7		0.0	0.0	0.0			0.0	0.0	0.0	4.9	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	10.3	5.0	0.0		0.0	0.0	0.0			0.0		2.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM25G	bA301J7.4	ENSG00000189090	"Family with sequence similarity 25 member G"	B3EWG6	10	47487219-47491693	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skin 1: 42.4"	"Cell line enriched"	"Detected in single"	29	"SK-BR-3: 22.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"						"unprognostic (1.97e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	3.8	0.0			0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.7	0.0	0.0	42.4	0.7	0.0	0.0	0.0	0.0	0.0			0.0		1.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;NB-4: 3.9;THP-1: 15.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		67000	67000	Cytosol	Cytosol	"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.5	0.0	0.2	0.1	0.0	0.0	3.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.6	0.0	0.9	0.4	0.4	0.3	0.0	0.2	0.1	0.0	0.2	3.9	1.3	0.6	0.2	0.1	0.1	0.1	0.8	0.2	0.4	0.4	0.1	0.0	0.0	15.1	0.2	0.1	0.2	0.2	0.2	0.6	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell line enriched"	"Detected in single"	42	"CACO-2: 42.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 55.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.8;PC-3: 10.4;RT4: 5.5"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"					"Cell type enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.8	0.1	0.0	0.0	0.2	0.4	4.8	0.3	0.5	0.4	0.5	0.0	0.5	0.3	0.1	0.2	0.8	1.5	0.3	0.0	1.8	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.1	0.0	0.0	1.4	0.5	10.4	0.1	0.0	0.0	0.0	5.5	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0										
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792203-40799959	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 4.6;skin 1: 14.6"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.6"	"Low region specificity"	"Detected in many"			HPA066890	Enhanced									"HPA066890: AB_2685742"																		0.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT38	KRTHA8	ENSG00000171360	"Keratin 38"	O76015	17	41436446-41440921	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 18.3"	"Cell line enhanced"	"Detected in some"		"BJ: 2.2;fHDF/TERT166: 1.3"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.1;urothelial cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																	170000000	170000000									"unprognostic (1.37e-1)"				"unprognostic (4.05e-1)"								0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		2.5	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.6	0.1	0.4	0.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 8.9;testis: 32.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced									"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.2	0.0	0.2	0.6	0.2	1.1	0.2	0.4	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.0	0.2	0.2	0.5	3.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	8.9	1.7	0.2	0.2	1.8	0.0	32.6	0.2	0.6	0.2	0.2	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.3	0.4	0.0	0.2	0.2	0.2	0.2
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 43.2;skin 1: 53.9"	"Cell line enhanced"	"Detected in some"		"A-431: 210.7;A549: 160.7;MCF7: 48.0;PC-3: 77.3;U-251 MG: 148.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	43	"basophil: 43.2"	"Lineage enriched"	"Detected in many"	43	"granulocytes: 43.2"									HPA049778	Supported					220000000	220000000			"HPA049778: AB_2680877"	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	0.8	0.0	0.2	0.2	0.2	0.4	7.4	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.5	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.3	0.2	0.5	0.0	0.2	4.6	0.4	0.2	53.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.7	0.2	0.2	0.2	0.2	0.0	0.0	43.2	0.0	1.0	0.0	0.0	210.7	160.7	0.0	0.0	0.0	0.0	0.0	1.3	0.2	1.7	0.1	0.4	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.0	0.0	0.4	0.0	77.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.7	0.8	0.0	0.8	0.0	0.0	40.7	0.0	148.1	0.0	0.3	0.2	0.0	0.4	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
KRT83	"Hb-3, KRTHB3"	ENSG00000170523	"Keratin 83"	P78385	12	52314301-52321398	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 36.3"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 16.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.1"	"Group enriched"	"Detected in many"	5	"amygdala: 1.2;cerebral cortex: 1.2;pons and medulla: 3.3;thalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049778	Supported					170000000	170000000			"HPA049778: AB_2680877"	"unprognostic (7.03e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.30e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-2)"		"unprognostic (2.43e-1)"	"unprognostic (1.12e-3)"	"unprognostic (7.49e-3)"		"unprognostic (2.16e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	0.8	0.0	1.2	0.0	0.0	0.0	1.5	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.6	0.1	0.0	36.3	0.0	0.0	2.1	0.0	0.0	0.8	2.7	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	3.2	0.0	0.0	0.0	0.2	0.0	0.0	16.6	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.4	0.0	3.3	2.7
KRTAP4-12	KAP4.12	ENSG00000213416	"Keratin associated protein 4-12"	Q9BQ66	17	41123091-41124167	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skin 1: 21.4"	"Cell line enriched"	"Detected in single"	5	"BJ: 3.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 1.5"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"																																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.9	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
NKPD1	FLJ33600	ENSG00000179846	"NTPase KAP family P-loop domain containing 1"	Q17RQ9	19	45149750-45158737	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 17.5"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043339	Uncertain									"HPA043339: AB_10962493"	"unprognostic (3.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.30e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.77e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	0.0	0.1	0.0	0.0	0.1	0.2	0.8	0.5	0.2	0.9	0.0			0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.3	0.0		0.5	0.0		0.6	0.8	0.1	17.5	0.0	0.0	0.0	0.0	0.0	0.6			0.1		0.0	0.0	2.4	0.2	0.2	0.5	0.1	0.2	1.8	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.4	0.3	0.7	0.0	0.3	0.0	0.0	0.0	0.5	0.6	1.4	0.1	0.1	0.1	0.0	0.0	0.2	4.0	0.0	0.1	0.1	0.4	0.6	0.0	1.1	0.7	0.5	0.3	0.4	0.1	0.0	0.3	0.0	0.1	0.6	0.3	3.5	1.7	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	7.2	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.6	0.0	0.2	1.8	0.1	0.4	0.2	0.0	0.2	0.0	0.0										
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA046806	Uncertain				"Secreted - unknown location"					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.3	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.6	0.1	0.7	1.3	1.2	0.3	1.5	0.6	0.7	2.1	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	0.0	0.2	4.3	0.3	1.3	0.6	1.9	0.5	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	1.3	0.5	0.8	1.5	1.0	1.0	0.3	3.8	1.8	1.3	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970666-152972574	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 51.9;tongue: 18.9"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.5;hTCEpi: 2.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055963	Enhanced									"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.1	0.0	0.1	0.7	0.1	0.0	4.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.4	0.1	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	51.9	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.8	0.1	18.9	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 28.8;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;THP-1: 4.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA028375	Uncertain									"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.4	0.2	0.2	0.2	0.0	1.7	0.2	0.6	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.7	0.2	0.2	28.8	0.3	0.2	0.2	4.7	0.0	1.9	0.2	0.6	0.2	40.9	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.4	0.6	0.0	1.6	0.1	8.0	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	2.1	0.2	0.3	2.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.4	0.7	0.0	0.6	4.3	0.1	0.2	2.0	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.2
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847263-151853697	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skin 1: 59.8;tongue: 24.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 20.0"												"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.1	0.6	0.3	0.5	0.2	0.0	1.8	0.2	1.6	3.6	0.1	0.2	0.1	0.3	0.8	0.1	4.4	0.1	1.0	1.1	0.3	0.2	0.3	0.2	0.3	1.9	0.2	0.8	0.1	0.3	0.0	0.2	5.8	0.1	0.1	0.0	0.1	1.5	0.1	0.2	59.8	0.1	0.1	0.3	0.1	0.5	0.3	0.1	0.4	0.1	24.7	1.7	0.6	1.1	0.0	0.5	0.5	0.2	0.0	4.2	5.6	4.3	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.6	0.0	0.0	0.0	38.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.2	0.1	0.0	4.6	0.3	0.0	0.2	0.5	0.0	0.0	0.3	0.1	5.9	1.4	0.8	1.0	1.4	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.8	0.2	4.2	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	1.9	5.6	0.3	0.2	0.2	1.3	0.3	0.2	0.2	0.8	0.1	0.1
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333629	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"esophagus: 14.3;skin 1: 38.2;tongue: 17.3"	"Group enriched"	"Detected in some"	7	"MCF7: 2.2;T-47d: 7.9"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	2.2	0.1	0.1	3.8	0.1	0.1	0.1	0.0	0.4	0.1	14.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.1	1.4	0.1	0.2	38.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	17.3	3.5	0.1	2.2	0.6	0.4	0.4	0.2	1.0	3.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	7.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.0	3.6	0.1	3.5	1.6	0.0	0.6	2.3	2.3	0.4	1.0	0.2	0.4	2.0	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell line enriched"	"Detected in some"	7	"hTCEpi: 32.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		2200000	2200000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavourable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	29000000	29000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	31.5	5.1	0.0	0.0	1.2	1.9	8.9	0.1	4.2	0.2	0.3	39.0	33.5	0.0	12.8	0.3	17.7	9.6	51.1	0.4	0.1	9.3	0.0	0.0	8.7	1.5	0.0	0.1	17.5	13.8	0.9	29.7	0.0	0.1	0.0	0.1	27.6	0.0	0.0	28.3	2.1	0.0	0.0	1.2	50.5	20.9	0.1	0.0	7.7	0.0	3.1	12.8	0.0	0.0	4.9	15.0	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 69.2;tongue: 67.3"	"Group enriched"	"Detected in some"	40	"A-431: 85.3;HaCaT: 83.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014343, CAB025503, CAB026341"	Enhanced				"Secreted in other tissues"					"CAB025503: , CAB026341: , HPA014343: AB_1852603"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavourable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavourable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavourable (3.85e-6)"	1.1	0.0	0.7	0.4	0.2	0.0	12.1	0.2	0.5	3.8	0.3	0.2	0.2	0.1	1.4	0.9	6.5	0.2	0.3	0.2	0.2	0.1	0.6	0.2	2.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	7.0	0.2	0.4	69.2	0.2	0.2	0.2	0.2	0.0	3.3	0.2	0.4	0.3	67.3	4.4	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	83.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.2
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 259.8;HBEC3-KT: 128.1;hTCEpi: 160.3;hTERT-HME1: 52.4;U-2197: 45.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		2200000000	2200000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favourable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	128.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	160.3	0.1	52.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KRT33A	"Ha-3I, Krt1-3, KRTHA3A"	ENSG00000006059	"Keratin 33A"	O76009	17	41346092-41350812	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 30.4"	"Cell line enriched"	"Detected in some"	5	"RT4: 5.4"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055194	Supported					160000000	160000000			"HPA055194: AB_2682733"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-2)"				"unprognostic (4.58e-2)"		"unprognostic (4.34e-1)"									"unprognostic (2.16e-1)"	0.5	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	5.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	30.4	0.1	0.1	0.1	0.1	0.0	3.3	0.1	2.8	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT37	KRTHA7	ENSG00000108417	"Keratin 37"	O76014	17	41420753-41424523	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 11.7"	"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.15e-1)"	"unprognostic (4.54e-1)"				"unprognostic (8.63e-2)"											"unprognostic (5.15e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP10-4	"KAP10.4, KRTAP18-4, KRTAP18.4"	ENSG00000215454	"Keratin associated protein 10-4"	P60372	21	44573724-44638284	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 10.6"	"Group enriched"	"Detected in some"	15	"RPMI-8226: 1.4;SCLC-21H: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP19-7	KAP19.7	ENSG00000244362	"Keratin associated protein 19-7"	Q3SYF9	21	30560875-30561314	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	6	"skin 1: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP2-3	KAP2.3	ENSG00000212724	"Keratin associated protein 2-3"	P0C7H8	17	41059240-41060114	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ: 20.8;fHDF/TERT166: 12.4;HBF TERT88: 18.6;LHCN-M2: 23.4;U-2 OS: 9.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: AB_2683947"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-2)"		"unprognostic (3.79e-3)"		"unprognostic (3.25e-3)"		"unprognostic (2.78e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-4)"		"unprognostic (7.83e-6)"			"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.7	5.2	4.4	0.2	0.1	0.0	0.0	12.4	0.0	0.0	0.3	18.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.0	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP23-1	KAP23.1	ENSG00000186980	"Keratin associated protein 23-1"	A1A580	21	30348399-30348609	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	6	"skin 1: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP3-1	KAP3.1	ENSG00000212901	"Keratin associated protein 3-1"	Q9BYR8	17	41008521-41019324	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 64.5"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;CACO-2: 10.8;HaCaT: 2.9;Hep G2: 5.4;T-47d: 3.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																	"unprognostic (4.24e-1)"				"unprognostic (3.00e-2)"				"unprognostic (7.37e-2)"						0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	1.7	0.0	0.0	64.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.4	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-1	"KAP4.1, KAP4.10, KRTAP4-10"	ENSG00000198443	"Keratin associated protein 4-1"	Q9BYQ7	17	41184102-41185342	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 14.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.2;A549: 3.4;CAPAN-2: 2.5;HDLM-2: 9.6;SCLC-21H: 2.4;SK-BR-3: 2.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (1.21e-1)"	"unprognostic (3.57e-1)"			"unprognostic (1.64e-2)"		"unprognostic (2.78e-2)"		"unprognostic (1.04e-1)"	"unprognostic (2.49e-2)"			"unprognostic (2.42e-2)"			"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	1.3	0.1	0.1	0.2	0.1	14.8	1.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	2.4	0.0	0.0	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP6-1	"C21orf103, KAP6.1"	ENSG00000184724	"Keratin associated protein 6-1"	Q3LI64	21	30613431-30613930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE1D	LEP4	ENSG00000172155	"Late cornified envelope 1D"	Q5T752	1	152796751-152798181	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 46.0"	"Group enriched"	"Detected in some"	16	"HaCaT: 1.6;Karpas-707: 1.5"	"Cancer enriched"	"Detected in single"	8	"melanoma: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (7.67e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE4A	"LEP8, SPRL4A"	ENSG00000187170	"Late cornified envelope 4A"	Q5TA78	1	152708160-152709491	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 10.1"	"Group enriched"	"Detected in some"	11	"BJ: 1.2;BJ hTERT+: 1.0;THP-1: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (1.61e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCE5A	"LEP18, SPRL5A"	ENSG00000186207	"Late cornified envelope 5A"	Q5TCM9	1	152510844-152512177	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skin 1: 42.7"	"Cell line enhanced"	"Detected in some"		"A549: 1.6;hTERT-HME1: 1.1"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"NK-cells: 1.4"																					"unprognostic (2.51e-1)"				"unprognostic (7.27e-3)"			"unprognostic (9.27e-2)"				"unprognostic (1.89e-1)"					0.1	0.0	0.1	0.1	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	42.7	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LOR		ENSG00000203782	Loricrin	P23490	1	153259700-153262122	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 181.8"	"Cell line enriched"	"Detected in single"	88	"HDLM-2: 27.5"	"Cancer enriched"	"Detected in some"	11	"melanoma: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA076123, HPA077266"	Enhanced									"HPA076123: AB_2732302, HPA077266: AB_2732338"	"unprognostic (1.97e-2)"	"unprognostic (1.93e-2)"			"unprognostic (4.16e-2)"	"prognostic favourable (8.53e-4)"		"unprognostic (1.65e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.41e-1)"			"unprognostic (1.47e-1)"	"unprognostic (3.03e-1)"		"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.9	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	181.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	15.7	0.1	31.2	2.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NHLH1	"bHLHa35, HEN1, NSCL, NSCL1"	ENSG00000171786	"Nescient helix-loop-helix 1"	Q02575	1	160367067-160372848	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 10.8;skin 1: 4.2"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 24.2"	"Group enriched"	"Detected in some"	6	"glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"Region enriched"	"Detected in some"	12	"cerebellum: 37.9"	HPA017943			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA017943: AB_2732421"	"unprognostic (6.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-8)"	"unprognostic (4.09e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.36e-1)"	1.0	0.5	0.9	1.1	4.1	0.4	0.3	10.8	2.0	0.3	0.8	0.3	0.3	0.4	0.3	0.5	0.3	0.2	0.4	0.3	3.2	2.2	0.3	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.2	0.4	0.3	2.3	0.3	0.3	0.6	1.3	0.3	0.6	4.2	0.6	0.5	2.5	1.0	0.4	0.8	0.3	0.3	0.3	0.3	0.4	0.4	0.3	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.1	2.4	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	1.0	0.5	0.2	0.5	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	0.1	0.0	0.0	24.2	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.7	0.6	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	4.1	10.8	1.6	3.2	2.2	0.8	0.3	2.3	0.3
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38044611-38046794	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.5;skin 1: 31.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HDLM-2: 18.8;NTERA-2: 5.2;SCLC-21H: 3.7;SK-MEL-30: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7"	"HPA055980, HPA073824"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.8	2.1	4.0	0.9	10.5	0.7	0.8	1.2	6.8	0.6	0.7	1.1	0.0	0.6	0.7	0.8	3.4	0.7	0.7	0.7	7.7	0.9	0.7	0.6	0.6	1.7	3.9	2.9	0.7	0.8	0.6	0.0	0.6	1.4	3.6	0.6	1.6	0.6	0.7	1.3	31.0	0.7	2.5	0.6	0.7	0.7	1.5	2.6	0.0	0.7	1.3	1.7	1.5	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	10.8	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.0	0.7	3.7	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	10.5	1.2	6.8	7.7	0.9	3.9	2.9	1.4	2.6
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell line enhanced"	"Detected in some"		"A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.2	0.2	0.0	14.3	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	2.8	1.8	4.3	3.6	0.1	0.0	4.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2
AC021097.2		ENSG00000285480			7	151207837-151210378	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skin 1: 8.0"	"Cell line enhanced"	"Detected in some"		"U-266/70: 9.0;U-266/84: 5.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043013	Uncertain									"HPA043013: AB_2678269"																		1.0	0.2		0.2		0.5	1.2		0.0	0.2	0.0			0.0	1.5	0.0	0.6	0.0	1.1	0.0			0.0	0.0	1.0	1.6			0.8	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.9	8.0	0.0	0.5		1.2	0.0	0.1			0.0		0.2	0.0		0.5	0.1	0.8	0.4	0.0	0.5	0.0	0.0	0.8	0.0	0.6	2.0	2.3	0.0	0.6	0.3	0.3	0.0	1.9	1.2	1.3	0.6	0.4	0.0	0.0	0.5	0.0	1.0	3.5	0.4	0.4	0.0	1.0	0.5	1.8	2.5	0.4	0.0	3.3	0.8	0.3	3.0	0.0	0.5	0.2	0.2	0.2	1.2	0.8	0.0	1.1	0.0	0.0	0.4	0.0	0.4	0.0	1.4	0.0	2.3	0.9	0.0	0.4	1.2	0.2	9.0	5.9	0.3	0.7	2.8	0.2	0.0	0.3	0.0	0.2	0.4	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.5	0.8	0.0	0.0	0.0	0.3	0.0										
AC116565.1		ENSG00000273238			4	573880-576300	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	5	"brain: 12.7;skin 1: 7.0"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;NTERA-2: 4.7;SCLC-21H: 10.4;U-2 OS: 2.6;U-251 MG: 3.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																						"unprognostic (4.13e-3)"						"unprognostic (6.97e-3)"				"unprognostic (2.65e-2)"			0.0	1.8	1.3	0.0	3.1	0.0	0.1	0.0	12.7	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1		0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.6	4.7	0.0	0.0	1.2	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC136616.1		ENSG00000273554			Unmapped	1139577-1147868	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"skin 1: 3.0;testis: 8.5"	"Cell line enriched"	"Detected in some"	6	"AN3-CA: 18.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	1.1		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0		0.0	0.0	8.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	18.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978357	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 131.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"									"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.23e-5)"	6.9	1.8	2.9	2.0	5.6	1.0	8.5	3.0	13.7	17.2	23.0	2.9	5.7	1.7	16.3	2.9	25.8	7.1	3.2	1.5	2.4	3.1	1.1	10.8	2.3	1.0	2.7	11.6	1.8	1.2	1.2	0.7	1.8	23.3	5.7	5.1	10.1	6.0	14.6	1.6	131.1	4.8	19.9	4.8	1.1	7.1	3.2	0.8	0.0	1.2	14.4	3.0	10.0	19.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	19.7	0.0	1.3	28.1	32.0	0.0	2.4	5.0	0.8	0.4	0.0	8.8	0.0	3.3	18.5	14.2	0.0	28.1	0.4	0.0	0.1	0.0	13.0	0.1	2.6	0.0	0.9	4.1	70.8	2.8	30.2	12.3	0.0	0.0	14.2	1.6	0.0	0.0	0.0	9.7	0.0	1.3	0.0	19.2	0.0	0.1	0.1	10.4	0.0	0.4	1.3	0.0	31.7	6.8	4.2	7.7	2.1	0.0	0.0	0.0	20.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	5.6	3.0	13.7	2.4	3.1	2.7	11.6	23.3	0.8
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"esophagus: 41.6;skin 1: 60.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 72.1;HBEC3-KT: 105.1;hTCEpi: 59.4;RT4: 26.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"											"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.1	3.7	0.1	0.0	2.3	0.1	0.1	2.9	0.4	0.1	0.1	0.0	0.1	1.3	41.6	0.2	0.1	0.1	0.1		0.1	0.1	2.4	0.1	0.1	0.1	0.4	0.1	0.0	0.1	7.7	0.1	1.2	0.0	0.3	0.1	1.8	0.1	60.7	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	2.5	9.5	10.2	0.1	0.0	5.5	1.1	2.1	0.7	0.0	0.5	20.1	2.5	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	1.3	5.8	0.0	0.4	0.1	72.1	0.0	105.1	0.0	4.6	0.0	0.0	6.5	0.0	4.3	0.0	0.2	0.0	59.4	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	10.4	3.0	0.0	0.0	0.5	0.0	0.0	6.2	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5										
BPIFC	"BPIL2, dJ149A16.7"	ENSG00000184459	"BPI fold containing family C"	Q8NFQ6	22	32413847-32464484	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"skin 1: 39.5;tongue: 16.4"	"Group enriched"	"Detected in some"	5	"HDLM-2: 3.3;hTCEpi: 1.6;SCLC-21H: 4.6;U-87 MG: 2.3"	"Group enriched"	"Detected in some"	11	"head and neck cancer: 1.6;melanoma: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	56	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	56	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"							"unprognostic (2.74e-1)"			"unprognostic (3.48e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.80e-1)"			0.0	0.0	0.4	0.0	0.5	0.0	2.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	39.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	16.4	0.8	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081058-27082514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 5.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	23	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 4.1"									HPA058728	Uncertain									"HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.0	0.1	0.4	0.1	3.8	0.2	0.8	0.3	0.4	0.1			0.2	0.1	0.0	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.3	0.0		0.1	0.3	0.0	0.1	0.0		0.2	0.0		0.3	0.0	0.5	2.5	0.4	0.0	0.0	0.5	0.1	7.4			0.1		0.0	0.2	0.2	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.5	0.2	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	1.2	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.0	0.6	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0										
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
CARMIL3	"BC008134, C14orf121, crml-1, LRRC16B"	ENSG00000186648	"Capping protein regulator and myosin 1 linker 3"	Q8ND23	14	24052000-24069728	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.6;pituitary gland: 7.8;skin 1: 9.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.2;HMC-1: 5.8;Karpas-707: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030596	Uncertain									"HPA030596: AB_10603012"	"unprognostic (2.67e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (6.13e-2)"	"unprognostic (8.92e-4)"	"unprognostic (4.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.16e-1)"	0.6	1.6	6.5	1.4	5.2	1.0	0.8	30.6	7.9	0.6	0.9	3.3	0.0	2.3	0.6	0.5	1.0	0.6	1.6	0.4	7.4	5.2	1.0	0.8	0.9	1.4	2.8	2.4	0.6	1.3	0.5	7.8	0.5	7.2	0.8	1.0	1.7	1.6	0.7	0.5	9.4	1.6	0.7	2.9	1.0	1.2	3.1	2.8	0.0	1.0	0.0	2.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	1.2	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	8.5	4.2	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	5.2	30.6	7.7	7.4	5.2	2.8	2.4	7.2	2.8
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"lung: 9.6;skin 1: 11.1"	"Cell line enriched"	"Detected in single"	63	"HDLM-2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"					"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.2	0.0	0.2	0.2	0.5	0.1	1.0	0.2	0.2	0.2	0.4	0.2	0.2	1.5	0.2	0.2	2.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	9.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	11.1	1.8	0.2	0.2	0.2	1.5	1.1	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
CSAG3	CSAG3A	ENSG00000268916	"CSAG family member 3"	Q9Y5P2	X	152753921-152760222	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.4;skin 1: 2.4;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.1;HMC-1: 11.9;Karpas-707: 9.5;SH-SY5Y: 15.4;SK-BR-3: 14.2;U-2 OS: 11.2;U-266/70: 36.8;U-266/84: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.56e-1)"			"unprognostic (9.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.12e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-2)"		"unprognostic (7.06e-2)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"		"unprognostic (2.91e-2)"	0.2	0.0		0.0		0.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	3.4			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	2.4	0.0	0.0		3.3	0.0	5.5			0.0		0.2	0.0		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	5.6	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.2	15.4	0.0	14.2	0.5	0.0	0.6	0.0	0.0	11.2	0.0	0.0	36.8	18.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Group enriched"	"Detected in some"	6	"A-431: 26.2;CAPAN-2: 73.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	110000000	110000000	"Plasma membrane"	"Plasma membrane"	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.2	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.1	73.1	0.0	0.4	0.9	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 78.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 1.0;HaCaT: 1.0;HEL: 1.5;hTCEpi: 1.0;MCF7: 1.0"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Region enriched"	"Detected in single"	13	"cerebral cortex: 7.0"	"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075379	Enhanced					18000000	18000000			"HPA075379: AB_2732290"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.2	0.1	0.1	0.3	0.5	0.0	3.5	0.1	7.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.8	0.1	0.0	9.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.1	0.0	1.3	1.2	0.0	0.2	78.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.1	0.1	16.6	1.5	0.1	0.2	0.0	0.0	0.7	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	0.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	5.7	5.2	0.7	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.1	7.0	0.1	0.1	0.1	0.1	0.0	0.0
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		2700000	2700000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB037328: , HPA049265: AB_2680695, HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505431-108593738	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.9;placenta: 45.1;skin 1: 23.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.2;hTERT-HME1: 10.4;RT4: 18.2;SK-BR-3: 8.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	14	"cerebellum: 74.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 23.5;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	10	"cerebellum: 64.1"												"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favourable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favourable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.7	0.6	0.8	1.2	2.7	0.1	2.6	74.9	1.1	3.3	3.3	1.4	0.0	0.5	0.9	2.5	9.8	1.5	0.3	0.7	1.1	0.8	3.4	6.7	4.7	0.0	1.6	1.0	0.8	1.4	9.3	2.2	45.1	5.4	1.6	3.8	0.7	6.2	0.1	0.6	23.1	1.1	0.6	2.6	0.6	2.8	1.7	2.4	0.6	1.9	7.1	5.2	1.7	1.9	0.7	0.9	3.0	0.6	3.2	2.2	0.5	3.4	0.4	0.2	0.1	0.0	0.0	2.9	0.2	0.1	0.0	0.6	0.9	5.4	0.0	0.2	0.2	7.2	5.1	1.9	0.2	0.1	1.5	1.5	0.7	0.0	0.5	0.7	0.1	0.1	3.0	0.0	10.4	0.0	2.6	0.0	2.9	0.6	0.9	0.0	0.2	2.2	0.0	0.1	0.0	0.6	18.2	1.3	0.8	0.9	8.9	0.2	5.9	0.1	0.1	0.0	2.2	0.0	1.0	0.1	0.0	0.0	0.1	0.3	0.0	2.0	0.6	0.5	0.7	0.3	0.3	0.7	1.1	0.4	0.5	0.7	2.1	2.2	3.0	3.2	0.4	0.9	0.3	0.5	0.8	2.7	74.9	1.1	1.1	0.8	1.6	1.0	5.4	2.4
FABP9	"PERF, PERF15, T-FABP"	ENSG00000205186	"Fatty acid binding protein 9"	Q0Z7S8	8	81458341-81461579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 28.1"	"Cell line enriched"	"Detected in single"	26	"PC-3: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA073619	Enhanced									"HPA073619: AB_2732229"															"unprognostic (2.99e-1)"			2.3	0.0	0.1	0.1	0.1	0.0	5.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.2	28.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 107.4"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.7"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			HPA028699	Approved					19000000	19000000			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	7.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.3	107.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.1	19.6	0.4	0.1	0.2	0.3	0.3	1.2	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.9	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024351-190027257	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.0;brain: 2.8;skin 1: 3.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HMC-1: 2.1;Karpas-707: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.0"									"HPA039264, HPA047769"	Uncertain									"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.8	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4			0.2		0.0	0.1	0.0	0.2	0.1	2.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.3	0.1	0.0	0.0	1.1	0.4	0.8	0.4	0.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.2	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.0										
GOLGA7B	"bA451M19.3, bA459F3.4, C10orf132, C10orf133"	ENSG00000155265	"Golgin A7 family member B"	Q2TAP0	10	97850239-97871580	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.6;epididymis: 35.9;skin 1: 21.4"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;HDLM-2: 5.4;SK-MEL-30: 21.4;U-87 MG: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain									"HPA046878: AB_2679854"	"unprognostic (7.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.90e-3)"	2.5	4.5	16.4	2.1	12.0	1.3	2.5	39.6	24.1	1.3	1.5	4.4	1.3	3.2	1.3	35.9	2.3	1.1	1.5	3.4	19.8	12.8	1.0	1.1	1.7	2.8	11.1	20.4	1.0	6.6	1.0	6.7	1.3	10.7	1.3	1.8	0.6	1.4	1.7	4.9	21.4	3.8	1.2	5.4	1.5	2.3	1.7	6.2	0.0	1.4	0.5	2.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	5.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	1.9	0.0	0.4	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	1.8	0.1	0.1	0.3	0.8	1.5	0.0	1.0	21.4	2.1	0.1	0.1	0.1	0.0	0.0	0.2	1.7	0.7	0.0	3.9	2.2	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	2.3	1.9	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	1.2	0.3	16.4	12.0	39.6	24.1	19.8	12.8	11.1	20.4	10.7	6.2
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 23.7;AN3-CA: 9.5;BEWO: 8.4;SH-SY5Y: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"					"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.94e-4)"	0.5	0.5	3.2	3.5	1.9	1.9	0.6	2.2	4.3	0.8	0.9	2.1	0.0	0.5	2.6	0.3	0.2	0.4	0.4	0.3	2.9	1.6	0.2	0.1	0.5	2.2	2.0	0.9	0.8	0.3	0.5	0.7	0.3	1.5	0.5	0.8	0.5	1.7	0.4	0.8	9.4	0.7	0.8	3.3	1.4	0.3	16.7	2.0	34.3	0.3	0.7	2.0	0.6	1.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.1	23.7	9.5	0.0	0.0	8.4	0.7	0.0	0.1	0.2	0.0	0.3	2.0	0.5	0.2	0.8	0.8	0.3	0.0	0.0	0.7	0.2	0.3	0.0	0.4	0.5	3.6	0.8	0.4	0.5	0.0	1.1	0.9	0.0	0.6	0.3	5.4	0.6	4.1	1.3	6.2	1.6	0.0	0.1	0.4	6.3	26.2	0.5	0.6	0.8	0.4	0.4	0.9	0.2	3.8	0.5	0.1	0.8	0.2	2.8	0.2	1.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.3	3.2	1.9	2.2	1.7	2.9	1.6	2.0	0.9	1.5	2.0
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 606.8"	"Group enriched"	"Detected in some"	37	"HaCaT: 43.9;hTCEpi: 18.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 313.8;melanoma: 478.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 5.8;memory CD8 T-cell: 2.1;naive CD4 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.8"									"CAB002153, HPA017917, HPA062908"	Enhanced					65000000000	65000000000			"CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901"	"unprognostic (8.05e-2)"	"unprognostic (8.49e-3)"	"unprognostic (5.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.23e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.09e-2)"	0.3	0.0	0.1	0.1	0.1	0.4	24.2	0.1	0.3	63.4	0.1	0.1	0.1	0.0	38.6	0.1	2.5	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.1	16.2	0.1	2.0	606.8	0.1	0.1	0.2	0.1	0.0	0.1	0.1	24.1	0.1	114.6	0.4	0.1	46.2	0.0	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	2.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		580000000	580000000	"Intermediate filaments"	"Intermediate filaments"	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755332	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 44.5"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 5.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 9.7"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 8.3;hippocampal formation: 6.1"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			1.6	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.0	0.0	0.0	1.9	0.0
KRT33B	"Ha-3II, KRTHA3B"	ENSG00000131738	"Keratin 33B"	Q14525	17	41363494-41369800	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 40.6"	"Cell line enhanced"	"Detected in some"		"BJ: 8.8;BJ hTERT+ SV40 Large T+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;hTEC/SVTERT24-B: 3.4;U-2197: 2.3"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055194	Supported					460000000	460000000			"HPA055194: AB_2682733"		"unprognostic (3.34e-2)"				"unprognostic (5.19e-2)"		"unprognostic (3.04e-1)"					"unprognostic (1.55e-2)"				"unprognostic (6.28e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	2.7	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.7	1.9	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 11.4;skin 1: 17.7"	"Cell line enhanced"	"Detected in some"		"HEL: 1.0;HMC-1: 2.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 11.4;naive CD8 T-cell: 3.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 11.4"	"Region enhanced"	"Detected in some"		"hippocampal formation: 5.3"	"Not detected"	"Not detected"			HPA044031	Enhanced									"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.5	0.0	0.0	0.8	0.0	1.5	0.4	0.0	0.0	0.0	0.0			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	17.7	1.0	0.0	0.0	0.7	0.0	0.0			0.0		0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	11.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.0	0.0	11.4	3.9	0.0	0.7	0.0	0.0	0.0	1.5										
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Group enriched"	"Detected in some"	6	"PC-3: 21.7;U-2 OS: 29.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.1"	"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		2200000000	2200000000	Cytosol	Cytosol	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821410-52834295	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 11.3;skin 1: 34.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 97.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5"	HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		950000000	950000000	"Nucleoplasm, Nuclear membrane, Cytosol"	"Nucleoplasm, Nuclear membrane, Cytosol"	"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	4.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	34.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	11.3	0.1	0.1	0.2	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	97.6	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.5;skin 1: 60.4;testis: 23.0"	"Cell line enhanced"	"Detected in some"		"A-431: 13.6;A549: 14.4;MCF7: 28.4;RPMI-8226: 17.9;U-251 MG: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 31.5"									"HPA039798, HPA049778"	Supported		Approved	Cytosol		240000000	240000000	Cytosol	Cytosol	"HPA039798: , HPA049778: AB_2680877"	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	0.8	0.3	0.2	0.1	0.2	3.5	0.9	0.5	1.1	0.4	0.3	0.1	1.0	0.6	0.6	2.4	0.3	1.1	1.0	0.1	0.2	0.3	3.8	0.2	1.0	0.1	0.3	0.1	0.6	7.9	0.0	0.2	0.6	0.3	0.5	0.0	0.3	6.3	0.4	1.5	60.4	0.2	0.1	0.7	0.1	0.2	23.0	0.1	0.1	7.6	0.1	0.3	1.2	0.2	0.0	0.0	31.5	0.0	3.8	0.0	0.2	13.6	14.4	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.2	0.0	0.1	0.7	0.0	0.6	0.0	0.8	0.0	2.5	0.0	6.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	0.0	28.4	0.0	1.6	0.0	3.4	0.0	0.0	17.9	0.2	1.8	1.7	0.0	2.6	1.1	1.1	0.8	0.0	0.4	0.0	0.7	0.0	8.0	0.0	0.0	0.0	0.0	2.9	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.5	0.2	0.3	0.3	0.1	0.3	0.1
KRTAP1-5	KAP1.5	ENSG00000221852	"Keratin associated protein 1-5"	Q9BYS1	17	41026026-41027202	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 37.4"	"Group enriched"	"Detected in some"	5	"BJ: 18.5;BJ hTERT+: 8.0;fHDF/TERT166: 23.9;LHCN-M2: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.76e-1)"		"unprognostic (2.96e-2)"		"unprognostic (2.24e-2)"				"unprognostic (2.55e-1)"		"unprognostic (1.90e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.80e-2)"			"unprognostic (5.60e-2)"	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	18.5	8.0	1.7	0.7	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP12-4	KRTAP12.4	ENSG00000212933	"Keratin associated protein 12-4"	P60329	21	44654213-44654659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"skin 1: 3.2;testis: 1.3"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP16-1	KAP16.1	ENSG00000212657	"Keratin associated protein 16-1"	A8MUX0	17	41307700-41309253	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skin 1: 16.9"	"Group enriched"	"Detected in some"	6	"HDLM-2: 1.1;SCLC-21H: 1.6;U-87 MG: 1.7;U-937: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"cerebral cortex: 1.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA070954	Enhanced									"HPA070954: AB_2686327"													"unprognostic (3.65e-5)"	"unprognostic (4.61e-2)"				0.6	0.0	0.0	2.5	0.0	3.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	16.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	1.9	0.3	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.0	0.9	0.3	0.2	1.9	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP5-5	"KRTAP5-11, KRTAP5.5"	ENSG00000185940	"Keratin associated protein 5-5"	Q701N2	11	1629775-1630707	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"skin 1: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (5.45e-2)"								"unprognostic (1.00e-2)"			"unprognostic (7.66e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5			0.7	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.1		0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	0.2	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LIPN	"bA186O14.3, LIPL4"	ENSG00000204020	"Lipase family member N"	Q5VXI9	10	88761406-88778242	"Disease related genes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 12.5;skin 1: 25.5"	"Group enriched"	"Detected in some"	7	"Daudi: 3.2;HL-60: 9.4"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"					"Group enriched"	"Detected in many"	5	"classical monocyte: 4.8;eosinophil: 12.5;intermediate monocyte: 10.7;neutrophil: 7.7;non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.13e-1)"		"unprognostic (2.99e-1)"	"unprognostic (1.08e-1)"		"unprognostic (3.27e-1)"	"unprognostic (1.07e-1)"		"unprognostic (2.03e-2)"		"unprognostic (9.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.65e-1)"	1.5	0.1	0.0	2.8	0.0	3.7	1.3	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.1	0.0	0.0	25.5	0.0	0.3	0.1	1.2	0.0	0.0			0.0		0.0	0.4	1.1	0.0	1.8	12.5	11.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	1.1	4.8	12.5	0.0	10.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	11.3	0.0	0.0	1.3										
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220495-84225589	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 25.4;skin 1: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced									"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.1	0.2	0.2	0.1	3.4	0.0	0.1	0.1	2.2	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	25.4	0.1	0.1	0.1	8.5	0.7	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.5	0.3	0.3	0.3	0.1	0.1	0.1
MT4	MTIV	ENSG00000102891	"Metallothionein 4"	P47944	16	56565049-56568957	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"skin 1: 42.3"	"Group enriched"	"Detected in some"	19	"HaCaT: 2.4;K-562: 1.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 6.7;endometrial cancer: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"thalamus: 0.4"	"Low region specificity"	"Detected in many"																												"unprognostic (8.81e-2)"			0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	1.5	0.1	0.1	0.1	0.0	0.1	0.1	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	42.3	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.6	0.1	8.5	0.1	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NHLH2	"bHLHa34, HEN2, NSCL2"	ENSG00000177551	"Nescient helix-loop-helix 2"	Q02577	1	115836377-115843917	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 16.6;skin 1: 10.5"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 35.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055238	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA055238: AB_2682752"	"unprognostic (2.20e-2)"	"unprognostic (2.28e-1)"		"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.11e-2)"	"unprognostic (5.26e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.25e-1)"	0.2	0.2	3.4	0.2	0.9	0.2	0.6	16.6	2.4	0.3	0.3	0.4	0.5	0.3	0.2	1.4	2.5	0.2	0.3	0.2	7.1	9.1	0.2	0.2	0.9	0.2	4.1	1.5	0.2	0.2	0.2	0.1	0.5	16.3	0.7	0.4	1.0	0.4	0.7	0.6	10.5	0.3	0.2	3.1	0.2	1.0	1.6	0.6	0.0	0.2	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	16.6	2.4	7.1	9.1	4.1	1.5	16.3	0.6
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7959424-7965426	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 13.2;skin 1: 10.5"	"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ: 5.3;HBF TERT88: 7.6;LHCN-M2: 3.4"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 2.6"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	0.2	0.0	5.3	2.6	1.2	2.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
OR10G3		ENSG00000169208	"Olfactory receptor family 10 subfamily G member 3"	Q8NGC4	14	21568520-21580076	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 3.4;bone marrow: 2.0;pituitary gland: 4.3;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA019766	Uncertain									"HPA019766: AB_1854780"																		0.3	0.4	0.0	0.2	0.0	2.0	0.2	0.0	0.2	0.1	0.1			0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0		0.1	0.0	0.1	4.3	0.0		0.0	0.1		0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.2	0.6			0.1		0.0	0.0	0.0	1.0	0.9	3.4	1.0	0.7	0.7	0.0	0.1	0.0	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.1	0.6	0.8	0.1	0.0	0.4	0.7	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.0	0.4	0.1	0.4	0.4	0.0	0.6	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.0	1.2	0.0	0.0	0.9	0.6	0.9	0.1	0.2	0.2	0.2	0.6	0.5	0.3	0.9	1.0	0.5	0.6	0.2	0.3	0.4	0.5	0.4	0.2	1.0	0.7	0.5	3.4	0.7	0.3	0.9	0.3	0.0										
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.3;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"					"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0										
RNF227	LINC02581	ENSG00000179859	"Ring finger protein 227"	A6NIN4	17	7913324-7916276	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"		"Evidence at transcript level"		"Group enriched"	"Detected in all"	5	"blood: 13.5;skin 1: 40.6"	"Cell line enhanced"	"Detected in many"		"SiHa: 15.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.85e-3)"	"prognostic favourable (8.89e-5)"	"unprognostic (1.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-5)"	"unprognostic (9.48e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.80e-2)"	2.1	2.8	4.4	2.9	5.8	1.3	4.2	4.1	5.8	2.2	1.5	2.8	4.2	2.9	3.5	4.0	2.4	4.2	2.4	1.5	3.7		1.6	1.0	2.4	1.9	2.2	4.7	4.4	5.6	2.0	2.3	1.9	3.1	2.5	1.8	3.7	2.3	1.9	1.1	40.6	2.0	2.3	3.1	2.3	1.9	4.1	3.3	1.1	1.7	1.8	2.2	3.6	1.2	2.4	2.3	13.5	1.5	3.0	4.6	1.6	7.5	1.5	2.9	2.8	2.3	2.0	2.5	7.2	3.0	2.0	2.2	4.4	2.2	1.4	4.3	2.8	5.6	1.6	3.6	3.7	0.9	1.9	1.9	5.2	0.3	4.4	4.1	3.8	2.6	10.5	3.3	3.5	0.5	2.2	1.4	4.5	0.8	5.4	5.2	2.0	1.1	2.6	7.1	1.6	2.9	1.0	1.2	4.1	15.4	0.6	3.0	1.9	3.0	0.5	0.1	4.1	3.5	1.4	2.0	0.7	2.0	4.4	4.5	5.5	13.5	1.5	0.5	2.1	1.1	2.8	2.4	2.4	2.7	2.3	1.8	4.6	3.1	1.0	3.0	0.8	1.6	1.7	1.6										
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0"	"Group enriched"	"Detected in some"	7	"HaCaT: 3.6;hTCEpi: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"					"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	71.0	33.2	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR2B		ENSG00000196805	"Small proline rich protein 2B"	P35325	1	153070224-153070840	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SiHa: 1.2;U-2197: 1.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 77.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.52e-1)"				"unprognostic (1.44e-2)"			"unprognostic (3.62e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		3.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	3.2			0.0		11.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530016-38605930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;salivary gland: 11.7;skin 1: 6.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.1;SCLC-21H: 16.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favourable (1.76e-4)"	1.3	2.6	7.9	0.5	9.5	0.6	1.7	16.3	21.2	1.3	0.8	18.4	0.0	1.2	1.0	1.3	0.5	2.1	0.4	0.6	7.0		0.5	1.8	0.8	0.6	9.0	10.5	0.4	1.6	2.2	0.0	0.6	10.2	0.8	0.7	0.5	11.7	1.7	0.9	6.1	0.9	0.5	5.5	0.6	0.9	0.8	10.7	0.0	0.8	0.0	0.4	0.9	0.0	0.3	0.3	1.3	0.2	0.2	0.2	0.0	0.5	0.5	1.2	3.4	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.6	1.0	1.1	0.0	1.2	1.5	0.2	0.1	1.2	1.4	0.0	0.5	1.4	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.1	5.1	0.0	3.1	0.0	0.0	1.6	0.1	0.1	0.0	0.1	0.5	2.5	16.1	2.3	0.0	1.4	0.9	2.5	0.5	0.0	0.0	1.6	0.0	0.0	1.1	0.2	0.1	0.1	0.7	0.7	1.3	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.2	0.6	0.2	0.0	0.3	0.0	0.0										
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787699	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 2.5;lymphoid tissue: 7.2;skin 1: 3.7;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;NTERA-2: 1.4;RT4: 6.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.3	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.9	0.1	0.0	0.1	0.8	2.5	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.1	0.0	5.5	0.1	7.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.5	0.1	0.1	0.4	0.1
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"											HPA042574	Approved									"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	0.0	0.1		0.2		2.2	0.4		0.4	0.0	0.0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0.0	0.4	0.2	0.2			0.5	0.0	0.0		0.0		0.1	0.1		0.5	0.0	4.4	2.1	0.4	0.1		0.6	0.0	0.5			0.2		0.0	0.0		1.5	1.2	5.5	1.0	1.3	1.0	0.5	0.7	0.5	3.1	3.2	0.7	0.8	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	1.3	0.6	0.5	0.7	2.2	0.3	1.1	1.9	0.5	0.7	0.9	1.4	0.5	1.0	0.3	0.3	0.0	1.1	2.3	0.2	1.9	0.4	1.4	1.5	1.2	1.1	0.7	1.0	0.0	1.7	2.7	1.7	1.0	2.1	0.8	0.9	2.7	0.5	2.0	1.1	1.2	0.8	2.2	0.9	1.3	0.9	2.1	0.9	3.6	1.0	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1.0	1.0	5.5	1.3	0.7	1.2	0.5	0.5										
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA076515	Enhanced									"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	1.9	0.9	1.0	1.4	0.0	0.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	1.0	0.9	0.0	1.0	0.0	2.1	2.0	0.7	0.6	0.4	0.2	0.8	1.3	1.5	1.2	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6										
AADACL3		ENSG00000188984	"Arylacetamide deacetylase like 3"	Q5VUY0	1	12716115-12728759	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"placenta: 13.4;skin 1: 4.7"	"Cell line enriched"	"Detected in single"	9	"BEWO: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-1)"					"unprognostic (2.54e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.4;brain: 40.5;skin 1: 19.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.9;SK-MEL-30: 3.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles				Vesicles	Vesicles	"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	1.1	11.4	16.9	1.5	26.9	4.5	3.8	6.6	27.0	1.1	1.2	10.5	0.0	1.6	1.2	2.3	1.3	5.9	1.3	1.1	16.4	8.5	1.0	1.0	1.7	1.6	21.1	13.9	1.2	1.0	0.9	0.3	1.1	32.9	2.0	1.1	0.0	1.5	1.4	1.2	19.9	1.5	1.2	40.5	1.3	1.2	5.4	19.0	0.0	1.2	0.0	1.1	1.5	0.2	0.4	3.9	1.2	0.2	0.6	0.2	1.5	0.7	0.1	1.6	2.3	0.0	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.6	0.7	0.2	0.1	0.9	0.1	0.3	0.2	0.4	1.3	0.7	1.4	0.6	0.0	0.7	1.6	0.6	0.0	0.4	0.2	0.2	0.5	1.1	0.1	0.4	0.6	1.4	7.9	0.3	0.3	1.0	0.5	0.0	0.9	0.5	0.9	0.4	1.0	3.7	0.5	0.5	0.9	0.6	0.6	0.5	0.3	0.9	0.3	0.8	0.3	0.5	1.5	0.4	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.4	0.2	0.1	1.2	0.6	0.2	3.9	0.0	1.5	16.9	26.9	6.6	17.9	16.4	8.5	21.1	13.9	32.9	19.0
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087703	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 38.9;tongue: 55.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HEK 293: 3.9;hTCEpi: 4.4;REH: 2.8;U-266/84: 2.8"	"Group enriched"	"Detected in many"	9	"cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024002	Supported		Approved	Cytosol				Cytosol	Cytosol	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	1.1	0.1	0.3	7.7	0.1	0.1	0.1	0.1	0.5	0.1	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.6	38.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	55.3	11.4	0.1	6.2	0.9	0.2	7.0	0.0	0.2	1.1	0.2	1.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.7	0.3	0.2	0.0	0.0	3.9	0.0	1.1	0.3	0.0	0.6	0.0	0.0	4.4	0.2	0.7	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.7	0.4	2.8	0.0	1.1	0.5	0.0	1.2	1.7	0.3	0.2	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.0	0.7	0.9	0.3	0.5	0.0	0.3	1.1	1.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 25.2;retina: 28.7;skin 1: 11.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.5"	HPA046229	Approved									"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1.0	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0.0	0.4	1.6	1.0	0.0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	1.8	0.0	0.5	0.6	3.3	1.5	2.4	3.2	0.9	0.4	1.1	5.1	0.5	0.3	0.4	0.3	0.3	0.6	1.5	0.5	3.0	0.8	1.9	3.0	2.6	0.4	1.3	0.5	1.0	1.2	1.9	1.9	1.5	0.7	0.6	1.8	0.9	2.6	0.9	1.0	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.8	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1.0	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Cell line enriched"	"Detected in some"	8	"RT4: 26.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	26.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194635-84219621	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;HEK 293: 5.3;HEL: 6.2;K-562: 4.4;NTERA-2: 4.5;RPTEC TERT1: 16.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 31.2"	"Cell type enriched"	"Detected in single"	11	"NK-cell: 10.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 10.5"	"Region enriched"	"Detected in some"	21	"olfactory region: 408.8"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"					"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.3	1.2	1.9	0.7	31.2	0.5	2.3	0.9	7.7	2.8	12.3	2.2	0.0	0.3	0.6	2.2	4.8	0.6	0.5	0.9	3.4	2.1	0.5	0.5	0.4	0.7	1.5	3.1	0.8	0.4	0.3	1.5	0.4	9.3	0.9	22.6	42.5	1.0	2.2	0.7	86.8	5.3	0.9	1.2	3.0	0.4	0.4	3.0	2.4	0.4	3.3	0.9	0.4	1.5	0.0	0.0	0.0	0.0	10.5	0.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	10.3	2.0	0.0	0.0	5.3	6.2	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	4.4	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.0	0.0	1.3	16.8	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	1.9	31.2	0.9	7.7	3.4	2.1	1.5	3.1	9.3	3.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.2	14.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 61.0;skin 1: 35.1"	"Group enriched"	"Detected in some"	9	"BEWO: 16.9;EFO-21: 10.1;HaCaT: 24.4;HBEC3-KT: 11.1;hTCEpi: 33.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in some"	34	"cerebellum: 61.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"cerebellum: 35.9"	"Region enriched"	"Detected in single"	67	"cerebellum: 442.8"	CAB033680	Enhanced									"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.0	0.4	0.4	1.7	0.0	2.2	61.0	0.4	2.4	0.4	0.4	0.4	0.0	0.4	1.0	11.8	0.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.4	0.0	0.4	0.4	0.9	0.9	0.0	0.4	3.8	3.2	0.4	35.1	0.4	0.4	0.4	0.4	0.0	2.7	0.4	0.4	0.4	0.4	1.9	1.0	4.9	0.2	0.6	0.1	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	24.4	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	1.7	61.0	0.4	0.4	0.0	0.4	0.4	0.9	0.4
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	27.9	8.0	0.2	1.1	1.7	1.0	0.1	12.3	0.9	2.2	0.7	2.8	0.3	6.9	4.7	0.0	0.1	0.1	0.2	0.7	10.9	13.4	0.0	7.7	15.8	12.4	1.7	13.3	13.5	0.1	19.2	0.1	0.5	0.6	1.3	0.1	2.8	0.4	2.7	6.9	0.5	0.1	2.0	0.5	0.2	8.5	3.8	15.1	0.4	17.2	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1;HaCaT: 14.9;Hep G2: 32.1;NTERA-2: 15.6;RT4: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	670000	670000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.0	2.6	0.0	0.1	9.2	1.0	0.1	0.4	0.2	19.1	0.4	0.0	7.6	0.3	14.9	2.6	0.1	0.1	0.1	9.6	5.9	1.5	32.1	0.0	0.0	0.1	0.0	5.0	0.1	0.0	0.0	6.4	0.0	0.0	9.5	0.3	0.2	15.6	0.0	0.5	0.5	0.1	1.3	19.1	2.6	0.7	0.8	1.6	0.0	8.9	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6
GAN	"GAN1, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314952-81390884	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 46.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules				Microtubules	Microtubules	"CAB011825: AB_732515, HPA049473: AB_2680782"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	3.1	2.8	7.5	2.9	7.6	2.8	6.2	8.0	7.8	3.9	4.0	10.9	3.2	3.0	3.3	3.7	8.4	2.6	2.8	2.9	10.8	5.0	2.5	2.5	3.0	2.8	5.5	7.5	3.0	3.5	4.1	2.9	3.1	7.5	3.9	3.9	2.7	4.1	3.0	4.0	46.9	3.0	4.3	8.1	3.0	4.2	3.2	7.7	2.0	3.1	6.2	4.0	3.3	6.6	2.2	3.3	2.4	1.6	3.2	3.7	0.6	2.1	3.1	2.0	2.6	2.6	1.3	13.2	1.8	1.2	1.4	0.7	6.3	2.4	3.3	2.1	2.1	3.9	4.1	1.7	3.0	0.9	1.8	2.9	2.5	4.9	2.5	2.7	3.2	1.5	4.8	1.9	4.6	2.4	3.7	1.5	1.5	11.1	2.4	3.5	5.1	1.1	4.6	2.0	1.3	2.1	6.9	2.3	1.3	6.3	5.3	1.7	3.8	2.4	3.3	3.0	3.9	1.2	2.4	2.8	3.6	8.1	1.6	2.9	2.4	2.4	1.6	0.8	3.1	1.4	2.8	1.7	3.1	2.5	0.9	2.2	2.9	3.7	1.3	3.2	1.3	3.3	2.2	0.6	7.5	7.6	8.0	7.8	10.8	5.0	5.5	7.5	7.5	7.7
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022091-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7"	"Cell line enriched"	"Detected in some"	21	"U-87 MG: 40.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035664	Uncertain				"Secreted to blood"					"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	7.9	6.8	3.3	7.2	4.8	2.9	7.8	4.8	3.4	2.6	2.6	2.7	9.9	8.3	2.7	2.7	16.3	3.3	4.3	1.1	8.4	2.9	5.0	16.7	3.5	6.2	1.3	14.8	3.7	15.5	2.6	3.4	1.7	5.4	8.7	1.9	13.6	6.0	4.2	0.5	10.1	15.1	0.2	4.9	10.8	12.5	10.4	9.5	3.4	10.6	3.8	27.9	2.7	4.6	5.1	15.4	5.4	4.8	4.3	2.0	2.3	9.9	7.0	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.6;HaCaT: 25.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	960000	960000	"Plasma membrane"	"Plasma membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.6	0.0	1.0	0.0	25.9	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0
KRT31	"Ha-1, KRTHA1"	ENSG00000094796	"Keratin 31"	Q15323	17	41393724-41397592	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.2;skin 1: 72.1"	"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 1.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	22	"cerebellum: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049550, HPA055194"	Enhanced					560000000	560000000			"HPA049550: AB_2680813, HPA055194: AB_2682733"	"unprognostic (3.92e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.71e-2)"		"unprognostic (4.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.84e-1)"			"unprognostic (4.07e-1)"			"unprognostic (4.26e-2)"	"unprognostic (1.65e-1)"	1.5	0.0	0.0	0.0	0.2	0.0	1.0	21.2	1.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.5	0.0	5.5	72.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.2	0.9	0.0	0.0	0.0	0.7	0.8	0.0
KRTAP1-4	KAP1.4	ENSG00000204887	"Keratin associated protein 1-4"	P0C5Y4	17	41029697-41030104	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skin 1: 4.8"	"Group enriched"	"Detected in some"	15	"HDLM-2: 1.7;HeLa: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP4-11	"KAP4.11, KAP4.14, KRTAP4-14"	ENSG00000212721	"Keratin associated protein 4-11"	Q9BYQ6	17	41117181-41118360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP5-11	"KRTAP5-6, KRTAP5.11"	ENSG00000204571	"Keratin associated protein 5-11"	Q6L8G4	11	71579714-71603353	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skin 1: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (2.08e-1)"			0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.6	0.4	0.0	0.0			1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.2	0.1		0.0	0.0	0.7	0.0	0.2		0.0	0.0		0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-2	"KRTAP5-8, KRTAP5.2"	ENSG00000205867	"Keratin associated protein 5-2"	Q701N4	11	1597177-1598294	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 6.3;pancreas: 5.2;skin 1: 10.2"	"Group enriched"	"Detected in some"	11	"HDLM-2: 1.6;MCF7: 5.8;SCLC-21H: 6.7;SH-SY5Y: 2.9;SK-BR-3: 1.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;memory CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.0"																																	"unprognostic (6.31e-2)"				0.0	0.8	0.8	0.2	1.3	0.0	0.0	5.4	6.3	0.0	0.6			1.2	0.2	0.9	0.0	0.0	1.5	0.3	0.7	1.4	0.0	0.0	0.3	0.1	0.4		0.0	5.2	0.0	0.4	0.0		0.0	0.0		1.6	0.0	0.1	10.2	1.5	0.0	0.1	0.0	0.8	0.0			0.0		0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.9	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3										
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 45.1;skin 1: 97.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 12.2"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"	3700000	3700000			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	8.3	0.0			0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		3.2	0.2	7.6	97.9	0.0	0.0	0.0	0.0	0.0	0.1			0.0		1.6	0.1	17.8	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.0										
LGALS7B	GAL7	ENSG00000178934	"Galectin 7B"	P47929	19	38789211-38791749	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 260.5"	"Cell line enriched"	"Detected in single"	18	"HaCaT: 9.5"	"Group enriched"	"Detected in many"	7	"cervical cancer: 142.7;head and neck cancer: 185.0;melanoma: 42.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.3"	"Low lineage specificity"	"Detected in single"											"HPA001549, CAB025100"	Supported				"Intracellular and membrane"	3700000	3700000			"CAB025100: , HPA001549: AB_1078938"	"unprognostic (4.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.29e-3)"	0.3	0.1	0.3	0.3	0.3	0.2	10.3	0.3	0.3	20.7	0.3	0.3	0.3	0.1	1.6	0.6	61.8	0.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.3	6.7	0.3	11.6	260.5	0.3	0.3	0.3	0.5	0.1	0.3	0.3	0.8	0.3	21.4	2.1	0.3	33.4	0.1	0.7	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.1	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol	Cytosol	"HPA024826: "	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 4.0;skin 1: 13.0;testis: 4.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.3;U-937: 6.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;dendritic cells: 2.9;T-cells: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039179	Uncertain				"Secreted in other tissues"					"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.5	0.5	0.1	0.4	0.7	1.7	0.0	0.7	0.7	0.0	0.1			1.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.1		0.0	0.0	0.0	0.4	0.0		0.1	0.0		1.1	0.0	0.9	13.0	0.2	0.0	0.0	0.5	0.5	4.8			0.3		0.0	0.0	0.0	4.0	2.9	0.3	0.7	0.5	2.5	0.0	0.8	1.1	1.0	1.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.9	0.7	2.2	0.5	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.5	1.2	0.3	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.5	0.5	1.5	0.8	3.1	0.6	1.5	1.2	2.9	0.8	1.2	0.3	0.2	0.2	0.0	0.9	4.3	1.6	1.7	1.2	0.2	1.0	0.6	2.0	0.3	0.8	6.1	1.2	0.0	0.7	0.3	1.2	0.2	0.6	1.9	2.5	1.4	0.2	4.0	1.0	0.9	0.3	0.5	0.0	2.9	0.4	0.0										
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;BEWO: 9.0;HaCaT: 9.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favourable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.8	0.0	0.3	0.0	0.1	0.0	9.0	0.4	0.0	0.8	1.0	0.6	2.0	0.3	1.1	0.7	9.3	0.0	1.0	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.8	2.6	0.4	1.1	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.6	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7
OPN1MW2		ENSG00000166160	"Opsin 1, medium wave sensitive 2"	P0DN77	X	154219756-154233286	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"skin 1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OPN1MW3		ENSG00000269433	"Opsin 1, medium wave sensitive 3"	P0DN78	X	154257538-154271805	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 2.2;skin 1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"gdTCR: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"																																					0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
OR5P2	JCG3	ENSG00000183303	"Olfactory receptor family 5 subfamily P member 2"	Q8WZ92	11	7795905-7796973	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"skin 1: 1.7;urinary bladder: 1.3"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.3	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119389-49151026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.1;pituitary gland: 14.9;skin 1: 25.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"	"Nucleoli fibrillar center, Vesicles"	"HPA043567: AB_2678558, HPA050340: AB_2681096"	"prognostic unfavourable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favourable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favourable (6.46e-7)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	1.6	3.9	13.9	1.6	9.3	0.9	2.2	22.1	20.8	1.2	4.3	1.6	1.7	5.1	1.6	1.1	4.4	1.3	1.4	1.4	12.8	12.2	1.1	1.6	1.8	1.6	7.4	13.7	1.0	4.9	4.1	14.9	1.1	7.3	3.4	2.0	1.6	2.7	1.6	1.7	25.3	4.6	1.2	2.4	1.3	2.3	2.1	1.8	0.0	1.8	1.2	2.2	1.1	1.9	0.0	0.0	0.0	0.0	0.2	1.1	0.3	1.9	2.0	2.0	5.1	0.0	0.0	3.9	0.2	0.2	1.0	1.4	1.4	0.8	4.5	2.7	0.2	1.0	3.1	0.4	0.2	4.8	6.8	2.8	1.8	1.0	0.2	1.1	7.3	0.2	1.1	0.6	0.3	0.0	5.4	7.1	0.1	8.7	1.4	1.9	0.9	23.0	4.6	4.0	2.2	0.3	1.0	4.2	5.8	0.8	18.8	2.0	10.4	2.7	0.4	1.1	4.0	0.7	0.1	13.3	10.9	3.3	1.1	4.5	2.6	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.4	0.0	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	13.9	9.3	22.1	19.8	12.8	12.2	7.4	13.7	7.3	1.8
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 33.1;tongue: 13.0"	"Group enriched"	"Detected in some"	4	"HaCaT: 6.2;K-562: 1.5;U-87 MG: 4.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027714	Approved									"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.3	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"	"Nuclear membrane, Nucleoli"	"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC5	"dJ211D12.5, WAP1"	ENSG00000175121	"WAP four-disulfide core domain 5"	Q8TCV5	20	45109452-45115172	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 99.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 2.4;Karpas-707: 3.7;RT4: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in other tissues"							"unprognostic (1.32e-1)"				"unprognostic (3.22e-2)"		"unprognostic (3.05e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-4)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (2.32e-5)"	"unprognostic (4.12e-2)"		"unprognostic (2.17e-1)"	"unprognostic (5.96e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.4	0.7	0.2	99.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	22.6	11.4	0.2	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872160-50904970	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;retina: 10.0;skin 1: 21.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;Hep G2: 1.5;NB-4: 2.5;NTERA-2: 1.7;RH-30: 2.1;SH-SY5Y: 1.4;T-47d: 1.4;THP-1: 2.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Region enriched"	"Detected in single"	5	"thalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	1.1	0.2	2.4	0.4	10.0	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2.0	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10.0	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0.0	0.4	0.0	0.3	0.2	0.2	0.0	0.1	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.5	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.9	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	2.4	10.0	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9
AC003002.2		ENSG00000268533			19	57394183-57438457	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skin 1: 7.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 8.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.96e-3)"	"unprognostic (5.13e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (8.52e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.17e-1)"	"unprognostic (1.58e-3)"	0.4	1.0	1.4	0.6	2.1	3.5	0.5	3.3	1.9	0.2	0.5			1.0	0.4	1.4	0.6	0.6	1.1	0.9	1.1	1.8	1.3	0.3	0.3	1.4	1.3		1.3	2.6	0.0	0.9	0.2		0.7	0.7		0.6	0.1	0.5	7.5	1.7	0.0	0.8	1.1	1.2	2.7			3.0		0.4	0.3	0.4	4.3	3.4	4.7	2.8	5.3	3.2	0.8	1.7	0.2	5.5	5.7	1.9	0.0	1.6	0.6	0.6	0.0	2.3	0.5	2.3	2.3	1.1	1.5	1.2	0.9	0.0	1.0	1.2	3.5	1.0	8.7	0.0	0.0	2.6	7.1	0.7	0.0	0.6	0.0	0.0	0.3	2.8	1.2	2.6	1.8	3.1	1.5	1.7	1.3	1.2	1.3	0.0	6.7	7.5	0.9	0.7	1.5	1.2	2.0	2.6	0.0	2.6	2.4	2.3	1.3	2.6	2.0	1.8	1.7	2.8	1.4	0.7	2.7	1.0	2.7	1.1	3.1	1.5	2.2	1.6	1.4	4.3	3.2	2.9	4.7	5.3	2.8	3.4	1.2	0.8										
AC007040.2		ENSG00000258881			2	70939318-70995336	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 2.7"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 5.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.86e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.36e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.53e-9)"	"unprognostic (6.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	0.4	0.1	0.9	0.3	0.7	1.0	0.5	1.5	0.8	0.3	0.3			0.4	0.4	0.4	0.3	0.5	0.3	0.2	0.6	0.4	0.6	0.0	0.2	0.4	0.2		0.5	0.4	0.0	0.1	0.2		0.6	0.1		1.6	0.1	0.7	2.8	0.1	0.1	0.3	0.2	0.0	2.7			0.5		0.0	0.2	0.3	0.7	0.4	1.5	0.5	1.0	1.3	0.1	2.7	0.3	0.2	1.5	0.3	0.3	1.1	0.2	0.1	0.5	0.7	0.3	0.3	3.9	0.4	0.5	0.6	1.1	0.1	0.8	3.1	2.8	2.4	0.4	0.9	0.0	0.1	1.0	0.3	0.1	0.8	0.1	1.5	0.2	1.0	0.5	0.7	0.3	0.3	0.3	0.4	3.1	1.0	0.1	0.8	0.3	0.3	0.3	0.6	0.6	1.2	1.0	0.1	1.1	3.0	5.4	0.8	2.5	0.4	0.1	0.1	3.3	1.4	2.9	0.7	0.5	1.5	0.7	0.3	0.8	0.6	0.5	0.3	0.2	0.7	1.3	0.8	1.1	1.0	0.3	0.4	0.4	0.1										
AC007325.2		ENSG00000277196			Unmapped	138082-161852	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 12.8;skin 1: 12.6"	"Cell line enriched"	"Detected in some"	9	"RPTEC TERT1: 63.3"									"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"									HPA020361	Uncertain									"HPA020361: AB_10963116"																		0.0	0.0		0.0		0.0	0.6		6.4	0.0	0.0			11.1	0.0	0.0	2.1	0.0	0.0	2.8			4.5	1.6	7.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	3.0	12.6	12.8	0.0		0.0	0.0	0.0			1.1		1.8	0.5		0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.8	0.1	0.8	1.8	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.1	0.0	3.4	6.4	0.1	0.0	0.0	0.2	0.0	0.0	0.3	1.3	0.0	0.0	0.1	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	0.0	0.0	63.3	0.2	0.1	0.1	0.0	2.4	0.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC011043.2		ENSG00000278198			Unmapped	173872-179372	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 1.2;skin 1: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.3;NB-4: 5.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.5	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0	0.0	0.0	0.0			1.2	1.0	0.0		0.1		1.1	0.3		0.9	0.2	0.1	1.8	0.3	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.2	0.1	0.0	0.0	0.5	0.7	0.0	6.3	0.4	1.8	2.4	0.5	0.1	1.7	0.8	0.5	0.7	1.4	2.6	0.6	0.1	0.3	0.1	1.9	1.7	0.5	1.9	1.4	2.0	1.2	1.7	2.5	0.1	2.5	2.7	0.0	0.8	0.6	1.2	0.3	0.5	2.1	0.9	0.4	0.5	5.4	1.1	0.1	0.1	0.4	0.0	0.3	0.3	0.6	0.3	0.3	0.2	1.2	0.1	1.2	0.1	1.2	0.5	0.4	1.2	0.6	0.5	0.1	0.6	1.8	1.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0										
AC011841.1		ENSG00000273496			Unmapped	99351-104855	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 1.2;skin 1: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.3;NB-4: 5.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.5	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0	0.0	0.0	0.0			1.2	1.0	0.0		0.1		1.1	0.3		0.9	0.2	0.1	1.8	0.3	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.2	0.1	0.0	0.0	0.5	0.7	0.0	6.3	0.4	1.8	2.4	0.5	0.1	1.7	0.8	0.5	0.7	1.4	2.6	0.6	0.1	0.3	0.1	1.9	1.7	0.5	1.9	1.4	2.0	1.2	1.7	2.5	0.1	2.5	2.7	0.0	0.8	0.6	1.2	0.3	0.5	2.1	0.9	0.4	0.5	5.4	1.1	0.1	0.1	0.4	0.0	0.3	0.3	0.6	0.3	0.3	0.2	1.2	0.1	1.2	0.1	1.2	0.5	0.4	1.2	0.6	0.5	0.1	0.6	1.8	1.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0										
AC025287.4		ENSG00000284484			16	75660227-75677009	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.2;bone marrow: 1.2;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;THP-1: 1.4"									"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"																																							0.0	0.0		0.0		1.2	0.0		0.1	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.2	0.0			0.5	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	1.2	0.0	0.0		0.1	0.2	0.1			0.4		0.0	0.3		0.9	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1										
AC099489.1		ENSG00000188897			16	11359845-11523588	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 7.2;lymphoid tissue: 9.9;skin 1: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 7.0;U-266/70: 3.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"					"Low region specificity"	"Detected in single"			HPA042154	Uncertain									"HPA042154: AB_2677877"	"unprognostic (4.69e-2)"	"unprognostic (3.80e-2)"	"unprognostic (7.24e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.91e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.04e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.72e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.33e-5)"	1.5	0.0	0.3	6.4	0.2	2.0	0.8	0.1	0.1	0.5	0.1			0.0	0.5	0.2	0.1	1.6	0.6	0.7	0.4	0.1	1.1	1.1	2.4	0.9	0.5		0.3	0.5	0.0	0.3	0.3		1.0	0.0		5.0	0.6	1.3	6.2	0.3	0.0	0.5	9.9	0.7	2.8			0.3		0.2	0.7	0.3	0.2	0.0	7.2	0.0	0.0	0.5	0.0	0.1	0.8	0.8	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	6.5	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.5	0.0	0.4	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.5	0.8	0.0	0.2	0.2	2.1	0.7	0.0	0.6	0.3	2.3	0.0	0.4	0.7	0.4	0.0	0.9	0.9	0.0	0.2	0.3	0.1	0.1	0.3	0.0	3.6	0.2	0.2	0.0	0.7	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	7.2	0.0	0.0	0.0	0.1	0.0										
ACCSL		ENSG00000205126	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like"	Q4AC99	11	44047981-44059977	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"HEL: 4.0;U-266/70: 1.0"	"Cancer enriched"	"Detected in single"	22	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"																		"unprognostic (2.37e-2)"				"unprognostic (2.91e-1)"				"unprognostic (9.76e-5)"	"unprognostic (7.42e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7										
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795224	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 4.2;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;Karpas-707: 2.8;U-266/84: 5.3"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1		0.2	0.7	1.1	0.0	0.0		0.0	0.0		0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.3	0.8	0.0	0.5	0.2	0.9	1.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	2.1	0.2	0.8	0.1	0.0	0.5	0.0	0.0	0.0	1.5	4.3	0.1	1.3	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.8	0.6	1.3	0.5	1.5	0.9	0.4	0.6	0.0	1.5	0.4	0.6	0.3	0.3	0.7	0.1	1.0	0.0	0.7	0.6	0.8	0.3	0.7	5.3	0.6	0.7	0.9	0.3	0.0	0.1	0.0	0.2	0.5	0.8	0.8	0.6	0.5	0.0	0.9	0.8	0.5	0.0	0.3	0.2	0.3	0.1	0.0										
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin, beta like 2"	Q562R1	5	57480016-57482809	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HaCaT: 1.7;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain					2600000000	2600000000			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.8	0.0	0.0	1.2	0.1	0.1	3.4	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA007131: AB_2667756, HPA007158: "	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.7	0.0	13.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0
AL157392.5		ENSG00000282246			10	13610047-13655929	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"skin 1: 6.8"	"Low cell line specificity"	"Detected in many"											"Cell type enhanced"	"Detected in some"		"basophil: 3.3;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 4.0;T-cells: 1.4"									HPA047950	Uncertain									"HPA047950: AB_2680221"																		1.0	0.0		1.2		1.8	1.9		0.6	0.0	0.5			2.0	0.7	3.7	0.0	0.0	0.4	0.0			0.1	0.0	0.4	2.3			0.4	1.1	0.4		0.5		0.9	1.4		2.6	0.4	1.0	6.8	1.1	0.0		2.2	1.6	2.5			0.6		1.1	0.6		0.4	0.1	3.3	4.0	0.0	1.4	0.7	2.1	2.9	10.6	2.4	2.2	0.7	6.4	3.4	0.2	1.4	1.5	4.7	3.8	0.8	2.6	1.6	6.1	1.9	2.4	1.5	1.7	3.6	1.1	5.4	5.7	2.0	1.8	3.7	1.6	5.8	0.6	0.6	0.5	3.5	3.3	0.6	2.3	3.0	5.2	0.8	2.1	1.2	1.8	0.9	1.5	1.3	1.6	1.7	1.4	3.3	2.6	3.0	2.6	9.5	6.0	2.0	5.0	2.7	3.8	2.3	1.1	2.4	3.2	5.6	3.3	0.3	0.0	0.5	0.6	0.4	0.0	0.6	0.2	0.0	0.4	0.3	1.4	1.8	0.0	4.0	0.1	0.0	0.7										
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Group enriched"	"Detected in some"	5	"MCF7: 30.9;SK-BR-3: 32.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA045132	Approved									"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	30.9	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	32.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALS2CL	"DKFZp686I0110, FLJ36525, RN49018"	ENSG00000178038	"ALS2 C-terminal like"	Q60I27	3	46668997-46693704	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.3;HaCaT: 11.3;HBEC3-KT: 21.3;hTCEpi: 15.1;RT4: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB046465, HPA048301"	Uncertain									"CAB046465: AB_10638285, HPA048301: AB_2680346"	"unprognostic (6.38e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-3)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.45e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.14e-3)"	3.8	1.8	0.7	2.9	1.3	0.6	3.0	5.2	3.3	5.4	5.1	0.9	3.0	4.3	4.2	3.4	22.2	2.6	11.7	5.5	1.7	0.9	15.2	4.2	9.3	2.0	0.7	3.2	1.9	3.5	0.5	4.5	4.3	1.7	2.7	1.5	4.9	7.0	4.3	6.1	31.8	3.3	4.9	1.1	5.9	3.6	0.5	0.2	0.7	9.8	17.9	12.1	5.6	10.7	0.0	0.7	0.0	0.3	0.0	3.1	0.6	6.1	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.1	20.3	0.0	6.1	0.5	11.3	0.0	21.3	0.0	0.0	0.0	0.5	2.9	0.0	0.1	0.0	0.0	0.0	15.1	0.0	2.5	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.5	0.0	0.0	7.2	5.2	11.2	0.2	0.1	8.1	6.2	0.0	1.4	0.1	4.3	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.0	0.4	0.7	0.0	3.1	0.3	0.0	0.0	0.0	0.0	1.7	0.6	0.7	1.3	5.2	3.3	1.7	0.9	0.7	3.2	1.7	0.2
ANKK1	X-kinase	ENSG00000170209	"Ankyrin repeat and kinase domain containing 1"	Q8NFD2	11	113387791-113400418	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.7;tongue: 6.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 6.5;RT4: 3.1;U-266/70: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012813	Uncertain									"HPA012813: AB_1844832"	"unprognostic (5.63e-3)"	"unprognostic (6.67e-3)"	"unprognostic (5.09e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.56e-4)"	"unprognostic (7.02e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.39e-6)"	"unprognostic (3.17e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.65e-2)"	0.6	0.5	0.6	0.6	2.0	0.4	1.2	0.6	1.4	1.5	0.6	0.6	0.6	0.4	0.7	0.9	0.6	3.3	0.6	0.6	0.6	1.2	0.6	0.6	0.6	1.1	0.6	0.6	1.0	0.6	0.4	4.7	0.6	0.6	1.9	0.1	0.6	1.8	1.0	0.7	9.7	0.6	0.6	2.3	0.9	0.2	1.0	0.6	0.6	1.2	6.3	1.5	0.6	1.2	1.3	0.2	1.4	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.1	0.3	3.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.6	0.0	0.0	0.1	0.0	1.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.0	1.3	0.2	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.6	2.0	0.6	1.4	0.6	1.2	0.6	0.6	0.6	0.6
ANKRD34C		ENSG00000235711	"Ankyrin repeat domain 34C"	P0C6C1	15	79293285-79298235	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 5.8;skin 1: 3.0"	"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 13.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045329	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA045329: AB_2679291"	"unprognostic (3.20e-1)"			"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"						"unprognostic (1.81e-1)"		"unprognostic (3.42e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.48e-1)"			0.5	0.3	0.6	0.0	0.5	0.0	0.0	5.8	5.0	0.5	0.0			0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.9	5.0	0.1	0.0	0.3	0.0	2.4		0.0	0.7	0.1	1.2	0.0		0.1	0.1		0.0	0.2	0.2	3.0	0.1	0.0	0.3	0.0	0.1	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.8;THP-1: 7.2;TIME: 9.2;U-87 MG: 9.2;U-937: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA035453: AB_10672864"	"prognostic favourable (9.35e-4)"	"prognostic favourable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	10.8	0.3	1.5	3.9	0.5	1.3	0.4	0.0	0.0	0.3	1.2	0.2	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.0	1.2	3.0	0.1	3.7	0.5	0.3	0.1	0.4	0.0	0.0	2.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	7.2	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.1	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 75.4;tongue: 34.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 71.2;HBEC3-KT: 108.3;hTCEpi: 28.7;SiHa: 25.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;monocytes: 3.2"									"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	4.8	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.7	1.2	35.9	1.2	0.0	0.9	0.0		0.0	0.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.9	0.0	0.0	1.1	0.7	0.0	75.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	34.2	13.3	6.9	0.6	0.0	5.0	0.8	3.2	0.5	0.0	0.5	14.2	3.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.0	71.2	0.0	108.3	0.0	6.1	0.0	0.0	6.9	0.0	2.5	0.0	0.1	0.0	28.7	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.0	16.6	0.0	0.0	25.6	2.2	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5										
AP002512.3		ENSG00000284732			11	56459221-56473352	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.3;bone marrow: 1.9;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"K-562: 1.9"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																																							0.0	0.0		0.1		1.9	0.1		0.1	0.0	0.0			0.2	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.3	0.2			0.0	0.1	0.0		0.0		0.0	0.0		0.1	0.0	0.3	1.2	0.0	0.0		0.1	0.2	0.3			0.2		0.0	0.0		0.7	0.3	1.3	0.3	0.8	0.5	0.0	0.3	0.5	0.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.1	1.9	0.6	0.0	0.0	0.4	0.7	0.6	1.2	0.0	0.5	0.6	0.1	0.4	0.6	0.8	0.1	0.2	0.1	0.8	1.1	0.5	0.6	0.7	0.5	0.3	0.7	0.5	0.2	1.0	0.2	0.4	1.2	0.3	0.3	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.5	1.3	0.8	0.2	0.3	0.2	0.0										
APCDD1	B7323	ENSG00000154856	"APC down-regulated 1"	Q8J025	18	10454628-10489948	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 84.9"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;BJ hTERT+: 33.5;HaCaT: 20.4;HHSteC: 9.4;HSkMC: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.21e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (6.39e-4)"	"prognostic favourable (8.23e-4)"	"unprognostic (5.61e-3)"	"unprognostic (6.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	32.9	10.6	21.8	5.3	17.9	1.2	15.9	14.4	26.4	27.0	8.7	22.9	3.9	3.2	23.0	11.9	19.7	23.6	30.6	16.8	29.6	11.2	4.3	1.7	7.3	2.3	12.2	17.4	24.1	8.0	1.5	1.9	18.6	20.8	29.0	10.1	12.0	7.9	11.1	5.2	84.9	7.0	11.2	8.9	4.0	13.7	3.6	17.7	0.0	3.0	16.1	4.0	21.6	18.5	0.7	3.3	2.3	0.9	0.1	0.1	0.8	0.0	0.0	15.5	0.0	2.7	0.0	0.0	1.1	33.5	1.5	2.4	0.0	0.0	0.0	0.0	6.1	20.4	0.1	0.0	1.6	0.0	0.7	0.0	0.0	0.3	9.4	0.0	0.0	19.5	0.7	2.9	0.0	0.2	0.0	0.0	1.5	0.9	0.8	0.2	2.5	0.0	0.4	0.0	0.5	0.0	0.2	0.4	0.1	0.0	0.0	1.7	0.0	0.2	0.0	1.8	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	2.3	2.3	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.8	0.1	0.0	3.3	0.0	0.8	21.8	17.9	14.4	21.7	29.6	11.2	12.2	17.4	20.8	17.7
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARHGEF4	"ASEF, KIAA1112, STM6"	ENSG00000136002	"Rho guanine nucleotide exchange factor 4"	Q9NR80	2	130836916-131047263	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;skin 1: 35.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 17.3;hTCEpi: 35.9;SCLC-21H: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 4.3"	"Group enriched"	"Detected in many"	35	"dendritic cells: 2.6;T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018267	Approved									"HPA018267: AB_1845006"	"unprognostic (2.30e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (3.93e-3)"	"unprognostic (9.71e-3)"	5.4	5.5	24.0	1.5	25.7	0.7	2.0	8.9	37.3	3.5	1.9	14.7	0.5	0.8	2.9	2.1	13.2	8.8	3.4	1.5	28.5	12.7	0.9	1.2	3.6	0.9	15.0	16.5	8.3	13.6	2.4	5.2	0.8	14.9	5.4	1.4	0.6	3.2	9.0	8.0	35.1	1.6	4.5	23.5	0.7	1.5	4.4	20.5	0.0	5.2	10.1	4.0	4.2	6.1	0.0	2.6	0.0	0.0	0.0	4.3	0.6	1.6	1.0	0.3	7.9	0.0	0.0	0.1	2.5	0.1	0.1	0.0	0.3	0.5	0.0	0.1	1.0	17.3	1.1	4.0	0.0	0.0	0.9	0.0	2.7	0.0	0.3	0.0	0.0	0.0	35.9	0.8	3.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.2	2.9	7.8	0.1	0.3	1.2	0.0	22.0	3.3	0.2	3.2	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.8	1.6	0.0	0.0	1.6	4.3	0.0	0.0	0.0	2.6	1.3	0.6	24.0	25.7	8.9	26.6	28.5	12.7	15.0	16.5	14.9	20.5
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"											HPA000549			Uncertain	Cytosol	"Secreted in other tissues"			Cytosol	Cytosol	"HPA000549: "	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.3	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0										
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.0;hTCEpi: 9.7;T-47d: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Mitochondria	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.4	1.0	0.3	2.1	0.2	0.1	1.0	0.1	0.0	0.3	0.6	3.4	0.4	0.5	0.9	0.0	2.0	2.6	2.1	0.1	8.0	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.7	0.1	0.4	0.0	1.5	0.6	0.2	4.8	0.0	0.7	0.6	2.0	0.4	0.6	1.0	1.4	0.6	1.3	1.7	1.5	1.0	0.5	7.5	0.1	0.1	0.5	2.8	0.5	0.3	0.6	4.9	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdTCR: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favourable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	3.0	0.0	1.8	32.6	0.5	0.3	0.0	5.1	0.0	0.0	0.0	1.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.9;skin 1: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favourable (3.15e-4)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favourable (3.93e-5)"	"prognostic favourable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	4.0	0.8	2.7	3.8	2.3	0.7	0.9	11.9	6.5	0.8	0.9			1.3	0.0	16.5	7.5	0.7	1.4	0.0	3.1	5.1	29.9	0.5	0.7	8.7	1.5		0.0	1.1	1.2	18.4	0.1		0.9	1.0		1.4	0.1	0.0	20.5	1.1	0.0	0.7	2.3	8.6	8.0			6.3		6.0	1.2	3.5	0.5	0.1	0.9	0.8	0.2	3.4	0.7	1.8	5.7	0.3	0.0	0.5	0.0	7.0	0.0	0.0	0.0	0.0	5.1	3.2	9.0	2.4	0.0	4.3	0.7	0.9	0.0	0.6	0.9	0.0	2.5	9.7	0.0	1.1	9.5	0.0	27.3	0.0	0.3	0.0	0.3	1.1	0.0	14.7	6.4	0.1	11.7	2.7	0.7	0.5	2.4	3.5	4.5	17.2	1.2	2.0	5.4	1.4	12.3	4.4	0.0	0.1	1.6	0.0	0.1	2.3	8.7	3.5	0.3	1.3	0.9	0.9	0.0	0.0	3.4	0.0	1.3	0.5	3.4	2.9	0.0	0.5	2.6	2.0	0.0	0.2	0.8	0.1	0.6	0.7										
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		59000000	59000000	"Nucleoplasm, Nuclear bodies, Cytosol"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.1	16.1	15.6	10.8	10.7	11.5	7.5	9.5	5.9	15.0	13.0	23.6	3.0	30.3	17.0	7.6	7.1	33.7	13.0	12.7	8.0	26.5	18.6	14.5	20.0	15.6	33.8	11.5	13.5	0.9	11.7	6.8	22.0	39.6	12.4	6.2	7.7	41.8	24.7	14.9	7.5	36.3	40.5	20.0	12.0	9.1	36.0	12.9	8.4	16.4	10.3	11.2	17.5	14.0	9.3	18.7	4.1	16.8	15.0	30.8	40.9	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036570-151047600	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.5;skin 1: 68.6"	"Cell line enriched"	"Detected in some"	10	"T-47d: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basal ganglia: 1.4;cerebellum: 2.7"	"Low region specificity"	"Detected in many"			HPA019946			Uncertain	Cytosol				Cytosol	Cytosol	"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favourable (4.32e-4)"	"unprognostic (6.81e-2)"	0.1	0.1	0.2	0.1	0.2	0.3	6.4	0.2	0.2	9.7	0.1	0.1	9.4	0.1	0.6	0.6	42.5	1.0	0.1	0.2	0.2	0.0	0.5	0.2	6.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	3.2	0.1	3.4	0.1	0.3	7.1	21.0	0.7	68.6	0.2	0.8	0.1	0.1	0.6	1.0	0.1	0.2	2.7	25.8	23.2	5.0	18.2	1.8	0.8	3.2	0.6	0.5	1.7	0.4	0.3	0.2	0.5	0.6	0.3	0.3	0.6	0.3	0.0	0.2	0.1	1.1	0.4	0.6	0.5	0.0	1.2	0.7	0.2	0.4	0.8	0.8	0.9	0.5	0.2	0.1	0.5	0.6	0.0	2.3	0.1	0.2	0.0	0.5	0.5	0.2	1.4	0.5	0.9	0.5	0.4	0.3	0.2	0.3	0.5	0.3	1.1	0.5	0.4	0.7	0.2	32.4	0.2	0.7	0.6	0.4	0.2	0.1	1.4	1.1	3.1	0.0	0.2	0.6	2.7	0.6	0.7	1.7	0.6	1.4	0.5	1.0	1.2	0.3	1.8	1.0	0.6	3.2	0.5	0.6	0.8	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 8.1;U-2 OS: 8.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.5	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.1	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.8	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.6	0.1	0.0	0.0	8.1	0.1	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2										
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23890525-23902655	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 17.7;testis: 8.5"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA056632	Uncertain				"Secreted - unknown location"					"HPA056632: AB_2683197"	"unprognostic (3.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.04e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-1)"	1.5	0.5	0.6	0.3	0.5	0.0	0.8	0.0	0.5	0.1	0.6			0.3	0.5	0.0	1.4	0.1	0.5	3.2	4.4	1.3	0.1	0.1	0.1	0.0	0.1		0.2	0.5	0.0	1.1	0.4		4.8	0.0		1.5	0.0	3.5	17.7	0.2	0.4	0.0	1.4	0.6	8.5			0.5		0.0	0.8	0.2	2.3	3.0	1.7	1.6	1.3	1.2	0.5	1.5	3.6	1.4	1.6	0.0	0.0	0.4	0.5	0.0	0.0	0.0	1.5	2.2	0.3	0.1	0.1	3.7	0.0	0.0	0.0	2.2	3.0	0.8	1.9	1.9	0.4	0.4	0.9	0.1	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.4	0.5	0.1	2.4	3.5	1.4	1.8	2.8	0.0	0.2	4.3	0.1	2.2	0.2	3.6	1.1	0.5	0.3	3.5	1.0	0.2	2.1	3.1	0.5	1.5	4.3	1.3	0.8	0.0	0.8	1.7	1.2	1.1	0.4	1.0	0.2	0.1	0.6	2.3	0.4	0.6	0.0	1.3	1.6	3.0	0.0	0.5										
C2CD4D	FAM148D	ENSG00000225556	"C2 calcium dependent domain containing 4D"	B7Z1M9	1	151837819-151840557	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 4.1;skin 1: 4.9"	"Cell line enriched"	"Detected in some"	9	"HDLM-2: 20.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0;T-reg: 2.2"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.17e-3)"	"unprognostic (5.08e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (9.03e-4)"	"unprognostic (2.69e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.28e-2)"	0.4	0.8	0.9	0.7	0.6	0.0	0.4	1.9	2.3	0.1	1.0			0.5	0.0	0.0	0.6	0.5	0.7	0.4	1.6	0.8	0.9	0.2	0.8	0.8	1.4		0.0	2.6	0.0	1.2	0.0		1.0	0.1		4.1	0.6	0.4	4.9	0.6	0.0	3.3	0.5	1.9	0.5			0.3		0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	20.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.1	1.5	1.1	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1										
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524009-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 108.7;skin 1: 40.8;vagina: 42.4"	"Group enriched"	"Detected in some"	6	"A-431: 16.5;hTCEpi: 6.5;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	15	"cervical cancer: 150.9;head and neck cancer: 196.3;lung cancer: 59.9;melanoma: 47.8;urothelial cancer: 43.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					500000	500000			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	24.5	0.0			0.0	0.0	0.0	108.7	0.2	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		29.8	0.0	0.1	40.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		9.0	0.0	42.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;Hep G2: 11.2;SK-BR-3: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.3	1.3	0.2	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	19.7	4.4	2.3	3.6	0.0	7.4	3.2	2.1	0.0	1.5	7.6	0.0	0.3	11.2	0.0	0.0	3.4	0.0	4.2	0.0	0.3	0.0	0.7	0.0	0.0	9.4	0.1	0.1	5.1	3.6	0.5	0.0	2.7	1.5	4.4	6.4	6.8	1.0	9.7	0.0	8.0	1.3	0.0	0.0	1.6	0.0	0.3	3.9	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 69.8"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	69.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.1;skin 1: 17.3;tongue: 12.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 7.1;SK-BR-3: 9.7;T-47d: 21.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.4	1.9	0.4	0.9	0.4	0.1	3.2	0.4	0.7	4.0	0.4	0.4	0.4	2.1	0.8	1.0	12.1	0.3	0.6	0.4	0.4	0.3	0.7	1.1	0.7	1.0	0.4	0.4	1.0	0.4	0.0	0.4	3.0	0.6	2.1	0.0	0.4	6.2	3.6	0.6	17.3	1.6	0.4	1.5	1.8	0.5	0.8	0.4	0.4	0.4	12.3	10.7	1.3	5.8	2.0	0.0	0.0	0.5	0.0	0.4	0.1	3.8	0.5	0.6	0.2	0.0	0.0	3.8	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	2.0	0.2	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	1.2	0.0	7.1	0.0	0.0	0.1	0.4	0.0	1.6	0.4	0.0	3.0	0.5	0.1	0.0	9.7	1.5	21.6	0.0	0.2	0.1	0.5	0.3	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.3	2.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.4	0.4	0.7	0.4	0.3	0.4	0.4	0.6	0.4
CARD17	INCA	ENSG00000255221	"Caspase recruitment domain family member 17"	Q5XLA6	11	105092469-105101431	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 14.4;skin 1: 6.7"	"Cell line enriched"	"Detected in single"	6	"AN3-CA: 5.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"T-reg: 14.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.4"																				"unprognostic (1.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.41e-2)"		"unprognostic (7.05e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.21e-2)"	1.3	0.1	1.2	1.9	1.1	0.2	0.3	0.1	1.5	1.4	0.8	0.1	0.1	0.0	0.1	0.1	4.5	0.0	0.7	0.1	0.1	0.1	0.8	0.2	1.5	3.4	2.5	0.1	0.1	0.1	0.0	0.1	0.9	1.1	0.7	0.0	0.1	0.5	0.1	0.1	6.7	0.9	0.1	0.1	1.8	0.1	0.1	0.9	0.1	0.1	4.0	3.1	2.0	2.0	0.0	1.2	3.1	1.3	0.0	14.4	0.9	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.9	1.2	1.9	0.0	3.5	1.0	1.2	0.0	0.1	0.4	3.1	0.0	0.3	0.1	14.4	0.9	1.2	1.1	0.1	1.5	0.1	0.1	2.5	0.1	1.1	0.9
CARD18	"ICEBERG, pseudo-ICE, UNQ5804"	ENSG00000255501	"Caspase recruitment domain family member 18"	P57730	11	105137721-105139726	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 8.2;skin 1: 26.7;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;EFO-21: 1.7;hTCEpi: 5.6;U-2 OS: 5.9;U-266/84: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.1"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038582	Approved									"HPA038582: AB_10960549"		"unprognostic (3.90e-1)"				"unprognostic (2.95e-1)"			"unprognostic (1.77e-1)"					"unprognostic (2.88e-1)"	"unprognostic (3.42e-1)"			0.1	0.0	0.1	0.1	1.2	0.0	8.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.0	0.1	0.3	0.1	0.1	26.7	0.1	0.1	0.1	0.1	0.0	0.5	0.1	1.8	0.1	6.6	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CCDC140	FLJ32447	ENSG00000163081	"Coiled-coil domain containing 140"	Q96MF4	2	222298147-222305217	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;NB-4: 3.7;RH-30: 2.1;SK-MEL-30: 3.9;WM-115: 2.3"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042500, HPA048166"	Uncertain									"HPA042500: AB_2678028, HPA048166: AB_2680295"					"unprognostic (2.50e-2)"	"unprognostic (3.54e-1)"			"unprognostic (5.25e-2)"									0.3	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.2	0.0	3.1	1.8	0.0	0.0	1.6	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.1	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.5;skin 1: 9.9"	"Cell line enhanced"	"Detected in some"		"A549: 4.0;THP-1: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA069716	Uncertain				"Secreted - unknown location"					"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.32e-4)"	0.9	1.0	2.7	1.1	5.1	2.4	1.6	4.7	4.6	1.2	0.9	2.7	0.4	1.3	1.5	1.6	3.9	1.0	0.6	0.6	3.1	2.4	0.9	2.1	0.9	1.5	2.5	0.4	1.0	0.6	1.4	2.6	0.7	9.5	1.1	0.9	1.4	1.1	1.2	4.4	9.9	1.4	0.8	3.5	1.2	1.1	4.0	1.4	0.4	0.8	0.4	0.8	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.3	4.0	1.0	0.4	0.7	0.2	0.8	0.0	0.0	0.1	0.2	0.3	1.5	2.8	0.3	0.2	0.4	0.6	0.1	0.0	1.1	1.3	0.2	0.8	0.0	0.0	1.6	1.6	0.4	0.7	0.3	0.0	0.0	0.7	2.7	0.0	2.6	0.6	1.2	0.9	0.5	2.0	0.4	0.7	0.3	1.9	1.2	0.8	0.5	0.5	0.0	3.0	4.0	0.0	0.2	2.0	0.1	0.1	1.8	1.3	0.7	0.3	2.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	2.7	5.1	4.7	4.6	3.1	2.4	2.5	0.4	9.5	1.4
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830214-70835822	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5;skin 1: 42.3"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"myeloid DC: 4.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002222, HPA011216"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.5	0.1	0.1	1.8	0.1	0.0	1.4	0.1	0.1	2.4	1.7	0.1	0.1	1.6	1.1	0.4	9.7	0.3	2.9	0.3	0.1	0.1	0.2	0.9	3.7	0.2	0.1	0.1	0.2	0.2	0.0	1.1	0.1	0.1	1.0	1.1	0.4	1.2	0.2	0.1	42.3	2.6	0.1	0.1	1.5	0.4	0.4	0.1	3.3	0.2	11.3	16.5	0.3	1.9	0.0	4.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	13.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.1;testis: 19.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"											HPA055952	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA055952: AB_2682983"	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.3	0.0	1.5	0.0	0.5	0.1	0.3	0.1	0.2	0.2			0.9	0.1	0.0	0.4	0.2	0.4	0.2	0.1	0.1	0.1	0.5	0.2	3.8	0.1		0.4	0.2	0.0	0.1	0.0		0.2	0.0		0.9	0.0	0.1	5.1	1.0	0.0	0.3	1.1	0.4	19.0			0.5		0.0	0.2	0.2	0.2	0.3	0.5	0.1	0.0	2.0	0.0	1.3	2.3	1.6	3.7	0.0	0.0	0.9	1.4	0.0	0.0	0.1	4.4	0.6	3.7	0.9	0.0	1.7	0.0	0.0	0.0	3.7	6.9	2.1	3.8	3.1	0.0	1.7	2.7	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.9	1.8	2.7	1.5	2.3	1.4	0.7	1.5	0.0	1.9	1.8	3.3	0.4	1.0	0.6	0.8	0.9	2.0	6.0	0.9	1.4	1.6	1.2	1.4	1.7	0.9	2.8	4.3	0.0	0.1	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0										
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Cell line enriched"	"Detected in single"	7	"A-431: 5.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Low region specificity"	"Detected in some"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELSR2	"ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3"	ENSG00000143126	"Cadherin EGF LAG seven-pass G-type receptor 2"	Q9HCU4	1	109250019-109275750	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7;skin 1: 27.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.7;HaCaT: 24.4;MCF7: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013952	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA013952: AB_1846518"	"unprognostic (4.46e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.16e-2)"	1.5	2.3	12.6	1.1	16.0	0.9	5.4	9.2	31.7	6.9	1.8	13.7	3.4	1.4	3.1	4.3	10.9	18.8	1.8	5.3	17.1	8.1	5.6	1.2	1.8	1.3	10.0	15.4	1.2	4.8	7.8	2.3	1.6	8.3	3.5	1.4	5.4	6.4	10.4	9.3	27.8	1.5	2.4	14.1	1.0	2.0	11.0	8.6	0.5	10.9	2.7	3.2	2.3	6.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	6.8	6.4	24.7	4.5	0.0	0.0	6.7	0.8	0.6	1.5	0.4	1.0	0.2	1.2	5.6	0.5	24.4	6.4	3.9	0.8	0.1	2.6	0.5	5.9	1.4	0.5	0.3	3.2	0.1	9.6	0.6	0.4	0.3	4.0	0.3	0.0	28.1	0.7	0.3	8.0	1.2	6.2	2.2	0.3	5.4	2.3	10.0	4.7	3.8	8.3	5.3	7.8	1.5	0.0	0.0	4.5	0.4	6.1	1.6	0.4	0.3	1.3	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	16.0	9.2	31.7	17.1	8.1	10.0	15.4	8.3	8.6
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.0	5.1	2.9	3.2	6.7	8.4	4.7	10.4	8.4	2.3	4.5	10.0	3.9	2.6	9.5	6.8	4.6	9.8	14.3	8.0	10.3	4.5	3.2	1.5	20.9	9.9	3.4	2.6	10.1	6.5	5.2	11.0	14.6	7.9	5.0	29.4	6.3	5.7	9.4	10.0	11.5	11.2	1.6	8.0	15.7	5.5	9.5	6.1	3.0	3.2	6.5	2.5	10.2	5.0	15.4	11.9	9.7	11.4	13.2	11.4	10.5	9.2	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell line enriched"	"Detected in some"	6	"hTCEpi: 37.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.9;HaCaT: 5.6;HBEC3-KT: 4.7;hTCEpi: 6.8;U-251 MG: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"			Cytosol	Cytosol	"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.8	0.2	1.5	0.0	0.2	6.9	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	5.6	0.1	4.7	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.8	0.4	0.7	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.1	0.1	1.4	0.1	0.1	1.0	0.1	0.2	2.2	2.3	0.0	10.2	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Cell line enriched"	"Detected in some"	8	"U-87 MG: 18.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"														"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell line enriched"	"Detected in some"	5	"hTCEpi: 67.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	66000	66000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	12.3	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	67.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Group enriched"	"Detected in some"	4	"EFO-21: 105.2;HaCaT: 36.8;hTCEpi: 45.9;RPTEC TERT1: 65.8;RT4: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced									"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.6	0.0	0.0	0.0	0.0	0.0	0.3	8.2	0.1	0.3	2.7	10.7	0.0	105.2	0.0	36.8	0.2	12.0	1.0	0.1	0.2	0.0	1.5	6.3	8.0	0.0	0.0	0.0	45.9	0.9	13.9	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	65.8	41.2	0.0	0.0	4.8	0.9	2.7	8.4	0.0	1.9	0.1	1.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1
CLDN25		ENSG00000228607	"Claudin 25"	C9JDP6	11	113779747-113780500	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.5;skin 1: 1.2"	"Cell line enriched"	"Detected in single"	33	"T-47d: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA053555	Uncertain									"HPA053555: AB_2682186"	"unprognostic (1.02e-2)"											"unprognostic (3.22e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0		0.0	0.0	0.0	2.5	0.0		0.0	0.0		0.2	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Plasma membrane"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favourable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.7	0.0	55.3	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.1	0.0	98.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HBEC3-KT: 31.2;HDLM-2: 29.5;HeLa: 38.3;SiHa: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA042420"	Enhanced				"Secreted to extracellular matrix"					"CAB016357: AB_2229746, HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favourable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	7.8	0.3	0.1	2.9	4.0	9.8	20.4	12.8	5.4	3.2	0.1	0.1	0.0	0.6	4.6	19.6	0.0	31.2	0.9	29.5	0.1	0.0	38.3	1.3	8.3	0.0	0.1	6.4	18.7	10.9	8.5	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.9	0.4	0.1	0.7	0.0	2.9	0.0	0.0	0.0	25.6	0.0	0.2	0.4	0.1	0.0	1.8	1.0	1.0	15.1	0.5	0.5	0.0	15.7	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	480000	480000	Nucleoplasm	Nucleoplasm	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CSAG2	"CSAG3B, CT24.2, TRAG3"	ENSG00000268902	"CSAG family member 2"		X	152708261-152714549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1;skin 1: 2.7;testis: 1.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 16.8;SK-BR-3: 6.9;U-266/70: 5.6;U-266/84: 6.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (5.87e-2)"				"unprognostic (3.82e-2)"		"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.81e-2)"				"unprognostic (3.35e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.50e-2)"	0.1	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.2			0.0	0.0	0.0	3.1			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.1	0.0	2.7	0.0	0.0		1.0	0.0	1.9			0.0		0.2	0.7		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	2.4	0.0	0.0	1.4	3.0	0.0	6.9	2.9	0.0	0.3	0.1	0.1	2.4	0.6	0.2	5.6	6.9	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
CTAGE4	"cTAGE-4, FLJ43692"	ENSG00000225932	"CTAGE family member 4"	Q8IX94	7	144183466-144186053	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.1"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;hTCEpi: 12.0;RPTEC TERT1: 10.7;T-47d: 7.6;WM-115: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdTCR: 1.3;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.0"									"HPA000387, HPA000922"	Uncertain									"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.17e-2)"		"unprognostic (2.80e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.15e-1)"		"unprognostic (1.26e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.68e-1)"	1.3	0.9	0.2	0.0	0.7	0.0	3.8	0.1	0.2	0.7	1.2			3.7	1.4	2.5	1.3	1.1	1.9	1.4	0.2	0.4	1.3	1.6	2.0	0.0	0.7		1.9	4.1	0.0	2.1	0.8		1.3	3.5		2.0	0.3	0.3	9.1	1.0	0.0	0.4	1.3	2.4	4.9			7.5		0.0	0.8	1.3	0.4	0.0	0.0	0.0	0.0	2.0	0.0	13.5	0.1	0.0	0.0	0.0	0.0	5.7	0.4	0.2	0.0	0.2	1.3	4.3	0.0	0.0	0.5	0.4	0.0	2.4	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.3	12.0	0.4	3.7	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	3.5	0.0	0.0	4.9	5.0	0.4	7.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0										
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"				"Plasma membrane, Cell Junctions, Mitochondria"	"Plasma membrane, Cell Junctions, Mitochondria"	"HPA042617: AB_2678081, HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	25.8	3.8	23.8	18.1	3.6	6.0	7.6	5.1	9.0	7.6	4.9	1.8	33.0	8.0	14.9	6.6	13.2	2.7	30.5	3.5	20.1	4.2	5.2	1.2	24.1	7.5	3.8	3.0	6.7	30.2	9.6	9.9	20.4	9.1	3.8	4.6	15.8	8.6	14.4	12.6	6.7	9.8	7.0	5.1	3.9	8.9	26.2	16.5	11.7	10.6	15.5	13.0	9.5	13.3	4.9	6.0	7.4	11.2	8.3	10.8	9.3	1.8	19.8	19.5	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 140.1"	"Group enriched"	"Detected in some"	12	"HAP1: 17.6;hTCEpi: 23.3;RPTEC TERT1: 63.3;U-2 OS: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;granulocytes: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"					"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favourable (1.71e-4)"	"prognostic favourable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	59.5	0.9	19.4	25.8	14.9	0.2	44.1	0.6	20.7	40.7	30.0	1.5	4.5	38.8	6.8	26.1	16.7	5.2	3.8	11.2	10.8	4.6	79.2	10.3	1.7	13.9	6.3	9.3	2.1	2.8	0.3	25.4	30.5	7.6	7.0	34.3	14.3	44.2	3.7	17.2	140.1	59.2	8.6	1.0	15.1	18.7	5.1	2.4	1.5	10.0	30.2	22.9	12.7	17.0	0.2	3.2	1.1	0.3	0.3	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	17.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.3	63.3	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.3	0.2	0.2	0.1	0.3	0.1	0.2	0.1	3.2	0.2	0.3	0.2	1.1	0.3	0.2	0.2	0.2	0.1	19.4	14.9	0.6	20.7	10.8	4.6	6.3	9.3	7.6	2.4
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127184120-127220078	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.6;HDLM-2: 12.4;TIME: 12.5;U-138 MG: 12.7;U-251 MG: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in some"			"HPA062460, HPA068731"			Enhanced	Vesicles				Vesicles	Vesicles	"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	2.7	1.0	0.6	2.4	2.4	0.8	0.6	0.4	1.8	5.2	1.9	1.5	0.4	0.5	1.3	0.8	4.4	1.0	1.5	2.0	0.4	0.9	0.4	0.4	0.4	0.6	2.9	0.4	0.4	0.4	0.0	0.4	0.4	0.7	2.2	0.7	4.2	0.4	1.5	0.8	10.6	1.0	0.4	0.4	0.4	0.5	0.7	3.6	0.4	0.4	2.2	1.6	2.7	4.5	1.5	1.3	3.6	1.0	1.8	1.4	0.2	1.3	3.9	2.0	0.2	0.1	0.0	0.2	0.5	3.6	2.0	0.9	0.1	3.0	0.2	0.1	2.3	8.6	3.2	1.8	0.6	12.4	1.5	0.0	2.2	0.1	0.0	0.1	0.1	0.1	0.1	0.5	1.2	0.5	0.1	0.5	2.3	0.1	0.3	0.1	4.4	1.1	0.1	0.2	0.0	6.5	1.1	0.1	0.7	5.5	0.0	0.0	0.2	0.1	12.5	12.7	2.2	6.2	8.3	0.2	0.1	0.1	0.1	0.1	0.9	2.4	1.0	0.7	1.2	0.7	1.0	0.9	1.0	0.8	0.3	1.5	1.1	1.4	3.6	1.8	0.7	1.3	0.8	0.2	0.6	2.4	0.4	1.3	0.4	0.9	2.9	0.4	0.7	3.6
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983199-989640	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1"	"Group enriched"	"Detected in some"	7	"CACO-2: 8.8;Hep G2: 32.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012753	Uncertain				"Intracellular and membrane"					"HPA012753: AB_1847444"	"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.85e-4)"	0.8	18.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.8	1.4	0.0	0.0	9.1	0.0	0.0	3.6	0.2	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	2.4	0.3	0.0	0.3	6.1	0.3	1.9	0.7	1.7	0.3	2.2	0.0	12.1	5.0	0.0	0.7	0.4	0.9	2.4	0.0	0.0	0.0	2.3	0.7	1.1	3.2	0.4	0.1	1.5	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.3	1.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.3	0.0
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508493-15552317	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 44.6;skin 1: 29.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;MCF7: 5.2;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2"	"Group enriched"	"Detected in many"	9	"monocytes: 13.2;T-cells: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain									"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.5	0.0	0.0	0.1	0.0	0.1	3.6	0.0	0.0	5.4	0.1	0.0	10.3	0.2	0.6	0.2	12.1	0.1	0.6	0.0	0.0	0.0	0.0	19.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.2	0.0	0.0	1.6	44.6	1.2	29.0	0.1	1.0	0.0	0.3	0.5	0.7	0.0	0.4	0.0	14.7	6.7	5.5	10.3	0.0	0.2	0.0	13.2	1.0	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.8	6.1	4.6	0.0	0.6	1.5	0.2	0.0	0.0	0.4	0.0	1.0	13.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9"	"Group enriched"	"Detected in all"	7	"cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"				"Nucleoplasm, Nuclear bodies, Microtubules"	"Nucleoplasm, Nuclear bodies, Microtubules"	"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	0.3	14.7	1.4	0.4	1.3	0.0	7.4	0.4	1.0	11.7	1.0	0.8	1.6	0.0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0.0	5.6	0.2	1.5	2.3	0.0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2.0	21.1	1.4	4.0	2.9	2.6	2.8	1.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.0	0.3	5.5	0.0	0.0	0.0	0.6	0.6	1.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	2.9	2.6	1.6	0.5	1.9	1.0	1.2	0.8	0.4	1.0	1.4	0.4	0.5	2.2	2.8	0.6	4.0	1.3	0.5	1.4	1.3	0.4	1.0	1.5	3.6	2.8	0.3	1.5	0.8
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 6.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in many"											HPA048308	Uncertain									"HPA048308: AB_2680349"																		0.2	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.6			0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.5	3.0	0.2		0.0	0.3	0.0	0.0	0.0		0.1	0.4		0.2	0.1	0.1	2.2	2.0	0.0	0.2	2.7	0.1	0.0			0.2		1.6	0.1	0.2	0.0	1.0	0.1	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.0										
DCST2	FLJ32934	ENSG00000163354	"DC-STAMP domain containing 2"	Q5T1A1	1	155018520-155033781	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 8.6;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.9;Karpas-707: 3.6;U-266/70: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (8.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.04e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.78e-10)"	"unprognostic (6.95e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-3)"	0.8	0.2	0.5	0.5	0.5	0.1	2.2	0.7	0.5	1.8	0.6	0.5	0.5	2.5	0.7	0.5	1.2	1.5	0.5	0.5	0.5	0.1	0.5	0.8	0.5	0.5	0.5	0.5	0.8	0.5	0.0	0.5	0.5	0.5	1.9	0.7	5.3	3.0	1.2	0.5	8.6	1.5	0.5	0.5	0.5	0.6	20.8	0.5	0.5	0.7	0.5	0.5	0.5	2.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.3	0.4	1.2	1.5	0.9	0.7	0.9	0.1	0.4	0.2	0.0	0.0	1.2	0.2	0.9	0.2	2.9	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.2	0.1	0.9	2.1	0.1	0.4	0.0	0.1	3.6	0.0	1.1	0.0	0.1	0.2	0.2	0.3	0.1	1.3	0.3	0.1	0.6	0.3	1.0	0.6	0.7	0.7	0.0	0.0	0.0	1.0	0.0	0.0	4.8	1.9	0.0	0.0	0.4	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.7	0.5	0.5	0.1	0.5	0.5	0.5	0.5
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 164.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavourable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (2.53e-4)"	19.2	10.7	14.7	14.1	15.7	20.0	28.6	11.9	17.8	17.8	17.0	19.9	15.8	15.0	17.2	13.4	16.1	13.1	13.5	16.6	15.1	16.4	12.8	17.3	16.1	24.5	22.0	17.4	14.4	9.3	11.8	15.1	40.1	17.9	27.6	9.4	15.9	14.8	20.1	7.6	164.4	12.1	23.3	22.1	13.0	14.6	9.2	19.3	7.7	19.7	12.3	15.7	15.5	24.9	31.7	39.5	43.6	25.7	16.1	24.4	16.8	14.8	10.5	13.9	10.2	60.2	38.9	10.7	41.5	46.7	29.2	35.0	9.6	11.4	11.8	54.0	37.5	15.7	16.1	14.1	32.4	17.2	28.7	8.5	11.5	5.8	36.6	17.0	18.4	38.7	31.6	26.8	15.1	28.7	12.5	13.0	37.3	5.4	8.6	9.2	17.2	15.5	7.9	19.6	7.6	37.0	4.0	9.0	14.5	22.1	34.8	21.9	11.8	24.8	26.1	28.0	8.9	32.2	40.4	9.3	11.0	10.8	30.2	8.5	31.4	32.3	22.3	43.6	12.7	25.7	24.4	23.9	21.5	17.5	39.5	31.7	17.1	15.0	26.1	16.1	17.4	13.2	22.0	16.8	14.7	15.7	11.9	17.8	15.1	16.4	22.0	17.4	17.9	19.3
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell line enriched"	"Detected in some"	20	"T-47d: 48.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.7	2.4	0.0	0.0	1.4	0.0	48.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 19.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	Nucleoplasm	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	1.0	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13.0	0.7	19.3	1.0	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1.0	0.5	2.5	3.2	0.3	5.1	1.8	0.5	7.7	0.0	0.4	1.7	1.9	2.1	2.1	1.0	1.8	0.2	0.9	1.2	0.3	16.2	5.4	8.8	0.4	1.0	2.0	0.4	0.9	2.7	0.5	0.3	1.1	0.9	26.6	0.6	5.0	0.0	0.4	0.7	0.8	1.9	0.4	0.4	0.7	1.9	1.0	0.9	0.5	0.3	1.8	5.7	0.5	0.6	0.2	0.3	0.5	1.6	0.5	0.8	2.5	0.6	3.7	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1.0	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 14.7;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.9;CACO-2: 13.3;HAP1: 9.1;K-562: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6.0	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0.0	1.3	1.0	0.8	0.3	0.4	1.1	0.0	0.1	0.1	0.0	18.9	0.1	0.1	0.0	0.3	13.3	0.8	0.5	2.7	0.2	1.8	9.1	0.3	0.0	3.6	4.8	0.3	4.5	1.4	0.0	0.7	3.1	0.0	2.3	0.1	0.0	0.0	10.5	0.0	0.0	2.3	0.3	4.7	0.2	0.0	0.0	4.3	0.4	0.1	0.7	1.5	0.0	0.3	1.6	0.8	3.3	3.2	0.0	0.0	0.9	0.2	0.0	0.8	0.1	0.0	0.4	2.5	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.7	0.1	0.2	0.0	0.0	1.0	1.3	0.9	0.0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020392-97024950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6"	"Group enriched"	"Detected in some"	5	"BEWO: 32.5;HAP1: 16.3"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory region: 36.5"	"Region enhanced"	"Detected in many"		"olfactory region: 24.3"	HPA005670	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.6	2.7	0.5	11.5	0.3	1.5	0.1	3.9	10.0	0.6	0.3	1.4	0.7	17.7	1.7	5.8	2.0	0.8	1.2	2.2	4.5	0.4	0.2	0.4	1.9	0.5	2.5	2.1	0.2	0.4	1.9	44.5	0.0	1.8	0.3	0.1	3.6	3.9	0.6	20.6	0.3	1.4	0.2	0.3	0.3	1.2	3.1	2.5	1.6	6.5	2.7	1.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.7	16.3	0.0	0.0	0.0	2.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.1	3.9	2.2	4.5	0.5	2.5	0.0	3.1
DNASE1L2	DNAS1L2	ENSG00000167968	"Deoxyribonuclease 1 like 2"	Q92874	16	2235816-2238711	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7;skin 1: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.4;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044714			Approved	Mitochondria	"Secreted in other tissues"			Mitochondria	Mitochondria	"HPA044714: AB_10962870"	"unprognostic (9.88e-2)"	"unprognostic (1.11e-3)"	"unprognostic (6.80e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.67e-4)"	"unprognostic (1.40e-4)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.94e-4)"	0.6	1.3	1.3	0.6	2.1	0.8	2.1	8.8	2.8	0.6	0.6	0.6	0.6	0.8	1.2	3.5	0.6	0.4	0.6	0.6	1.6	2.1	0.9	1.6	0.6	0.6	1.5	0.6	0.7	1.9	0.2	2.1	1.3	1.3	0.8	0.2	0.6	11.7	0.6	0.7	20.6	0.8	0.6	1.3	1.0	0.9	1.9	0.6	2.4	2.7	7.1	3.4	0.6	0.6	0.0	0.0	1.6	0.0	0.0	0.2	0.0	1.9	3.9	1.7	1.7	1.4	0.7	6.8	0.6	0.5	1.6	0.8	4.3	4.1	2.6	2.1	0.2	0.6	0.6	0.2	0.1	5.0	3.7	1.1	6.2	1.0	0.2	1.2	4.1	0.9	1.4	1.2	0.3	0.3	3.5	3.8	0.6	4.5	3.5	7.4	1.6	2.6	6.6	2.0	3.5	0.9	0.8	3.5	1.8	0.9	1.5	2.7	6.1	2.7	0.1	3.3	4.4	1.9	1.3	9.3	4.5	2.3	1.1	2.4	1.7	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	2.1	8.8	2.8	1.6	2.1	1.5	0.6	1.3	0.6
DSG1	"CDHF4, DSG"	ENSG00000134760	"Desmoglein 1"	Q02413	18	31318089-31357029	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 124.8;tongue: 117.4"	"Cell line enriched"	"Detected in single"	18	"hTCEpi: 14.2"	"Group enriched"	"Detected in many"	10	"head and neck cancer: 57.0;melanoma: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"CAB009394, HPA022128"	Enhanced					140000000	140000000			"CAB009394: AB_2293011, HPA022128: AB_1847620"	"unprognostic (2.55e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.22e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.44e-1)"		"prognostic unfavourable (2.99e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	30.9	0.0	0.0	0.0	0.0	1.3	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	4.2	0.0	0.3	124.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	117.4	2.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSG4	"CDHF13, LAH"	ENSG00000175065	"Desmoglein 4"	Q86SJ6	18	31376777-31414912	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 7.3;testis: 2.6"	"Cell line enriched"	"Detected in single"	170	"HaCaT: 30.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	HPA059456	Enhanced					300000	300000			"HPA059456: AB_2684025"	"unprognostic (9.86e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"		"unprognostic (5.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.11e-2)"			"unprognostic (6.00e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.58e-1)"	"unprognostic (2.14e-1)"		"unprognostic (1.79e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5			1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	1.2		0.1	0.0	0.0	7.3	0.7	0.0	0.0	0.0	1.0	2.6			0.0		0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.5;HaCaT: 49.1;HBEC3-KT: 35.3;hTCEpi: 111.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		110000000	110000000	"Cell Junctions"	"Cell Junctions"	"CAB037324: , HPA045840: AB_2679468, HPA054950: "	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favourable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.6	6.2	0.0	0.0	0.9	1.4	45.5	4.0	3.5	2.0	2.0	17.7	5.4	0.0	5.8	6.5	49.1	7.5	35.3	0.3	0.0	8.7	0.0	3.5	23.8	0.0	0.1	0.1	0.3	111.4	1.8	20.4	0.0	0.0	0.0	3.6	9.7	0.0	0.1	0.9	3.1	0.0	0.0	5.2	7.5	5.6	2.1	0.0	4.6	9.8	0.0	11.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1
EFNA3	"Ehk1-L, EPLG3, LERK3"	ENSG00000143590	"Ephrin A3"	P52797	1	155078872-155087538	"Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3;skin 1: 41.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.7;HAP1: 12.8;SCLC-21H: 19.0;SK-BR-3: 12.4;T-47d: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB010494	Uncertain									"CAB010494: AB_2097783"	"unprognostic (3.75e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (9.66e-10)"	"unprognostic (2.83e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-3)"	1.0	1.3	5.9	1.1	15.5	0.7	5.8	1.7	17.3	4.7	3.9	0.8	0.0	1.5	1.3	4.4	13.3	1.3	1.1	0.8	6.4	5.6	0.7	1.1	1.0	1.0	2.2	8.6	1.5	1.3	1.6	5.6	1.2	12.2	1.8	4.1	0.4	4.0	1.0	1.1	41.3	1.5	1.2	1.3	1.1	1.3	2.2	1.7	0.0	0.9	8.9	3.8	1.1	9.0	3.1	3.4	2.0	1.8	6.5	3.5	1.1	4.1	1.0	1.8	11.7	2.0	1.0	1.4	0.2	0.3	0.5	0.7	0.7	1.8	3.2	1.9	0.4	7.0	12.8	2.6	0.4	1.9	2.8	0.4	0.4	0.9	0.2	0.5	2.4	0.6	3.1	0.2	0.7	1.0	2.0	2.0	0.4	5.4	0.6	1.7	1.2	3.3	4.1	1.0	10.5	1.4	0.1	19.0	5.8	0.7	12.4	0.3	17.7	0.6	0.3	1.3	3.7	0.5	0.3	4.0	1.7	0.8	2.2	1.6	0.1	0.0	1.4	2.0	2.1	1.8	2.1	2.6	1.7	1.1	3.4	3.1	2.5	1.2	0.1	6.5	0.8	2.6	3.5	1.1	5.9	15.5	1.7	17.3	6.4	5.6	2.2	8.6	12.2	1.7
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924231-34462774	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 49.6;skin 1: 44.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;RPTEC TERT1: 15.2;RT4: 47.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 19.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064895			Supported	Cytosol				Cytosol	Cytosol	"HPA064895: AB_2685384"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	6.3	0.8	12.9	4.8	10.6	0.4	6.0	3.0	11.9	7.3	14.3	13.4	4.9	19.3	5.9	2.8	10.4	5.4	7.8	49.6	10.9	7.3	6.1	2.4	3.0	3.0	10.7	8.1	2.5	6.5	0.4	1.5	19.6	9.9	9.9	11.3	3.5	4.2	11.3	9.7	44.1	21.7	11.7	9.7	2.8	19.9	1.0	12.5	3.4	1.2	1.3	5.3	25.6	16.1	0.0	19.0	1.2	0.0	0.8	1.0	0.6	11.8	3.1	0.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	4.0	0.0	0.3	5.9	11.5	0.0	1.2	3.1	3.2	8.7	0.4	0.0	0.0	0.1	1.6	5.8	0.0	0.0	0.0	6.3	0.0	0.1	1.0	0.2	0.0	9.6	1.1	0.0	17.8	4.2	15.2	47.8	2.5	2.8	0.8	4.6	1.2	4.7	0.0	0.0	0.1	1.3	0.0	0.6	0.1	2.5	0.0	2.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.1	0.0	0.1	0.8	0.0	19.0	0.0	0.6	12.9	10.6	3.0	9.8	10.9	7.3	10.7	8.1	9.9	12.5
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226328-102229589	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 8.1;HSkMC: 11.9;NB-4: 9.2;SiHa: 18.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.6;monocytes: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036236	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	6.3	1.1	1.2	2.1	2.4	3.6	7.3	0.4	0.9	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.3	2.5	2.5	0.6	0.2	0.5	0.2	1.8	0.1	0.7	0.0	0.2	0.2	0.0	1.8	2.4	1.1	0.3	0.2	1.6	3.4	1.7	1.7	24.6	0.3	0.0	0.2	0.8	0.2	6.8	0.0	0.0	0.2	2.8	0.0	0.6	2.6	0.0	2.6	0.5	9.4	0.0	0.0	1.9	2.6	0.2	0.1	6.5	8.2	8.1	2.3	0.1	0.2	0.3	0.4	0.4	2.5	0.0	0.3	0.0	0.0	4.9	0.0	0.4	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.1	11.9	1.4	3.0	0.0	0.0	0.1	2.9	0.7	0.0	0.0	9.2	0.1	0.9	0.0	4.3	0.0	1.6	0.0	0.0	0.3	18.5	0.8	0.6	6.7	2.2	0.0	1.3	0.0	0.3	0.2	0.4	5.7	0.0	2.9	5.3	0.0	0.0	9.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	6.6	0.0	0.0	1.9	1.2	2.4	0.4	0.9	0.6	0.2	0.7	0.0	1.1	0.0
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.6	7.5	8.3	6.3	6.1	1.1	3.8	4.2	3.3	7.2	1.0	0.0	0.0	0.7	5.2	0.7	9.7	5.4	2.4	0.0	12.6	0.3	1.6	0.0	5.8	2.9	1.2	4.9	2.0	3.3	3.4	5.3	0.0	0.0	6.9	1.3	21.5	0.0	7.2	3.9	0.0	10.8	0.0	0.1	0.0	9.9	2.9	4.1	6.6	1.1	2.6	0.2	0.5	1.5	2.9	2.2	2.9	5.0	10.0	0.0	3.5	0.0	2.2	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Group enriched"	"Detected in some"	6	"MOLT-4: 17.8;RT4: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Approved	"Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"	"Nuclear speckles"	"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favourable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favourable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	1.9	1.0	0.0	0.2	0.4	0.1	0.0	0.5	1.3	0.0	0.0	0.1	4.4	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.2	0.1	0.3	0.0	1.1	0.0	0.2	0.6	0.0	0.0	0.0	17.8	3.2	3.0	1.3	0.4	0.0	0.0	0.0	33.8	0.0	0.0	1.2	0.8	0.0	2.8	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;NTERA-2: 5.9;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.2	0.6	1.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.7	0.8	0.5	6.3	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.3	0.4	0.0	1.0	0.1	0.8	5.9	0.8	0.0	0.0	0.1	0.2	1.3	2.6	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.8	0.1	0.3	0.1	0.6	0.8	0.1	0.2	0.2	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.9;EFO-21: 10.2;HaCaT: 10.1;HeLa: 16.9;MCF7: 14.6;SK-BR-3: 7.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	5.4	0.4	0.0	10.2	0.0	10.1	1.0	0.1	0.0	0.0	2.6	0.0	16.9	3.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.6	1.7	0.0	1.6	7.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0										
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;skin 1: 13.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.5"	"Low region specificity"	"Detected in all"			HPA039200	Approved									"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favourable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.6	0.8	5.7	0.6	5.8	0.5	2.6	28.5	5.9	1.3	4.9	0.6	0.2	0.7	5.3	0.8	0.9	1.0	2.8	1.1	5.3	3.0	1.8	0.5	12.4	0.5	1.9	4.0	0.9	2.0	3.5	3.0	1.5	4.2	1.0	1.1	0.7	0.8	0.7	0.8	13.7	0.7	4.8	1.2	0.5	2.7	1.4	1.2	0.0	11.5	1.8	1.6	2.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	0.4	0.0	2.0	1.8	0.6	3.0	0.2	0.0	0.5	0.1	0.2	1.0	1.1	0.3	0.1	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.7	7.5	0.5	0.0	0.1	0.0	0.8	0.2	8.1	0.0	3.3	0.4	4.0	0.9	0.3	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	5.8	28.5	5.9	5.3	3.0	1.9	4.0	4.2	1.2
ETDC		ENSG00000283644	"Embryonic testis differentiation homolog C"		X	135309480-135309659	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;seminal vesicle: 2.9;skin 1: 3.9"	"Group enriched"	"Detected in some"	30	"HeLa: 3.6;SK-MEL-30: 3.6;U-937: 1.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		2.2	0.0		0.0	0.0	0.9			0.0	0.0	0.0	0.5	0.0	0.0	0.0			0.0	1.2	0.0	0.3			0.6	0.0	0.0		0.0		0.1	0.0		0.0	2.9	0.0	3.9	0.0	0.0		0.2	0.2	0.0			1.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9										
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"		11	47586693-47589194	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9"	"Cell line enhanced"	"Detected in some"		"HEL: 2.2;NB-4: 2.0;SK-MEL-30: 4.1;U-937: 3.1"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"					"Cell type enriched"	"Detected in single"	5	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"					"Not detected"	"Not detected"			HPA029408	Uncertain									"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	4.6	0.4	0.2	0.0	1.4	0.3	6.9	0.7	1.2	0.5	0.4			0.1	0.1	0.3	0.0	0.7	0.8	0.6	0.2	0.9	0.0	0.0	0.1	0.1	1.4		0.1	0.0	0.0	0.0	0.0		0.0	0.4		0.8	0.0	1.1	5.2	0.0	0.1	1.2	0.0	0.3	0.7			3.9		0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.2	1.3	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.3	2.2	0.4	0.7	0.0	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.5	0.2	0.2	2.0	0.1	2.0	0.3	0.2	0.6	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	4.1	0.2	0.6	1.1	0.5	0.3	0.2	0.0	0.3	0.2	0.1	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
FAM212A	"C3orf54, INKA1"	ENSG00000185614	"Family with sequence similarity 212 member A"	Q96EL1	3	49803254-49805030	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 25.8;skin 1: 30.0"	"Cell line enhanced"	"Detected in many"		"HEL: 31.3;HMC-1: 21.5;NB-4: 17.4;THP-1: 19.3;U-937: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4"	"Group enriched"	"Detected in many"	6	"B-cells: 25.8;granulocytes: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	6.0	4.1	5.8	3.2	4.7	5.0	3.5	8.0	6.3	6.8	2.6	4.9	1.4	1.7	5.5	2.8	16.3	2.9	4.8	7.6	4.4	4.3	3.4	1.2	7.3	5.9	6.3	4.8	3.6	2.3	0.8	2.0	5.2	5.6	5.4	1.4	3.2	4.5	3.9	15.3	30.0	3.5	5.3	8.3	6.9	2.2	2.4	4.3	1.8	1.9	10.4	8.4	4.8	8.5	25.8	3.6	19.0	2.9	0.0	1.5	2.8	0.6	0.5	0.7	0.5	0.9	2.0	0.0	1.4	0.9	0.6	0.8	0.0	0.0	6.8	0.2	1.0	4.0	0.2	4.8	0.0	1.2	0.0	31.3	0.3	0.1	1.2	4.7	21.5	2.6	6.9	1.4	1.2	2.9	2.1	0.5	0.5	0.3	0.4	17.4	0.5	2.7	6.3	0.3	1.5	0.0	7.8	0.3	2.5	1.2	0.2	0.6	0.1	19.3	1.7	3.5	0.4	1.6	0.6	0.8	0.7	0.5	1.5	16.0	0.8	19.0	0.9	4.3	0.6	2.2	0.1	25.8	0.6	0.7	0.2	23.4	0.9	1.5	0.5	0.0	2.9	3.6	0.6	2.8	5.8	4.7	8.0	6.3	4.4	4.3	6.3	4.8	5.6	4.3
FAM25A	bA96C23.5	ENSG00000188100	"Family with sequence similarity 25 member A"	B3EWG3	10	87020306-87024730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.5;skin 1: 30.9;tongue: 61.1;vagina: 30.8"	"Group enriched"	"Detected in some"	6	"A-431: 13.3;SK-BR-3: 39.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-1)"				"unprognostic (7.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.05e-5)"						"unprognostic (1.21e-1)"	0.2	0.1	0.2	0.2	0.2	0.0	1.9	0.2	0.2	21.6	0.2	0.2	0.2	0.0	1.1	0.2	85.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.0	0.2	19.9	0.2	0.3	30.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	61.1	16.9	0.2	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	39.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FAM57A	"CT120, FLJ22282"	ENSG00000167695	"Family with sequence similarity 57 member A"	Q8TBR7	17	732412-742972	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 43.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.6;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.46e-1)"	"unprognostic (6.16e-2)"	"unprognostic (5.64e-2)"	"prognostic favourable (3.53e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.39e-2)"	5.5	2.2	3.8	3.6	3.3	1.4	8.7	4.7	5.1	8.0	9.1	2.7	23.7	7.0	4.7	5.8	15.3	4.6	15.3	3.6	3.1	3.6	3.8	3.5	4.3	3.7	2.9	1.7	7.0	14.3	3.3	5.8	4.7	6.2	6.9	6.0	4.9	7.8	17.8	3.0	43.8	13.6	5.1	3.0	2.1	10.7	7.2	1.8	2.5	6.3	16.6	11.8	8.4	9.5	1.6	0.4	0.0	0.0	0.0	3.4	0.4	21.7	14.5	10.9	14.3	14.4	18.4	10.1	17.2	15.8	17.7	20.1	7.0	4.0	5.5	10.2	19.3	22.1	21.5	15.2	19.3	13.5	15.7	5.1	9.6	16.9	11.4	4.8	7.8	15.0	15.4	10.2	24.3	13.4	4.4	0.7	10.7	8.7	2.0	1.1	4.9	4.6	8.8	4.2	0.6	15.6	18.9	5.3	9.1	10.5	1.0	6.5	4.2	5.7	9.4	18.1	8.8	22.9	21.0	1.4	4.4	5.8	17.7	8.3	10.7	0.0	0.0	0.0	3.2	0.0	3.0	0.3	0.6	1.3	0.4	1.6	0.2	0.8	0.0	0.0	0.0	0.4	3.4	0.4	3.8	3.3	4.7	5.1	3.1	3.6	2.9	1.7	6.2	1.8
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292401	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain									"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.1	29.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	22.3	12.1	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.4	0.2	0.3	2.0	0.0	0.5	0.0	0.0	0.4	0.2	0.5	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.8	0.1	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004804	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.0;skin 1: 33.8;tongue: 28.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	1.8	1.0	0.5	5.1	0.8	0.6	2.2	1.0	0.8	6.2	5.5	0.4	1.3	6.6	1.4	0.9	36.0	0.8	13.4	8.7	0.9	0.6	2.6	26.5	2.3	1.5	0.4	0.4	1.1	7.0	4.7	2.2	2.6	1.6	1.7	3.2	1.5	5.7	3.0	3.4	33.8	10.1	1.6	0.4	1.0	5.9	0.8	0.3	3.2	3.3	28.9	19.1	2.4	6.9	1.5	0.2	3.4	0.7	0.0	2.6	0.7	12.7	11.8	0.1	0.0	0.4	1.1	19.6	13.5	5.9	11.4	8.6	15.1	4.7	8.4	8.3	8.8	15.2	1.9	11.3	5.3	6.9	4.3	0.2	5.8	8.2	8.5	1.5	4.3	1.5	21.2	7.4	12.3	4.1	4.0	0.3	3.2	7.8	0.3	3.1	6.0	0.0	0.0	0.0	4.1	5.6	3.3	6.1	0.0	4.6	2.9	0.8	5.0	1.9	7.6	7.1	11.9	3.3	15.5	1.2	2.0	2.1	5.5	0.0	4.6	3.4	0.0	0.0	2.6	0.1	1.4	1.1	1.5	0.8	0.2	1.5	1.4	0.2	0.0	0.0	0.7	0.2	1.8	0.7	0.5	0.8	1.0	0.8	0.9	0.6	0.4	0.4	1.6	0.3
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536063	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.1;skin 1: 45.0"	"Cell line enhanced"	"Detected in all"		"U-266/70: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	9.2	6.8	27.0	8.9	27.9	11.1	9.8	27.2	60.1	5.5	6.1	3.6	3.8	4.9	6.0	18.3	9.8	10.6	6.3	10.9	21.4	10.1	4.1	7.3	6.9	9.8	9.1	40.5	6.4	8.0	6.4	7.3	6.2	37.2	5.1	6.9	2.8	7.6	5.3	15.8	45.0	6.5	6.1	6.4	10.1	8.0	13.7	5.7	6.5	6.8	10.6	12.3	7.9	6.5	2.9	2.2	16.6	3.4	7.8	5.0	1.3	4.9	3.9	10.2	7.4	7.1	5.1	8.4	7.1	6.5	4.4	4.2	7.9	6.3	12.7	2.0	6.8	2.9	8.7	16.0	6.2	7.2	4.1	5.9	4.8	5.6	7.2	14.4	5.4	8.1	25.3	7.6	12.9	7.7	9.3	13.6	5.5	6.9	16.5	5.7	5.0	3.1	16.6	4.3	2.5	5.4	8.5	6.5	5.6	4.5	6.2	3.9	3.4	6.8	8.1	6.0	6.8	3.1	4.0	37.4	21.3	12.4	4.8	4.7	4.3	16.6	3.1	1.7	5.0	3.4	3.3	2.9	3.7	3.2	1.8	2.4	3.9	3.2	5.5	7.8	2.5	2.2	3.3	1.3	27.0	27.9	27.2	60.1	21.4	10.1	9.1	40.5	37.2	5.7
FGF22		ENSG00000070388	"Fibroblast growth factor 22"	Q9HCT0	19	639879-644371	"Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.25e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.66e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.36e-2)"	0.5	0.7	2.2	0.0	2.6	0.1	0.4	0.9	3.5	0.1	0.1			0.4	0.4	0.0	0.1	0.2	0.0	0.1	1.8	2.3	0.2	0.1	0.2	0.1	2.0		2.7	0.0	0.0	0.0	0.2		0.6	0.1		1.2	0.4	1.3	14.1	0.2	0.1	0.8	0.2	0.1	0.6			0.1		0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	1.0	0.3	5.8	0.4	0.0	1.4	0.4	0.0	0.2	0.0	1.4	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.9	2.5	0.3	1.7	0.7	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	2.1	0.0	0.0	1.1	0.6	1.2	2.1	1.4	0.0	0.3	0.2	1.0	0.5	0.7	0.5	0.6	0.0	0.4	0.1	1.7	0.3	0.5	0.6	0.4	0.2	0.4	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;NTERA-2: 4.4;TIME: 3.0;U-2 OS: 3.4;U-2197: 3.6"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		500000	500000	"Cytoplasmic bodies"	"Cytoplasmic bodies"	"CAB002210: AB_563731, HPA027505: , HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	14.0	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	3.0	1.2	3.4	3.6	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FOXN1	"FKHL20, RONU, WHN"	ENSG00000109101	"Forkhead box N1"	O15353	17	28506243-28538896	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.1;lymphoid tissue: 37.0;skin 1: 27.9;tongue: 18.4"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 15.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 7.0;head and neck cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.60e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (2.68e-3)"	"unprognostic (5.98e-6)"		"prognostic favourable (5.00e-4)"		"unprognostic (2.85e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.6	0.0	15.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	1.6	0.2	0.1	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	37.0	0.1	18.4	11.3	0.7	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.6;MCF7: 77.8;RT4: 31.8;SH-SY5Y: 27.3;T-47d: 101.3"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdTCR: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	46	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB016217: AB_2108591, HPA029730: "	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.4	1.3	0.0	0.0	0.0	0.0	32.6	0.1	0.0	0.0	0.0	2.0	4.9	0.0	0.0	0.0	4.7	0.5	0.1	0.0	15.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	2.5	0.0	0.0	0.0	77.8	8.5	0.0	0.5	0.7	0.4	0.4	0.1	0.0	31.8	1.6	27.3	0.0	4.4	0.0	101.3	0.0	0.0	0.4	1.0	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1
GCSAM	"GCET2, HGAL, MGC40441"	ENSG00000174500	"Germinal center associated signaling and motility"	Q8N6F7	3	112120841-112133305	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.7;skin 1: 15.4"	"Group enriched"	"Detected in some"	7	"Daudi: 49.5;U-698: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002473	Approved									"HPA002473: AB_1078960"	"unprognostic (8.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.17e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.38e-2)"	0.8	0.2	0.1	29.0	0.3	1.2	0.6	0.1	0.3	0.6	1.6	0.3	0.7	1.3	0.3	0.5	3.2	0.5	1.0	0.8	0.1	0.0	1.0	1.1	2.4	16.4	0.3	0.1	0.5	4.4	0.0	0.8	0.1	0.3	1.0	0.6	0.4	3.0	0.4	0.6	15.4	4.0	0.5	0.2	11.1	2.7	0.4	0.2	59.7	3.4	1.3	24.6	1.8	1.0	10.8	5.7	5.9	0.1	0.5	10.1	3.1	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.3	0.0	49.5	0.0	0.0	1.1	0.0	0.9	0.0	0.9	0.3	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	4.6	0.0	0.3	0.2	5.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.1	0.5	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.0	28.3	0.0	0.0	0.1	5.9	0.0	0.0	2.0	0.1	0.4	9.0	10.1	5.2	5.7	10.8	9.5	5.1	0.3	0.5	0.0	3.1	1.5	3.1	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.2
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HaCaT: 9.8;HBEC3-KT: 6.4;hTCEpi: 4.2;RPTEC TERT1: 3.8;RT4: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favourable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavourable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	9.8	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;HaCaT: 31.1;HBEC3-KT: 13.9;hTCEpi: 51.5;RT4: 17.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain									"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	31.1	0.0	13.9	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	51.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	1.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056461	Approved		Supported	Cytosol		280000	280000	Cytosol	Cytosol	"HPA056461: AB_2683138"	"unprognostic (1.18e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.0	10.0	5.8	6.2	13.9	16.0	4.3	17.4	21.7	13.6	11.4	4.0	5.4	12.4	9.4	21.4	17.3	9.0	20.6	19.3	12.6	8.0	8.1	6.1	6.0	12.2	8.6	9.6	11.8	25.9	24.2	17.2	22.7	3.7	8.6	19.8	19.5	11.7	7.1	10.5	13.6	10.5	13.8	13.0	7.6	42.3	7.4	7.4	11.0	28.6	9.3	13.3	3.1	31.0	15.5	8.3	22.8	13.1	11.4	9.4	8.5	31.3	9.1	9.6	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7
GNG14		ENSG00000283980	"G protein subunit gamma 14"	A0A1W2PPG7	19	12687998-12688422	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 3.1;skin 1: 3.2;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.3;MCF7: 5.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	44	"thalamus: 132.6"	"Low region specificity"	"Detected in all"																															0.1	0.0		0.0		1.0	0.0		1.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.5			0.0	0.0	0.1	0.0			0.7	3.1	0.0		0.0		0.2	0.0		0.9	0.0	0.0	3.2	0.3	0.0		0.0	0.0	2.5			1.5		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	2.4	0.0	0.0	1.8	0.9	0.0	0.0	0.0	2.0	0.3	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	5.3	0.0	2.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	5.1	0.6	1.3	0.4	1.4	0.2	0.0	0.7	0.0	1.9	0.7	1.4	0.6	0.0	0.0	2.0	0.3	0.0	0.7	0.7	2.1	0.1	0.2	2.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030571	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	6500000	6500000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA030571: AB_10602322"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (5.78e-5)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.0	22.1	5.2	13.7	16.0	15.4	21.3	38.6	19.2	4.5	5.2	7.9	18.0	0.4	5.3	40.8	44.4	2.8	27.4	0.9	7.7	2.3	0.0	20.3	9.7	23.0	0.3	1.5	13.5	17.9	10.0	5.2	2.3	0.1	0.8	11.4	8.4	0.2	0.1	8.2	4.9	2.8	23.9	3.7	3.6	26.0	5.2	3.5	25.2	22.3	2.3	7.0	1.6	10.8	24.0	40.7	11.4	15.9	0.1	0.1	0.1	17.1	0.4	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell line enhanced"	"Detected in some"		"A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"				"Lipid droplets, Mitochondria"	"Lipid droplets, Mitochondria"	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	24.6	0.0	32.8	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	43.8	0.0	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.7	0.0	0.0	0.0	1.1	12.9	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0
GPRC5D		ENSG00000111291	"G protein-coupled receptor class C group 5 member D"	Q9NZD1	12	12940775-12952147	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.4;skin 1: 33.9"	"Group enriched"	"Detected in some"	10	"Karpas-707: 36.6;RPMI-8226: 35.5;U-266/84: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.1"	"Cell type enriched"	"Detected in some"	4	"memory B-cell: 18.4"	"Lineage enriched"	"Detected in many"	17	"B-cells: 18.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071909	Approved									"HPA071909: AB_2686470"	"unprognostic (4.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (5.09e-4)"	"unprognostic (3.00e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.63e-2)"	1.0	0.5	0.4	3.1	0.4	0.3	4.2	0.4	0.4	0.8	3.8	0.4	0.4	2.4	1.0	0.4	3.7	0.3	1.5	0.7	0.4	0.2	0.8	0.7	4.4	5.9	0.4	0.4	0.4	2.9	0.0	1.0	0.9	2.1	0.9	3.4	0.7	8.6	0.4	0.4	33.9	3.8	0.4	0.4	5.1	3.3	3.7	0.4	0.4	1.3	5.2	4.1	1.3	0.7	18.4	0.1	1.0	0.0	0.0	0.2	1.9	0.5	0.6	0.0	0.6	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.5	1.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	36.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.0	35.5	0.0	1.4	1.1	0.2	0.8	0.6	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	1.9	10.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	2.1	0.4
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.9;lung: 10.5;skin 1: 13.8"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;A549: 27.8;SiHa: 5.2;SK-BR-3: 15.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA038129	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038129: AB_2675846"	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.0	0.0	0.0	0.6	0.2	0.0	1.1	6.5	0.0	0.2	5.7			6.6	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.2	1.7	0.0	10.5	0.0	1.2		0.0	4.1	0.0	3.0	0.0		1.6	4.0		4.2	1.5	0.0	13.8	8.9	0.0	0.2	0.0	5.1	1.3			2.3		0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.4	0.6	0.1	5.2	15.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	3.8	4.0	16.6	4.4	17.9	13.9	8.5	10.1	20.6	7.5	13.6	17.9	2.5	8.0	6.9	4.3	30.4	2.9	3.1	3.0	15.2	14.1	2.6	1.9	6.6	5.8	19.7	9.0	2.4	2.4	4.0	2.1	7.6	19.6	6.3	15.4	1.3	7.0	5.7	8.0	35.6	10.1	10.6	25.1	2.0	5.3	11.4	18.8	14.1	2.3	23.5	12.1	6.5	10.6	1.8	1.6	8.6	1.2	0.7	4.4	0.4	40.7	5.9	13.4	10.6	13.5	8.1	10.1	8.2	20.8	10.2	15.7	6.3	10.5	9.3	2.2	11.4	8.9	8.6	21.5	13.1	9.6	5.8	6.9	11.4	6.9	1.8	9.2	6.3	1.5	44.0	11.0	43.9	10.8	5.2	14.1	21.8	12.7	7.3	4.7	3.4	9.9	6.5	21.7	2.5	8.8	6.4	10.2	8.9	11.2	22.9	8.6	9.0	8.9	6.7	7.8	12.3	20.8	15.4	6.3	5.8	9.2	12.5	15.3	36.2	0.1	1.2	8.6	0.8	0.9	0.5	0.7	0.6	1.1	1.6	1.8	1.1	0.8	1.6	0.7	0.4	0.7	4.4	0.4	16.6	17.9	10.1	13.6	15.2	14.1	19.7	9.0	19.6	18.8
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.3;skin 1: 34.4"	"Group enriched"	"Detected in some"	4	"BEWO: 64.8;SK-BR-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 4.8;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	1.7	0.6	1.5	0.2	2.4	2.8	15.9	2.0	1.6	10.2	0.9	0.2	10.8	0.3	0.9	3.8	40.3	0.7	1.0	1.6	1.9	1.2	2.5	4.9	2.3	0.2	0.7	1.4	0.5	1.5	12.9	2.6	31.0	0.8	6.1	0.2	1.8	17.5	9.7	0.9	34.4	0.7	5.1	0.6	0.6	1.3	1.6	0.4	0.4	2.8	22.3	25.3	6.7	16.9	0.1	0.2	4.8	0.2	0.5	0.6	4.5	3.1	0.0	0.3	0.9	0.1	0.1	64.8	0.3	0.4	0.2	0.3	0.2	2.2	0.4	0.1	0.0	1.9	3.9	0.4	0.9	0.9	1.7	0.1	0.6	1.2	0.0	0.2	0.3	0.1	1.7	1.8	0.0	0.3	0.6	1.2	0.0	4.1	0.6	0.5	0.2	0.7	0.2	0.3	0.5	0.4	12.3	0.7	0.5	0.6	34.1	0.7	4.1	0.1	0.3	0.2	0.8	1.0	0.3	0.8	0.4	0.4	0.1	0.5	0.5	0.0	0.2	4.8	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.6	4.5	1.5	2.4	2.0	1.6	1.9	1.2	0.7	1.4	0.8	0.4
GRIFIN		ENSG00000275572	"Galectin-related inter-fiber protein"	A4D1Z8	7	2474844-2476894	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.6;skin 1: 3.4"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.18e-2)"			"unprognostic (2.98e-2)"		"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"			1.6	0.7		0.0		0.8	0.0		0.1	0.5	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.4			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.2	3.4	0.0	0.0		0.1	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRXCR2	DFNB101	ENSG00000204928	"Glutaredoxin and cysteine rich domain containing 2"	A6NFK2	5	145858521-145937126	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;skin 1: 2.0;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;RPMI-8226: 1.5;T-47d: 1.1;U-87 MG: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.3"	"Low region specificity"	"Detected in all"			HPA059421	Uncertain									"HPA059421: AB_2684010"						"unprognostic (4.71e-2)"						"unprognostic (2.91e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.0	0.0	1.6	0.2	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.7	0.0		1.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	3.5			0.2		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.5	0.4	0.1	0.2	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0										
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		7100	7100	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	7.1	0.0	0.1	0.5	0.9	0.6	0.4	0.0	0.3	1.6	0.0	4.9	0.8	9.6	0.0	0.2	2.3	0.0	1.0	0.0	0.2	0.1	0.1	0.6	0.0	0.8	0.2	0.6	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Cell line enhanced"	"Detected in some"		"A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA023670, HPA024767, HPA026317"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA023670: , HPA024767: , HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 2.9;lung: 2.2;skin 1: 2.0"	"Group enriched"	"Detected in some"	8	"HAP1: 5.1;HEK 293: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain									"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.5	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763534	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6;skin 1: 25.8"	"Group enriched"	"Detected in some"	4	"Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Group enriched"	"Detected in many"	7	"B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2"									HPA073187	Enhanced									"HPA073187: "	"prognostic favourable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	2.1	0.9	0.4	3.5	0.4	0.3	2.0	0.4	0.3	2.1	0.5	0.6	0.2	0.4	0.3	1.8	5.5	0.6	0.8	0.3	0.3	0.2	1.2	0.4	9.7	3.0	1.3	0.2	0.9	0.2	0.0	0.8	0.2	0.8	0.6	1.1	0.8	2.7	0.8	0.5	25.8	3.1	0.2	1.4	7.2	2.2	0.5	0.3	25.6	1.0	11.3	17.8	1.1	2.3	3.0	3.1	0.3	1.2	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.2	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.4	0.2	0.1	0.2	0.8	0.1	0.1	1.2	0.0	2.8	0.0	0.1	3.1	3.0	0.1	0.1	0.3	0.3	0.4	0.5	0.2	1.2	0.4	0.4	0.4	0.3	0.3	0.2	1.3	0.2	0.8	0.3
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.8;skin 1: 154.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.1;HUVEC TERT2: 29.0;RT4: 21.6;TIME: 32.8;U-266/70: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 68.6;NK-cell: 90.9"	"Group enriched"	"Detected in many"	14	"NK-cells: 90.9;T-cells: 68.6"									"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	1.7	5.0	24.1	5.2	13.0	2.0	23.1	4.0	28.2	26.4	3.1	3.6	3.0	3.4	2.5	106.2	90.3	2.3	6.7	5.7	20.0	8.2	2.3	0.7	112.4	3.4	12.1	12.9	1.4	1.1	2.3	1.2	128.8	15.0	4.5	1.6	1.0	19.0	12.9	3.4	154.6	3.4	20.9	11.2	2.3	3.2	9.6	1.9	1.8	65.9	93.2	66.3	6.8	37.8	5.6	0.4	1.5	0.5	90.9	68.6	38.2	0.0	0.0	0.0	0.0	2.2	7.1	2.6	0.0	0.0	0.6	0.4	0.0	0.0	5.3	0.3	0.1	0.9	0.6	0.0	0.8	13.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.3	1.6	0.0	29.0	0.0	0.2	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	21.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.1	0.2	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.6	0.1	0.2	68.6	0.4	37.4	5.6	17.1	30.1	0.3	4.3	3.1	21.0	1.5	90.9	0.5	0.4	1.0	38.2	24.1	13.0	4.0	28.2	20.0	8.2	12.1	12.9	15.0	1.9
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.7	0.0	23.0	2.2	3.3	0.0	3.3	11.6	4.9	3.6	0.2	0.9	0.0	0.2	3.1	10.1	4.4	0.0	2.2	0.6	0.1	0.1	7.5	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.9	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.2	2.0	18.1	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954834-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.0;lymphoid tissue: 8.1;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.8;K-562: 6.0;SiHa: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain									"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXC13	"HOX3, HOX3G"	ENSG00000123364	"Homeobox C13"	P31276	12	53938765-53946544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.4;skin 1: 13.5;tongue: 4.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.4;HaCaT: 32.4;SK-BR-3: 17.9;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051634	Enhanced									"HPA051634: AB_2616459"	"unprognostic (5.16e-3)"	"unprognostic (1.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.78e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.74e-9)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.68e-1)"	2.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	2.5	0.0	0.6	13.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.1	0.0	15.4	0.2	0.0	9.2	0.9	2.1	1.4	0.8	1.3	0.2	0.0	0.2	0.0	32.4	3.9	1.0	0.8	0.0	3.1	0.0	4.2	0.0	0.0	0.0	3.3	0.0	7.6	0.0	3.0	0.0	5.5	0.0	5.6	9.5	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	5.1	17.9	2.3	13.8	0.0	0.0	0.0	6.7	0.1	2.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
HR	"ALUNC, AU"	ENSG00000168453	"HR, lysine demethylase and nuclear receptor corepressor"	O43593	8	22114415-22133384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 50.5;tongue: 23.8"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;EFO-21: 9.9;HaCaT: 38.4;SiHa: 13.3;T-47d: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.6	1.8	3.8	3.2	6.1	0.8	4.7	19.8	17.0	2.1	7.5	9.6	0.1	5.5	1.5	0.9	12.1	1.9	6.7	1.9	5.3	4.0	0.9	0.8	1.2	1.0	6.1	6.8	0.8	1.3	0.7	1.7	0.9	4.9	2.3	4.0	6.7	3.4	5.4	1.1	50.5	5.3	2.3	3.8	1.1	8.4	5.2	6.6	0.0	2.6	23.8	4.4	3.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	9.9	0.7	38.4	0.0	0.9	0.0	0.0	0.0	0.0	8.1	0.0	2.2	0.0	0.0	2.0	6.2	0.0	0.6	0.0	0.0	0.1	0.0	5.7	0.6	0.1	0.0	7.7	0.8	0.0	0.2	0.1	2.6	0.4	2.2	13.3	3.0	3.0	14.2	0.0	0.0	0.2	8.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.1	19.8	17.0	5.3	4.0	6.1	6.8	4.9	6.6
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212082-152224193	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.1;U-2 OS: 1.5;U-2197: 1.4"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"									HPA031469	Uncertain		Approved	Mitochondria		210000000	210000000	Mitochondria	Mitochondria	"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.3	0.4	0.0	0.1	0.2	0.1	0.3	0.0	1.3	0.7	0.1			0.1	0.5	0.0	1.8	0.8	0.6	0.5	0.1	0.1	1.0	0.0	0.1	0.4	0.0		1.6	1.5	0.0	0.4	0.1		0.6	0.0		0.2	0.0	0.1	4.0	0.2	0.0	0.1	0.1	0.1	1.3			1.6		0.0	0.4	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.6	1.2	0.1	1.5	1.4	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0										
HS3ST6	HS3ST5	ENSG00000162040	"Heparan sulfate-glucosamine 3-sulfotransferase 6"	Q96QI5	16	1911463-1918440	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.8;skin 1: 15.0"	"Group enriched"	"Detected in some"	5	"A549: 2.8;HaCaT: 2.7;U-2 OS: 1.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (5.72e-2)"	"prognostic favourable (3.73e-4)"		"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"		"unprognostic (1.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.99e-3)"		"unprognostic (2.10e-2)"		"unprognostic (6.55e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.26e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.1	6.6	0.4	0.0	0.4	0.0	0.3	0.9	18.8	1.2	0.0	0.1	0.1	0.1	0.2	0.1	1.9	0.1	0.1	0.0	0.5	0.1	0.0	0.2	1.9	0.0	3.6	0.0	0.6	0.4	0.1	0.3	15.0	0.1	1.0	0.1	0.1	0.1	0.1	0.0	2.1	0.1	2.7	3.2	6.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA015987: AB_2121678, HPA064603: AB_2685296"	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.2	13.5	3.6	10.0	2.3	1.9	5.9	6.2	4.1	3.4	2.4	18.5	9.7	0.1	8.1	4.7	20.8	2.7	13.3	2.8	49.4	2.4	0.1	2.5	7.2	1.7	1.4	15.9	1.2	13.5	4.6	5.9	7.3	0.6	1.6	2.2	1.7	1.3	1.3	1.5	3.2	4.6	2.2	3.5	2.0	5.3	11.7	0.6	4.7	6.7	4.6	1.8	0.7	19.8	4.6	6.4	2.7	18.0	3.6	3.9	0.2	3.1	2.0	5.4	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6
IFNK		ENSG00000147896	"Interferon kappa"	Q9P0W0	9	27524314-27526498	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;skin 1: 1.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.7"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (5.58e-3)"				"unprognostic (4.64e-3)"								"unprognostic (1.06e-1)"				0.1	0.0	0.1	0.1	0.5	0.7	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.1	0.1	1.7	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.1	0.0	0.1	0.1	1.9	0.1
IFNL3	"IL-28B, IL28B, IL28C"	ENSG00000197110	"Interferon lambda 3"	Q8IZI9	19	39243553-39245129	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5"	"Group enriched"	"Detected in some"	5	"AN3-CA: 1.1;CACO-2: 3.5;HDLM-2: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (2.67e-1)"	"unprognostic (9.19e-2)"				"unprognostic (4.17e-1)"				"unprognostic (6.86e-2)"				"unprognostic (1.89e-2)"	"unprognostic (1.66e-1)"			0.1	0.0	0.5	0.0	0.3	0.2	0.0	1.1	0.7	0.1	0.0			0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.2		0.0	0.0		1.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	1.5			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0										
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 6.9;RH-30: 3.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA047655: AB_2680113"	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	7.7	0.2	0.6	0.0	1.3	0.5	0.0	0.0	0.0	0.0	1.7	0.3	1.1	0.1	0.1	6.9	0.0	0.0	0.0	0.8	1.2	0.0	0.9	1.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.9	0.1	0.6	0.3	0.4	0.1	3.3	1.6	0.0	0.4	0.5	0.5	0.0	0.2	2.0	0.5	1.4	0.7	0.9	1.6	0.5	0.5	1.0	0.5	0.2	0.2	1.0	2.1	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell line enhanced"	"Detected in many"		"A-431: 26.0;CAPAN-2: 41.2;HaCaT: 37.8;HBEC3-KT: 28.4;hTCEpi: 43.5;PC-3: 25.2;U-2 OS: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"			"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.0	9.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.0	41.2	0.0	6.0	0.0	37.8	0.0	28.4	0.0	0.0	0.2	3.9	9.3	2.1	0.9	2.0	7.6	0.0	43.5	0.0	10.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	25.2	0.0	0.0	0.0	18.6	5.6	0.0	0.0	17.9	11.9	0.1	7.1	5.7	0.0	0.1	49.0	0.3	8.0	0.1	0.0	0.1	0.0	15.1	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5
IL1RL2	"IL1R-rp2, IL1RRP2"	ENSG00000115598	"Interleukin 1 receptor like 2"	Q9HB29	2	102186973-102240002	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 14.4"	"Cell line enhanced"	"Detected in some"		"A-431: 11.1;ASC TERT1: 7.5;HaCaT: 5.3;HSkMC: 6.1;hTCEpi: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA015485	Uncertain									"HPA015485: AB_1851612"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.76e-4)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.10e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.33e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.65e-2)"	1.0	1.8	1.1	0.5	1.1	0.0	2.8	0.5	1.4	1.8	0.7	0.5	6.0	0.0	1.0	2.0	7.4	2.4	2.4	0.7	0.6	0.7	2.3	3.3	0.8	0.5	0.5	0.5	0.5	0.5	6.0	0.5	0.5	1.1	1.3	1.0	0.5	2.9	10.3	0.9	14.4	0.5	0.5	0.5	0.5	1.6	0.5	0.5	0.5	3.7	8.8	4.0	0.9	3.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	2.2	7.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	5.3	0.0	1.2	0.6	0.6	0.0	0.0	1.5	0.0	2.2	0.0	0.0	6.1	3.4	1.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.5	1.4	0.6	0.7	0.5	0.5	1.1	0.5
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 28.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 9.6;HaCaT: 6.9;RT4: 11.4;SH-SY5Y: 11.1;T-47d: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favourable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.6	7.0	2.0	1.6	5.9	0.1	21.2	4.4	2.8	13.9	3.5	4.3	0.6	2.4	5.5	3.7	6.4	13.6	7.9	5.9	3.6	3.0	0.4	0.8	4.7	0.1	3.7	2.3	5.4	16.3	0.2	1.8	0.4	4.6	7.3	3.7	3.5	11.8	7.8	0.5	28.9	1.3	2.9	5.5	0.0	4.9	2.9	3.3	1.0	2.2	3.7	5.6	5.6	9.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	9.6	0.0	0.1	1.4	6.9	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.4	1.4	0.0	0.4	0.0	0.0	11.4	0.7	11.1	0.5	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	4.4	2.8	3.6	3.0	3.7	2.3	4.6	3.3
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 104.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.8	0.0	0.0	0.0	2.9	12.6	0.4	0.1	0.3	0.0	0.1	0.4	0.5	0.0	2.7	1.7	15.7	0.0	25.8	0.1	0.0	0.0	0.0	3.2	0.0	17.4	0.0	0.0	2.1	104.1	0.8	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.1;skin 1: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;Hep G2: 4.4;HSkMC: 4.2;NTERA-2: 9.3;U-138 MG: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.76e-3)"	"prognostic favourable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	3.3	10.8	13.4	3.3	13.1	0.6	5.3	5.4	17.7	3.8	2.7	2.7	2.7	4.6	2.2	1.8	10.1	2.8	4.9	3.4	8.6	6.6	2.6	1.6	7.6	5.6	3.9	9.5	1.6	1.5	1.5	5.5	0.9	4.8	2.6	2.2	9.8	6.7	3.4	3.4	31.9	5.1	2.3	1.7	65.1	1.9	2.7	3.0	0.3	2.3	5.0	4.3	3.7	6.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.4	3.7	0.4	0.2	3.3	0.3	0.3	0.7	0.1	0.0	0.5	0.5	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.0	4.4	1.6	0.0	2.8	4.2	0.2	0.4	0.0	0.8	0.0	0.0	1.1	0.0	0.1	0.1	9.3	0.0	0.2	3.1	0.0	0.0	0.0	0.3	0.8	0.2	0.3	0.1	0.0	0.0	0.0	6.1	0.3	0.3	0.4	0.4	0.0	0.0	0.7	1.8	0.1	1.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.1	5.4	17.7	8.6	6.6	3.9	9.5	4.8	3.0
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985665	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;BJ hTERT+: 1.9;HaCaT: 3.4;HMC-1: 3.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	10.9	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	2.8	0.1	0.1	22.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	94.1	31.5	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	2.5	0.0	0.0	0.0	0.7	0.0	1.9	0.1	1.3	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.6	0.3	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.6	0.4	0.0	1.2	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL36RN	"FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840"	ENSG00000136695	"Interleukin 36 receptor antagonist"	Q9UBH0	2	113058638-113065382	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 26.7;skin 1: 31.9;tongue: 68.9"	"Group enriched"	"Detected in some"	17	"BEWO: 21.5;U-87 MG: 16.6"	"Cancer enriched"	"Detected in some"	7	"head and neck cancer: 25.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (3.88e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"		"unprognostic (4.29e-1)"	"unprognostic (8.68e-3)"		"unprognostic (9.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"		"unprognostic (3.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.23e-3)"	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	68.9	26.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
IL9	"HP40, IL-9, P40"	ENSG00000145839	"Interleukin 9"	P15248	5	135892246-135895827	"Cancer-related genes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.0;skin 1: 2.1"	"Cell line enriched"	"Detected in single"	267	"HDLM-2: 30.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"																							0.1	0.2	0.3	0.0	2.2	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	2.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.2	0.3	1.1	0.7	0.2	2.1	0.0	0.0	0.0
IQANK1		ENSG00000203499	"IQ motif and ankyrin repeat containing 1"		8	143734140-143790644	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.2;skin 1: 15.5;testis: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.6;HaCaT: 13.0;hTCEpi: 15.9;MCF7: 30.9;RT4: 13.2;SK-BR-3: 13.4;T-47d: 28.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.45e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.40e-2)"	0.2	0.0	0.2	0.2	0.9	0.0	2.9	0.2	0.7	1.0	0.3	0.9	1.6	0.1	0.4	12.2	6.1	3.7	0.2	0.2	0.8		0.6	0.5	1.5	0.2	0.2	0.4	0.7	1.0	1.7	1.0	1.3	0.8	1.8	0.8	2.4	1.5	3.2	0.2	15.5	0.7	0.6	0.7	0.2	1.7	31.2	0.3	0.2	2.0	0.2	1.4	2.1	0.2	1.6	0.9	5.1	1.0	0.9	0.7	0.2	7.5	0.4	0.1	0.4	0.0	0.1	8.8	0.1	0.0	0.0	0.1	4.0	11.6	0.0	0.9	0.0	13.0	0.4	1.5	0.1	0.1	0.3	0.0	1.1	0.9	0.2	0.1	0.1	0.1	15.9	0.1	0.3	0.0	0.5	0.1	0.0	30.9	0.0	0.1	0.7	0.5	0.1	0.0	0.2	0.8	13.2	4.4	0.1	1.1	13.4	0.4	28.5	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.2	2.1	1.0	0.7	0.7	0.9	0.4	1.0	0.6	0.5	0.2	1.6	0.5	0.6	5.1	0.9	0.9	0.9	0.3	0.2										
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	10.4	0.0	0.2	0.1	0.1	1.7	6.6	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2
JAG2		ENSG00000184916	"Jagged 2"	Q9Y219	14	105140981-105168824	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.3;SCLC-21H: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol		120000	120000	Vesicles	Vesicles	"CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178"	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	11.5	2.5	5.4	3.5	6.3	1.3	11.4	6.4	8.4	4.2	3.0	3.5	5.2	3.2	7.5	8.4	8.1	5.0	4.4	9.5	5.6	6.4	3.0	1.5	6.6	2.4	4.5	5.3	2.7	5.8	4.3	15.9	6.8	8.7	7.1	1.7	5.9	12.2	6.9	16.8	36.0	4.3	3.2	2.9	3.7	3.8	4.2	3.0	2.7	4.2	11.0	4.1	5.2	5.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	8.4	3.4	0.2	0.8	0.0	0.0	10.5	0.1	0.1	0.0	0.0	2.8	10.5	0.0	7.3	0.0	32.3	2.1	10.8	0.0	1.1	5.0	0.0	9.3	0.0	0.1	0.0	2.0	0.1	5.3	0.0	1.2	2.6	2.0	0.0	0.0	3.8	0.0	0.0	1.0	1.2	2.6	2.0	3.6	0.1	2.2	16.6	0.5	2.9	0.7	0.1	8.2	1.2	8.9	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	5.4	6.3	6.4	8.4	5.6	6.4	4.5	5.3	8.7	3.0
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		61000000	61000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favourable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	30.2	25.1	2.5	2.1	0.0	0.0	39.3	1.7	10.4	0.7	0.6	37.9	33.5	0.6	18.7	1.1	126.0	3.6	28.0	0.1	0.0	8.9	1.3	20.0	8.3	4.2	0.8	13.4	0.0	63.6	0.1	5.2	11.2	11.1	11.0	0.0	38.8	0.2	10.9	4.9	4.2	35.4	0.0	22.7	19.4	77.4	6.2	4.6	3.9	76.5	0.2	63.8	0.9	17.6	0.0	1.8	0.8	0.5	0.9	3.4	0.6	0.1	1.4	0.3	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.2	1.6	0.7	0.7	0.2	3.7	0.0	0.0	0.0	0.8	2.6	0.8	1.1	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	1.4	2.2	0.7	1.7	0.9	0.7	1.0	2.1	1.5	0.0	0.3	1.0	0.2	12.1	2.7	0.5	0.7	1.2	0.6	2.1	0.0	0.6	1.8	1.9	0.1	2.0	1.3	0.4	1.3	1.0	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 47.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	8.7	4.0	10.5	7.1	7.9	3.4	7.7	7.7	11.0	15.5	13.6	8.6	4.6	4.7	20.3	6.2	14.6	12.7	9.4	6.8	13.0	5.1	6.2	7.1	13.3	4.1	5.8	8.4	14.3	15.6	1.6	3.4	7.3	9.4	9.0	4.2	12.4	3.7	13.7	4.8	47.3	5.8	13.8	9.3	8.3	8.1	10.6	8.9	1.0	8.9	5.1	4.6	9.4	13.0	0.0	3.4	7.7	6.3	0.0	1.2	0.9	5.7	13.3	12.0	18.2	4.0	2.1	9.5	7.6	1.4	4.3	2.2	7.4	3.9	0.0	17.3	10.6	6.8	8.7	6.0	1.6	6.2	15.3	23.8	8.2	7.1	11.1	4.6	4.3	4.1	25.2	1.6	9.7	8.3	5.8	0.1	0.7	14.6	0.1	13.1	10.9	22.5	11.1	6.5	2.2	4.8	2.6	9.3	32.0	14.9	21.3	27.7	15.7	12.2	13.5	20.0	18.0	0.4	1.3	14.8	0.7	9.4	0.0	8.0	24.4	0.6	2.5	7.7	0.0	4.6	0.1	0.0	1.2	0.2	3.4	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.7	0.9	10.5	7.9	7.7	9.2	13.0	5.1	5.8	8.4	9.4	8.9
KDM4E	"JMJD2E, KDM4DL, KDM5E"	ENSG00000235268	"Lysine demethylase 4E"	B2RXH2	11	95025258-95027596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 2.0"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051740, HPA054225"	Uncertain									"HPA051740: AB_2681586, HPA054225: AB_2682421"	"unprognostic (1.32e-1)"										"unprognostic (6.31e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.10e-4)"		0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.0			0.0	0.3	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.1		0.5	0.3	0.0	0.8	0.8		0.5	0.0		1.8	0.0	0.1	2.0	0.3	0.0	0.2	0.7	0.0	1.7			0.7		0.0	0.7	0.3	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0										
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5;tongue: 25.3"	"Cell line enhanced"	"Detected in some"		"A-431: 25.2;HaCaT: 11.7;HBEC3-KT: 7.6;hTCEpi: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.1	0.2	0.0	0.2	1.2	1.9	1.9	0.0	0.5	4.0	0.1	0.0	0.0	0.1	0.6	2.9	10.6	0.1	0.2	0.1	0.2	0.0	1.9	0.1	0.7	0.2	0.0	0.0	0.3	4.5	1.5	1.1	0.9	0.5	1.7	0.2	4.0	7.8	2.2	0.6	39.5	0.3	0.0	0.0	0.2	0.2	2.8	0.2	0.3	1.1	25.3	9.2	0.2	7.9	1.5	1.0	3.3	0.9	1.0	1.3	0.6	25.2	0.2	0.1	0.3	0.1	0.1	2.1	0.2	0.0	0.0	0.1	2.5	4.7	0.2	2.1	0.0	11.7	1.6	7.6	0.1	0.6	3.8	0.1	0.7	0.5	0.0	0.2	1.6	0.0	9.5	0.1	1.8	0.0	0.4	0.3	0.1	3.3	0.1	0.3	0.6	0.8	4.0	0.0	0.2	0.2	0.9	3.4	0.5	0.2	5.4	0.7	4.7	0.1	0.0	0.3	2.7	0.2	0.3	0.6	0.5	0.2	0.1	0.1	0.3	3.3	0.7	0.6	0.8	0.5	0.7	0.9	1.0	0.9	0.3	1.5	1.0	1.3	2.6	1.0	0.9	1.0	0.8	0.6	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.0	0.5	0.2
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 92.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.3;hTCEpi: 32.4;hTERT-HME1: 20.1;U-2197: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.4;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002926	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	29.2	8.5	2.7	23.8	3.9	14.4	23.7	1.8	3.5	39.1	28.9	5.6	5.5	10.2	17.8	18.6	34.9	22.0	32.4	18.6	2.4	2.2	4.8	5.1	35.6	4.4	2.7	2.2	18.6	2.3	2.7	2.8	41.0	6.2	11.3	29.6	11.7	11.9	6.5	13.6	92.1	39.4	16.0	3.3	21.8	22.2	11.2	2.0	1.9	7.8	81.1	30.7	16.8	24.1	0.0	4.4	0.4	7.4	0.1	0.0	1.3	5.6	2.3	0.2	0.0	6.0	15.3	2.2	2.0	10.5	2.7	3.1	0.8	7.2	0.0	0.3	2.6	4.2	2.6	1.4	1.0	0.0	1.1	0.0	4.0	0.1	8.9	0.0	0.0	2.0	32.4	5.4	20.1	0.2	0.2	0.0	1.4	3.7	0.0	0.6	1.7	11.4	0.1	0.6	0.1	0.8	1.6	0.1	0.1	1.5	4.8	6.0	0.7	2.5	1.2	1.6	0.0	49.3	0.8	0.0	0.0	0.0	1.5	1.0	2.7	0.0	5.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.1	2.9	0.4	0.0	1.3	2.7	3.9	1.8	3.5	2.4	2.2	2.7	2.2	6.2	2.0
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;HEK 293: 3.9;U-266/84: 7.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026228	Uncertain				"Secreted in other tissues"					"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.2	0.0	0.4	0.2	1.2	0.1	2.7	2.1	0.9	3.8	0.6			1.8	0.4	0.9	1.2	0.8	0.3	1.1	0.6	0.5	0.1	0.1	0.5	0.4	0.3		0.9	0.4	0.0	0.3	0.0		0.7	0.4		1.1	0.7	0.3	14.2	1.0	0.0	0.3	0.4	0.8	0.7			0.1		0.6	0.2	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.7	0.7	0.1	0.9	0.6	0.6	0.7	0.2	0.0	0.0	0.2	1.7	2.1	0.8	0.6	0.3	13.7	0.2	0.3	0.0	0.5	3.9	0.3	1.0	0.0	0.2	0.3	0.3	0.4	0.4	0.5	0.6	0.2	0.3	0.5	0.0	1.2	0.2	0.8	0.8	1.5	0.2	0.1	0.8	0.0	0.7	0.1	0.0	0.3	1.2	0.4	0.6	0.0	0.0	0.2	0.6	0.9	0.2	3.6	7.1	0.5	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	7	"A-431: 31.5;CAPAN-2: 41.3;HaCaT: 30.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	950000	950000	Vesicles	Vesicles	"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavourable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	41.3	0.0	0.8	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1
KLRF2	NKp65	ENSG00000256797	"Killer cell lectin like receptor F2"	D3W0D1	12	9881489-9895833	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;skin 1: 16.7"	"Cell line enriched"	"Detected in single"	47	"U-937: 25.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	56	"NK-cell: 5.2;plasmacytoid DC: 6.0"	"Group enriched"	"Detected in many"	56	"dendritic cells: 6.0;NK-cells: 5.2"																					"unprognostic (1.04e-1)"				"unprognostic (1.25e-1)"		"unprognostic (6.24e-2)"		"unprognostic (1.63e-1)"	"unprognostic (5.57e-2)"		"unprognostic (3.40e-5)"	"unprognostic (9.03e-2)"		"unprognostic (3.16e-1)"		0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.9	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.6	3.9	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	0.6	0.2	0.5	2.9	0.0	0.0	16.7	2.4	0.0	0.1	0.7	0.1	0.4	0.0	0.0	0.5	0.0	1.2	0.1	0.1	0.0	6.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli	Nucleoli	"HPA003223: "	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.9	1.1	5.2	1.4	0.0	5.9	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	19.9	0.2	0.0	0.0	0.1	0.0	2.1	2.1	0.0	10.0	1.2	2.3	2.0	1.5	3.1	8.2	18.7	0.0	0.2	2.1	1.2	1.4	3.2	3.2	10.1	1.9	0.1	0.6	8.7	0.7	0.4	3.7	0.8	3.1	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867210	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;retina: 3.6;skin 1: 1.9"	"Cell line enriched"	"Detected in single"	6	"HeLa: 3.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055217, HPA055835"	Enhanced									"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.9	0.1	3.3	0.1	0.1	1.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	3.6	0.1	0.1	0.1	1.9	3.3	0.1	0.1	0.1	0.4	0.7	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in some"	7	"hTCEpi: 638.7;SiHa: 265.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		750000000	750000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favourable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	64.6	0.0	66.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	638.7	0.0	49.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	265.9	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Group enriched"	"Detected in some"	9	"HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		170000	170000	"Intermediate filaments"	"Intermediate filaments"	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.3	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Cell line enriched"	"Detected in some"	4	"BJ: 64.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		170000000	170000000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	64.5	2.8	7.7	15.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT40	"FLJ36600, KA36"	ENSG00000204889	"Keratin 40"	Q6A162	17	40977716-40987135	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.5;skin 1: 5.2"	"Cell line enriched"	"Detected in single"	7	"SK-BR-3: 4.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075961	Supported									"HPA075961: "	"unprognostic (2.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.92e-1)"		"unprognostic (9.09e-3)"		"unprognostic (2.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.47e-2)"			"unprognostic (9.60e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	1.0	0.1	0.1	1.5	0.1	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.6	0.0	9.5	0.1	0.4	0.1	0.4	1.8	0.7	0.2	0.1	5.2	0.9	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 118.0;HBEC3-KT: 211.3;hTCEpi: 483.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		6500000000	6500000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favourable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	118.0	0.0	211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	483.0	0.0	42.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell line enhanced"	"Detected in many"		"A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		290000000	290000000	"Intermediate filaments"	"Intermediate filaments"	"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavourable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.0	14.8	0.0	0.0	0.0	0.0	12.4	0.6	0.4	3.5	1.0	1.0	19.3	0.0	21.7	0.5	22.0	0.0	0.2	1.2	0.0	0.0	0.0	23.1	0.5	2.3	0.0	0.0	0.2	2.7	0.7	5.3	5.2	0.0	0.0	1.2	62.9	0.0	0.0	0.0	2.2	0.0	18.1	0.6	19.8	7.9	5.6	0.3	11.2	29.1	0.2	5.4	0.2	3.0	0.0	40.8	0.0	15.8	0.0	0.0	0.1	4.1	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KRTAP19-6	KAP19.6	ENSG00000186925	"Keratin associated protein 19-6"	Q3LI70	21	30541535-30541864	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.4;HMC-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP19-8		ENSG00000206102	"Keratin associated protein 19-8"	Q3LI54	21	31038159-31038476	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.4;testis: 2.7"	"Group enriched"	"Detected in some"	23	"NTERA-2: 1.7;U-937: 2.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.94e-1)"			0.0	0.0	0.1	0.0	0.0	1.4	0.4	0.1	0.0	0.8	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP22-2	KAP22.2	ENSG00000206106	"Keratin associated protein 22-2"	Q3LI68	21	30590105-30590397	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 2.3"	"Cell line enriched"	"Detected in single"	13	"U-2 OS: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP29-1	KAP29.2	ENSG00000212658	"Keratin associated protein 29-1"	A8MX34	17	41301826-41302851	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;lymphoid tissue: 1.3;skin 1: 5.9"	"Cell line enriched"	"Detected in single"	21	"HDLM-2: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																			"unprognostic (1.15e-2)"						"unprognostic (2.18e-3)"									"unprognostic (9.76e-2)"	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.1			0.0		1.3	0.2	0.0	0.9	0.0	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.5	0.2	0.0	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.3										
KRTAP5-10	KRTAP5.10	ENSG00000204572	"Keratin associated protein 5-10"	Q6L8G5	11	71565563-71566738	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.6;skin 1: 8.3"	"Cell line enriched"	"Detected in single"	10	"RT4: 8.7"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.05e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-4)"	0.3	0.0	0.2	0.0	0.7	0.1	0.6	0.4	0.1	0.1	0.1			0.0	0.0	5.6	0.1	0.9	0.2	0.0	0.2	0.1	0.4	0.4	0.1	0.0	0.1		0.1	1.8	0.0	0.2	0.0		0.4	0.3		0.1	1.1	0.7	8.3	0.3	0.0	0.2	0.2	0.1	0.8			0.2		0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-7	"KRTAP5-3, KRTAP5.7"	ENSG00000244411	"Keratin associated protein 5-7"	Q6L8G8	11	71527267-71528674	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 9.2;testis: 4.8"	"Cell line enriched"	"Detected in single"	9	"RT4: 6.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	20	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.6"																				"unprognostic (3.69e-1)"			"unprognostic (2.49e-4)"	"unprognostic (1.64e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.40e-2)"		"unprognostic (7.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.35e-3)"		"unprognostic (2.35e-1)"	"unprognostic (5.68e-3)"	0.0	0.1	0.8	0.3	1.2	0.3	0.7	0.5	0.9	0.1	0.2			0.6	0.0	2.2	0.1	0.1	0.2	0.0	1.1	1.3	0.6	0.6	0.0	0.1	1.5		0.0	0.0	0.3	0.0	0.0		0.3	0.1		0.3	0.2	0.5	9.2	0.0	0.1	1.1	0.0	0.1	4.8			0.0		0.1	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP7-1	KAP7.1	ENSG00000274749	"Keratin associated protein 7-1 (gene/pseudogene)"	Q8IUC3	21	30829039-30829759	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.6;tongue: 3.1"	"Group enriched"	"Detected in some"	8	"SiHa: 3.3;SK-MEL-30: 2.0;WM-115: 2.6"	"Cancer enriched"	"Detected in single"	16	"urothelial cancer: 1.2"					"Cell type enriched"	"Detected in single"	13	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 2.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0										
KRTAP9-1	"KAP9.1, KRTAP9L3"	ENSG00000240542	"Keratin associated protein 9-1"	A8MXZ3	17	41189887-41190639	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.2"	"Cell line enriched"	"Detected in single"	98	"HDLM-2: 9.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell line enriched"	"Detected in single"	55	"hTCEpi: 41.5"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	62000000	62000000			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 50.8;tongue: 90.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HAP1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 1.9"					"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		9700000	9700000	Nucleoplasm	Nucleoplasm	"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	6.5	9.2	4.8	3.4	6.2	3.5	12.0	11.0	7.2	6.9	11.5	2.7	2.4	5.0	4.2	6.4	12.7	3.5	4.9	8.1	4.6	5.0	5.6	4.8	18.0	2.9	3.8	3.9	5.7	5.5	10.0	6.3	5.3	4.3	8.2	6.1	14.7	6.4	3.9	30.7	50.8	13.4	5.2	2.8	4.0	4.4	4.0	1.2	0.8	3.1	90.3	13.6	5.1	6.2	0.3	0.1	4.1	0.3	0.0	1.9	3.8	5.7	3.6	10.4	24.4	0.3	0.1	3.1	1.6	3.9	3.1	2.9	17.0	1.2	0.0	2.4	0.8	6.8	35.6	6.6	2.5	6.4	9.3	0.1	1.8	8.3	3.1	1.6	2.4	1.5	4.2	1.3	4.7	1.9	0.0	1.7	0.0	4.4	2.3	0.3	8.1	4.3	2.6	6.4	1.8	3.6	4.1	1.7	6.9	5.1	3.5	3.0	2.4	0.2	0.8	2.0	6.2	1.3	3.0	7.3	3.4	4.8	0.0	1.0	2.6	0.0	0.3	3.7	0.0	0.0	1.9	0.3	0.4	0.4	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	3.8	4.8	6.2	11.0	7.2	4.6	5.0	3.8	3.9	4.3	1.2
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856868-46918642	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;skin 1: 33.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"	"Nucleoplasm, Nucleoli, Mitochondria"	"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	1.2	1.9	16.0	1.3	20.3	0.5	2.1	7.3	23.7	3.0	5.4	11.6	0.6	3.9	2.1	1.3	2.4	2.0	2.5	7.2	20.4	5.8	1.2	0.7	3.4	0.5	9.6	12.6	5.4	2.7	9.3	3.3	3.1	14.5	2.7	4.1	1.3	2.1	3.0	4.4	33.0	5.3	2.0	9.7	4.2	9.6	1.6	19.0	0.0	2.9	1.0	0.8	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.6	17.3	5.2	10.8	2.9	4.0	0.7	1.5	2.3	2.6	2.2	0.0	0.0	1.1	8.9	3.1	9.6	5.9	1.8	0.0	8.1	0.8	3.0	5.3	2.3	0.1	1.5	3.7	3.4	3.6	0.9	2.0	0.7	0.0	1.3	0.6	0.1	0.2	9.4	0.7	1.2	5.9	0.0	0.2	2.2	0.0	11.4	0.9	0.0	2.8	0.2	0.4	0.1	4.7	2.9	5.3	1.6	0.0	0.0	0.3	3.5	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	20.3	7.3	17.3	20.4	5.8	9.6	12.6	14.5	19.0
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;skin 1: 47.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.8;monocytes: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003873	Approved									"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	7.8	2.7	0.4	3.5	1.7	9.8	2.9	1.7	2.2	8.4	2.8	0.9	0.4	3.0	2.4	4.0	27.0	2.5	2.6	6.5	1.0	0.2	3.1	10.8	9.2	27.7	1.4	0.4	3.6	3.5	0.6	2.5	2.3	1.2	3.9	1.3	2.9	5.9	2.0	2.6	47.0	2.6	1.3	2.1	23.9	1.6	1.7	1.0	2.4	2.3	14.3	7.2	2.5	11.6	0.1	4.0	36.8	13.8	0.7	1.2	4.3	2.1	4.8	1.7	1.4	1.1	1.1	7.2	0.9	0.7	1.1	1.3	3.6	2.6	3.5	1.6	0.9	17.4	1.5	2.8	1.5	9.3	5.4	3.8	5.8	2.3	0.6	5.0	4.9	0.6	4.9	2.2	2.6	2.0	2.9	14.7	0.4	4.7	2.0	8.6	1.3	3.7	7.6	1.5	6.0	0.6	3.4	3.8	1.4	5.1	2.4	2.3	4.0	5.1	1.1	3.6	3.6	3.6	1.2	8.3	1.9	5.7	0.7	13.3	2.3	4.9	13.8	13.9	1.2	1.7	0.9	0.0	0.9	1.0	4.0	0.1	0.4	0.3	36.8	0.7	0.3	0.4	0.2	4.3	0.4	1.7	1.7	2.2	1.0	0.2	1.4	0.4	1.2	1.0
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784880-142786592	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 236.9;skin 1: 111.6;tongue: 316.2"	"Cell line enriched"	"Detected in some"	20	"A-431: 55.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					92000	92000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	0.2	3.7	0.2	0.2	0.2	0.1	3.7	0.2	0.2	23.0	0.2	0.2	0.2	0.1	2.1	0.2	236.9	0.1	0.5	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	1.2	0.1	0.2	18.1	0.2	0.4	111.6	0.2	0.9	0.2	0.2	2.0	0.2	0.2	0.9	0.2	316.2	61.8	6.3	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.4;skin 1: 21.4"	"Cell line enriched"	"Detected in some"	4	"HEL: 6.1"	"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"					HPA054412	Uncertain				"Intracellular and membrane"					"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.6	0.2	0.1	0.0	0.7	0.2	0.1	0.0	0.6	5.1	2.7	0.3	1.7	0.1	0.5	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	5.6	0.6	0.3	0.3	7.4	0.1	21.4	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.7	0.0	0.6	0.5	0.0	0.1	0.0	0.4	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Cell line enriched"	"Detected in single"	111	"HEL: 22.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0
LY6G6F-LY6G6D		ENSG00000250641	"LY6G6F-LY6G6D readthrough"		6	31706904-31717918	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"skin 1: 9.3;testis: 4.0"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.7"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA008053	Uncertain									"HPA008053: AB_1840160"			"unprognostic (5.02e-2)"		"unprognostic (1.31e-1)"	"unprognostic (3.47e-1)"				"unprognostic (5.90e-2)"		"unprognostic (1.07e-2)"			"unprognostic (2.66e-1)"	"unprognostic (2.42e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.7	0.1	0.0	0.0	0.4	0.0	9.3	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		9700000	9700000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.0	0.1	0.0	0.2	0.1	0.0	4.6	0.4	1.1	0.4	0.5	0.1	12.5	0.0	0.5	0.3	29.4	0.0	1.3	0.2	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.1	0.0	0.1	0.0	0.0	0.0	0.0	32.8	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.3	31.5	0.0	0.0	0.1	47.3	0.5	5.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 25.4;LHCN-M2: 40.8;NB-4: 13.3;RT4: 21.5;SK-BR-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049239	Uncertain				"Intracellular and membrane"					"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.2	0.2	1.4	0.1	1.5	0.0	8.9	0.7	2.4	1.4	2.3	0.6	21.8	1.1	1.1	0.5	2.1	12.2	27.3	0.1	5.0	2.4	4.0	0.4	2.7	2.4	0.7	0.6	1.7	13.2	9.8	0.6	0.6	0.9	5.0	1.5	2.5	11.9	26.6	0.1	38.9	2.9	1.8	0.6	1.3	20.3	16.9	0.7	0.2	0.2	0.6	2.3	9.1	3.7	2.8	0.0	14.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.6	2.6	1.0	0.3	0.0	0.0	0.0	25.4	5.5	0.6	0.6	8.4	0.0	2.9	0.0	0.8	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	40.8	9.2	0.0	13.3	0.8	0.1	0.0	0.1	1.6	1.3	21.5	1.5	0.0	0.1	12.9	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	14.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.7	2.4	5.0	2.4	0.7	0.6	0.9	0.7
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.9;skin 1: 8.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.3;RT4: 14.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039551, HPA046187"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039551: AB_2676565, HPA046187: AB_10964208"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.3	0.0	0.3	2.7	0.3	0.8	0.5	0.3	0.3	2.8	2.1	0.3	0.3	0.2	0.3	0.3	9.9	0.0	0.3	0.3	0.3	0.2	2.0	3.1	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	2.2	0.3	1.1	1.8	0.3	1.3	0.7	0.6	8.7	3.4	0.3	0.3	0.3	0.4	0.7	0.3	0.3	0.3	2.5	1.7	2.1	4.2	2.6	1.3	5.5	1.2	4.4	0.7	0.0	3.4	0.1	0.7	0.6	0.1	0.0	5.2	0.6	0.2	0.0	0.0	0.3	1.2	2.0	15.3	0.1	2.8	0.1	0.1	0.1	0.7	0.1	0.9	0.4	2.7	0.0	0.9	0.5	0.0	0.4	0.0	0.3	0.0	0.9	2.4	0.0	0.3	0.5	0.5	2.2	1.0	0.8	0.8	0.4	0.6	14.8	0.5	0.8	2.3	1.9	0.6	2.4	0.4	0.5	1.0	2.4	0.7	0.6	2.2	3.9	0.9	0.5	0.3	1.0	2.6	1.2	0.3	0.6	0.6	0.5	0.8	0.4	0.5	0.3	2.6	0.7	0.7	5.5	4.4	0.7	1.3	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.13e-4)"	"prognostic favourable (7.26e-4)"	"prognostic unfavourable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7.0	5.3	2.0	10.0	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16.0	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell line enhanced"	"Detected in many"		"BJ: 23.9;HeLa: 21.6;U-2197: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	580000	580000	Microtubules	Microtubules	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favourable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.8	7.6	1.7	3.3	0.1	0.1	0.6	23.9	6.7	2.1	0.6	1.6	5.6	0.0	7.6	8.2	3.0	0.0	0.2	0.2	0.0	0.1	0.0	21.6	1.4	0.0	0.1	0.5	0.0	0.2	0.1	0.2	2.6	0.0	0.0	0.0	2.7	0.0	4.4	1.0	0.4	1.0	1.0	2.9	0.4	1.5	1.7	1.6	8.7	0.5	3.0	2.3	0.5	1.1	8.7	0.8	21.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favourable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.7	4.9	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.3	0.5	3.1	0.2	19.5	0.0	21.2	0.0	0.3	0.3	0.0	8.4	0.3	0.3	0.0	0.4	0.1	29.8	0.1	4.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.1	10.3	0.8	0.0	0.3	13.0	22.8	0.3	0.0	3.6	8.2	0.0	6.5	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Group enriched"	"Detected in some"	7	"U-266/70: 94.1;U-266/84: 69.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favourable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.7	2.0	0.5	0.1	0.4	1.0	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.3	0.0	0.2	0.2	0.7	0.0	0.1	0.2	0.0	0.0	2.7	0.1	0.2	3.3	0.6	0.2	11.3	0.5	0.7	0.2	0.4	0.1	0.7	3.6	0.0	0.0	1.1	1.3	0.1	94.1	69.1	0.1	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6
NANOGP8		ENSG00000255192	"Nanog homeobox retrogene P8"		15	35084193-35085110	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.5;skin 1: 1.7;testis: 2.3"	"Cell line enriched"	"Detected in single"	116	"NTERA-2: 33.5"	"Cancer enriched"	"Detected in single"	415	"testis cancer: 20.7"					"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"																													"unprognostic (1.58e-1)"			"unprognostic (9.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"			0.0	0.0		0.0		0.1	0.6		0.0	0.0	0.0			0.4	0.0	1.1	0.0	0.0	0.2	0.0			0.0	0.0	0.2	0.0			0.2	0.0	0.8		0.0		0.3	0.1		0.0	0.2	0.0	1.7	0.0	0.1		0.0	0.0	2.3			0.0		0.0	0.1		0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1										
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)"	Q6ZVX7	19	39196961-39201884	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 101.7;lymphoid tissue: 113.1;skin 1: 49.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 2.0"	"Not detected"	"Not detected"			HPA052812	Approved					1200000	1200000			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.1	0.1	0.0	3.1	0.0	0.3	2.1	0.0	0.4	21.5	0.8	0.0	0.4	0.6	2.1	0.3	101.7	0.4	0.3	0.1	0.0	0.0	0.9	0.1	0.8	2.4	0.0	0.0	0.1	2.9	0.1	0.0	7.5	0.0	0.4	0.6	20.2	10.5	0.4	0.3	49.6	2.4	0.2	0.0	0.4	0.1	0.1	0.0	4.3	0.2	42.7	113.1	1.2	31.2	0.7	0.8	3.4	0.6	0.9	0.6	0.1	0.2	0.2	1.0	0.2	0.1	0.7	2.1	0.1	0.0	0.1	0.1	0.5	0.5	0.6	2.0	0.4	0.9	1.4	0.5	0.4	0.0	0.4	0.2	0.8	0.2	0.1	0.4	0.3	0.5	0.4	0.0	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.2	0.4	0.4	0.1	0.5	0.6	1.0	2.5	26.2	0.2	0.3	0.9	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.5	0.2	0.5	3.4	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.3	0.2	0.7	0.5	0.4	2.0	0.9	0.5	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NDUFA4L2	"FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4, mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.5;skin 1: 93.4"	"Cell line enriched"	"Detected in many"	7	"AN3-CA: 54.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	24	"B-cells: 2.4;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055323			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA055323: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	24.5	9.6	8.3	4.9	15.5	1.3	11.5	7.7	10.4	19.1	4.4	8.3	1.1	4.6	4.6	5.4	82.5	3.6	11.0	30.9	9.8	7.3	5.4	4.2	12.7	4.6	10.9	10.7	6.1	6.7	4.6	6.2	42.7	13.2	6.8	2.4	13.7	10.3	7.4	19.0	93.4	4.7	5.6	5.6	29.9	4.3	3.0	8.9	0.7	12.0	14.8	11.9	10.2	31.4	2.4	0.1	0.0	0.0	0.0	2.8	0.3	0.3	0.5	0.1	54.1	2.2	1.3	0.1	0.8	0.6	0.2	0.5	0.0	0.6	2.1	2.3	0.8	0.4	0.3	0.4	0.0	1.1	0.1	0.2	0.1	0.0	7.8	1.6	0.8	5.0	1.0	0.1	1.9	0.0	0.2	2.9	0.1	1.0	0.4	0.0	0.1	0.9	0.8	0.4	4.1	0.0	0.0	2.9	1.0	0.1	0.1	1.8	0.6	5.7	0.2	0.5	0.0	0.4	0.2	4.1	1.3	0.9	2.0	3.8	0.3	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.7	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.3	8.3	15.5	7.7	10.4	9.8	7.3	10.9	10.7	13.2	8.9
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729084	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.3;skin 1: 73.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 58.1;hTCEpi: 36.2;RT4: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	97000000	97000000			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	3.1	3.0	7.7	3.0	11.1	11.9	5.3	8.4	20.8	6.6	7.3	27.3	2.4	9.6	2.3	2.0	55.3	2.9	2.5	3.0	16.1	8.2	3.0	2.4	2.5	1.7	12.7	10.6	1.8	10.8	2.4	4.1	8.2	10.1	5.9	7.8	6.3	8.7	4.4	1.6	73.5	6.9	3.1	14.3	2.2	3.2	1.3	12.4	2.5	1.8	25.3	20.8	17.3	14.8	0.1	4.8	1.0	1.5	0.1	0.1	0.2	4.0	3.4	3.2	4.6	1.7	0.5	22.7	1.6	1.5	1.4	1.0	7.1	13.9	5.4	6.7	1.9	58.1	8.2	29.6	0.6	12.7	1.2	0.7	1.1	3.3	0.7	3.6	9.1	0.5	36.2	4.4	16.2	4.1	0.1	28.9	1.8	10.6	0.0	2.2	10.6	4.7	0.3	19.4	6.5	1.3	39.4	7.8	17.7	5.5	14.6	0.5	13.3	0.5	2.2	1.2	4.6	10.0	1.4	5.3	6.6	0.0	0.4	3.0	2.8	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	1.0	0.1	1.5	4.8	0.0	0.2	7.7	11.1	8.4	20.8	16.1	8.2	12.7	10.6	10.1	12.4
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	11000	11000	"Plasma membrane"	"Plasma membrane"	"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	18.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.2	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.1	23.4	0.0	15.2	0.0	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460019-157474717	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;skin 1: 38.1"	"Group enriched"	"Detected in some"	11	"hTCEpi: 13.8;RT4: 45.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.6;naive B-cell: 8.7"	"Lineage enriched"	"Detected in single"	51	"B-cells: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038259	Approved									"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favourable (6.82e-4)"	0.6	0.5	1.5	2.5	7.1	3.3	3.0	0.4	7.7	3.6	2.1	25.9	0.0	0.8	1.7	0.6	10.6	0.5	1.0	1.0	3.1	1.7	0.5	0.5	0.5	0.9	8.0	2.5	0.5	0.5	0.5	0.4	1.1	10.9	2.6	1.1	0.0	1.2	1.9	0.6	38.1	0.7	5.8	11.9	0.7	1.9	0.6	6.9	0.0	0.8	15.8	6.0	10.7	7.7	8.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	2.7	0.1	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	13.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	45.8	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.1	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.1	0.4	7.7	3.1	1.7	8.0	2.5	10.9	6.9
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445239-124450184	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;intestine: 2.9;skin 1: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HEK 293: 2.7;hTCEpi: 6.7;NTERA-2: 13.3;SCLC-21H: 5.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029367	Uncertain									"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.9	0.2	2.9	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.4	0.0	0.7	3.7	0.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	1.2	0.0	0.0	2.2	2.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.6	0.9	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.2	2.9	0.6	0.3	0.7	3.7	2.2	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 79.5;K-562: 62.4;Karpas-707: 28.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in single"			HPA025926	Uncertain				"Secreted in other tissues"					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.3	0.0	4.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	12.8	18.4	1.8	0.0	79.5	9.6	0.7	0.5	1.1	5.2	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	62.4	28.7	0.0	2.0	0.2	0.0	2.4	2.4	0.0	0.0	0.1	0.4	0.0	4.1	10.4	6.4	0.1	0.0	4.4	0.0	0.5	0.0	6.0	0.0	11.1	8.3	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0
NPAS1	"bHLHe11, MOP5, PASD5"	ENSG00000130751	"Neuronal PAS domain protein 1"	Q99742	19	47019820-47045775	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.2;skin 1: 10.5;stomach 1: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ: 8.7;Daudi: 8.9;HEK 293: 9.8;HMC-1: 8.1;NB-4: 15.6;U-266/84: 9.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043364, HPA072259"		Approved	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043364: , HPA072259: AB_2686500"	"unprognostic (2.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.14e-8)"	"unprognostic (8.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.20e-2)"	0.6	0.6	9.5	1.3	4.1	0.9	1.3	0.4	14.2	0.4	0.9	0.4	0.0	0.5	0.6	0.4	0.8	1.2	0.5	0.9	9.0	5.2	1.2	0.8	0.9	1.7	3.0	4.1	0.4	1.5	0.7	1.1	0.8	5.1	0.6	0.5	3.4	0.7	0.5	0.5	10.5	0.4	0.7	0.8	3.9	8.0	0.8	0.2	0.0	0.6	0.0	1.3	0.5	0.4	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.1	0.2	0.4	0.2	0.1	0.0	8.7	0.2	0.1	0.4	0.6	0.5	8.9	2.0	7.0	0.2	1.8	0.2	0.1	0.6	9.8	0.7	0.8	2.1	0.0	4.7	8.1	0.8	0.3	0.0	0.1	0.2	3.0	0.7	1.1	0.7	0.3	15.6	2.1	1.5	0.8	0.3	0.7	0.5	0.5	0.7	0.6	0.7	0.3	2.0	1.9	1.5	0.1	0.1	0.9	0.1	0.2	4.9	9.5	1.9	1.1	0.9	6.4	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.1	0.4	14.2	9.0	5.2	3.0	4.1	5.1	0.2
NPIPB4		ENSG00000185864	"Nuclear pore complex interacting protein family member B4"	C9JG80	16	21834569-21880827	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skin 1: 31.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053611: AB_2682206"	"unprognostic (3.09e-3)"	"unprognostic (3.51e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.04e-8)"	"unprognostic (3.37e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.46e-3)"	5.5	3.7	4.4	7.0	4.6	23.5	6.1	10.4	5.4	5.1	6.5			4.5	5.4	22.4	4.5	5.7	4.9	4.2	5.0	4.0	5.4	6.6	6.0	10.7	3.8		5.9	5.3	3.3	5.4	3.8		6.6	8.2		5.5	3.2	7.1	31.2	8.6	3.5	4.4	10.1	7.3	4.3			7.9		7.5	4.1	5.4	6.3	3.7	4.7	2.5	5.2	2.3	0.3	7.1	9.6	9.2	7.2	6.6	9.6	15.6	8.7	2.7	3.0	4.9	20.4	10.1	13.7	6.7	7.6	8.1	5.1	7.4	5.9	5.5	4.6	5.4	24.5	27.0	4.4	22.4	14.5	7.2	9.1	7.9	13.2	6.4	11.7	12.0	4.4	20.7	8.5	14.1	11.2	5.4	12.9	5.6	7.9	3.3	7.0	9.3	5.6	5.8	6.8	4.7	8.9	6.7	14.1	15.8	7.9	7.6	7.5	6.3	5.8	14.5	5.0	10.7	7.3	4.7	2.5	0.7	1.8	1.0	1.3	2.2	2.3	1.1	0.4	6.3	1.8	1.9	3.0	5.2	1.2	3.7	0.6	0.3										
NPY4R	"PP1, PPYR1, Y4"	ENSG00000204174	"Neuropeptide Y receptor Y4"	P50391	10	46461099-46465881	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 9.4;skin 1: 4.3"	"Cell line enriched"	"Detected in some"	5	"A549: 24.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 1.6;cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Approved									"HPA027863: AB_10602819"		"unprognostic (2.26e-6)"	"unprognostic (2.94e-1)"			"unprognostic (8.17e-2)"		"unprognostic (1.20e-1)"		"unprognostic (1.30e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-3)"	"unprognostic (6.58e-2)"			"unprognostic (9.79e-2)"	0.2	0.0	0.2	0.7	0.2	0.0	0.2	1.6	1.2	0.3	7.4	0.2	0.2	2.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.9	9.4	0.2	0.2	0.2	0.2	4.3	2.6	1.4	0.2	0.2	2.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	24.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.7	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.6	1.2	0.2	0.2	0.2	0.2	0.2	0.2
NPY4R2	CH17-360D5.1	ENSG00000264717	"Neuropeptide Y receptor Y4-2"		10	47918739-47923524	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 4.2;intestine: 6.3;skin 1: 3.3"	"Cell line enriched"	"Detected in some"	11	"A549: 20.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Uncertain									"HPA027863: AB_10602819"		"unprognostic (1.74e-2)"	"unprognostic (1.24e-2)"			"unprognostic (1.59e-1)"		"unprognostic (7.78e-2)"			"unprognostic (6.72e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.46e-2)"			"unprognostic (3.25e-1)"	0.2	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.4	0.0	6.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7		0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	0.0	0.0	0.0	3.3	3.4	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8;pituitary gland: 49.1;skin 1: 70.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 22.9;SCLC-21H: 46.6;SH-SY5Y: 22.7;SK-MEL-30: 21.8;TIME: 55.1;U-698: 19.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 25.5"	"Lineage enriched"	"Detected in single"	58	"T-cells: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favourable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	1.4	16.1	8.9	2.8	44.8	1.0	4.2	32.2	32.0	4.7	5.1	3.1	0.4	4.4	5.3	2.6	17.2	12.7	1.3	3.8	6.0	31.9	1.3	0.7	1.4	2.3	15.8	19.2	29.5	1.6	0.5	49.1	20.9	38.8	14.4	4.8	7.6	4.5	12.5	1.0	70.0	3.8	4.7	6.2	1.8	5.3	9.8	4.4	3.7	0.8	4.3	2.6	10.2	8.3	0.0	0.0	0.4	0.0	0.3	25.5	6.9	0.0	0.0	0.2	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.8	0.1	0.6	22.9	1.4	0.1	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.3	0.0	0.6	3.9	0.0	0.0	0.3	0.0	1.7	0.1	2.7	0.1	0.0	0.0	0.1	0.0	1.2	46.6	22.7	0.1	0.0	21.8	0.2	0.0	55.1	0.0	3.6	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.1	0.0	0.0	0.0	19.2	0.0	25.5	0.0	18.0	15.6	0.0	0.0	4.7	12.0	0.4	0.3	0.0	0.0	1.7	6.9	8.9	44.8	32.2	32.0	6.0	31.9	15.8	19.2	38.8	4.4
NTF4	"GLC1O, NT-4/5, NTF5"	ENSG00000225950	"Neurotrophin 4"	P34130	19	49061066-49065054	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HaCaT: 18.3;HBEC3-KT: 6.8;hTCEpi: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049376			Approved	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"	"Golgi apparatus"	"HPA049376: AB_2680735"	"unprognostic (4.15e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.27e-4)"	"unprognostic (1.76e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.90e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.71e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.46e-3)"	0.3	0.0	0.3	0.3	0.3	0.0	3.6	0.3	1.0	2.8	0.3	0.3	5.7	0.0	0.3	8.0	7.1	1.7	0.3	0.3	0.3	0.0	0.3	0.3	3.3	0.3	0.3	0.3	0.3	0.3	0.0	2.3	3.0	0.3	11.9	0.0	0.3	5.7	6.1	11.9	24.3	0.3	1.4	0.3	0.3	0.0	1.3	0.3	1.4	0.9	2.3	2.2	6.2	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.1	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.0	8.1	0.0	2.1	0.0	18.3	0.0	6.8	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.9	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.1	1.1	2.2	0.1	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.3	0.3	0.3
NXPH4	NPH4	ENSG00000182379	"Neurexophilin 4"	O95158	12	57216795-57226449	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.1;skin 1: 17.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.4;RH-30: 28.2;RPMI-8226: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"						"unprognostic (1.08e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavourable (6.21e-4)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (7.68e-6)"	"unprognostic (7.83e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-3)"	2.8	1.4	2.6	0.8	3.8	0.9	1.9	18.1	9.4	1.9	0.4	0.0	0.0	0.3	0.3	0.7	2.5	0.4	0.4	4.6	1.6	3.7	0.7	1.1	0.4	1.1	2.6	6.2	0.3	1.6	0.7	0.7	4.8	10.9	8.2	0.3	2.7	3.2	0.4	0.6	17.7	0.4	0.5	3.4	0.8	0.4	1.3	0.0	0.0	1.0	0.7	1.7	0.5	2.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.6	0.1	34.4	4.0	1.0	3.2	2.2	5.1	0.9	1.2	2.2	0.4	8.5	3.5	2.2	7.2	4.6	1.0	0.3	1.4	9.2	0.0	0.3	0.1	3.4	0.3	1.1	0.9	1.8	0.9	1.4	0.0	0.3	9.0	0.7	8.0	0.0	0.0	0.3	6.0	0.4	28.2	18.5	0.0	1.4	5.6	0.3	4.9	10.1	9.8	10.0	0.2	0.0	2.5	8.2	1.0	2.5	4.9	0.9	3.0	1.6	4.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.8	18.1	5.7	1.6	3.7	2.6	6.2	10.9	0.0
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 3.6;skin 1: 3.0;testis: 12.1"	"Cell line enhanced"	"Detected in single"		"U-266/84: 2.3"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0			0.0	1.2	2.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.8;SK-MEL-30: 22.2"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.8	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.4;skin 1: 60.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.4;ASC diff: 14.6;BJ hTERT+: 11.1;SH-SY5Y: 14.8;U-2 OS: 17.8;WM-115: 15.4"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in many"	27	"granulocytes: 24.9;T-cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	2300000	2300000	Nucleoplasm	Nucleoplasm	"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	20.9	12.2	37.2	2.7	39.7	0.8	5.8	9.1	51.4	4.5	1.9	11.6	0.3	2.1	7.9	3.8	3.9	6.6	4.9	3.9	26.2	21.6	1.8	23.5	3.2	5.0	19.6	17.9	3.5	7.9	1.1	4.4	5.2	15.4	5.2	1.4	3.2	7.1	10.3	1.7	60.2	2.0	5.1	9.0	2.2	1.4	5.2	4.6	16.0	8.4	1.1	3.7	2.6	3.2	0.0	0.0	24.9	0.0	0.6	8.9	1.7	0.0	2.2	1.8	15.4	14.6	9.0	1.0	3.3	11.1	0.7	0.9	0.1	1.4	0.0	1.4	2.5	0.9	5.9	1.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	2.6	4.7	0.9	0.1	0.1	0.0	0.1	0.2	0.0	4.8	0.1	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	14.8	0.5	0.0	3.0	0.5	0.0	0.1	6.5	17.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	15.4	9.6	0.0	24.9	3.5	0.0	3.8	0.0	4.1	3.1	0.0	0.0	8.0	5.1	0.3	0.6	0.0	0.0	8.9	1.7	37.2	39.7	9.1	38.0	26.2	21.6	19.6	17.9	15.4	4.6
OR10A3	"HSHTPCRX12, HTPCRX12"	ENSG00000170683	"Olfactory receptor family 10 subfamily A member 3"	P58181	11	7937171-7941708	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;bone marrow: 1.4;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HMC-1: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"																																		"unprognostic (2.53e-2)"		"unprognostic (3.24e-3)"	0.1	0.1	0.0	0.2	0.0	1.4	0.4	0.0	0.1	0.2	0.0			0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.2	0.1	0.0	0.0	0.0		0.3	0.1		0.2	0.0	0.0	1.8	0.2	0.0	0.0	0.4	0.3	0.2			0.1		0.0	0.9	0.1	0.5	0.4	2.2	0.3	0.2	0.3	0.1	2.1	0.2	0.0	0.4	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.8	0.2	0.0	0.2	0.0	0.1	0.2	0.8	0.3	0.4	0.2	0.5	0.2	0.2	0.3	0.2	0.1	0.0	0.3	0.3	0.2	0.6	0.5	0.0	0.1	0.0	0.3	0.1	0.2	0.3	0.3	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	1.7	0.2	0.1	0.4	0.2	0.1										
OR10A6		ENSG00000279000	"Olfactory receptor family 10 subfamily A member 6 (gene/pseudogene)"	Q8NH74	11	7924592-7931268	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;Karpas-707: 1.1;LHCN-M2: 2.4;RPMI-8226: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.7	0.4		0.0	0.0	0.0			0.0	0.1	0.5	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.1	1.3	0.0	0.0		0.0	0.4	0.3			0.0		0.0	0.0		0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
OR11H4		ENSG00000176198	"Olfactory receptor family 11 subfamily H member 4"	Q8NGC9	14	20239286-20244349	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-266/70: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA052790	Uncertain									"HPA052790: AB_2681950"																		0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.9	0.3	0.1	0.0			0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.2	0.0		0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6			0.3		0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4K13		ENSG00000176253	"Olfactory receptor family 4 subfamily K member 13"	Q8NH42	14	20029399-20036038	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;skin 1: 1.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																																							0.1	0.6	0.1	0.4	0.1	1.2	0.1	0.1	0.3	0.4	0.1			0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0		0.3	0.1	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.3	1.6	0.1	0.0	0.1	0.4	0.1	0.5			0.4		0.0	0.2	0.3	0.8	0.6	1.7	0.6	0.8	0.3	0.2	0.2	0.1	0.4	0.7	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.3	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.5	1.1	0.5	0.3	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.0	0.5	0.6	0.4	0.4	0.0	0.4	0.1	0.2	0.0	0.4	0.4	0.3	0.1	0.2	0.1	0.8	0.0	0.2	0.8	0.4	0.7	0.2	0.6	0.3	0.3	0.6	0.3	0.1	1.7	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.1	0.8	0.3	0.3	1.3	0.8	0.3	0.6	0.2	0.2										
OR5P3	JCG1	ENSG00000182334	"Olfactory receptor family 5 subfamily P member 3"	Q8WZ94	11	7824818-7830840	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060787	Uncertain									"HPA060787: AB_2684364"																	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.5			0.0		0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5T2		ENSG00000181718	"Olfactory receptor family 5 subfamily T member 2"	Q8NGG2	11	56231282-56234255	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	0.3	0.1			0.1	0.2	0.0	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.2		0.1	0.5	0.0	0.1	0.1		0.1	0.0		0.7	0.2	0.3	1.6	0.3	0.0	0.4	0.1	0.1	0.9			0.1		0.0	0.3	0.1	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.6	2.1	0.2	0.6	0.2	0.3	0.6	0.2	0.4	1.4	0.0	0.8	0.1	0.1	1.2	0.5	0.6	0.1	1.2	1.8	0.6	0.7	1.4	0.0	0.4	0.5	0.2	0.0	0.3	0.2	0.9	0.6	0.5	0.0	0.4	0.6	1.1	0.9	0.4	0.4	0.8	0.2	0.0	1.0	0.7	0.5	0.1	0.3	0.3	0.5	0.4	0.4	1.0	0.2	0.5	0.4	1.1	2.4	0.6	0.3	1.0	0.8	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0										
OR6C6		ENSG00000188324	"Olfactory receptor family 6 subfamily C member 6"	A6NF89	12	55293988-55296569	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;MCF7: 1.5;THP-1: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA051090	Uncertain									"HPA051090: AB_2681341"																		0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.1	0.2	0.5	0.1			0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.2		0.1	0.0		0.2	0.0	0.5	1.7	0.0	0.2	0.1	0.1	0.1	0.3			0.0		0.0	0.0	0.0	1.1	1.0	2.3	0.5	0.5	0.6	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.4	0.0	0.4	0.0	0.0	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.5	0.8	0.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.2	2.3	0.5	0.9	0.6	0.1	0.3	0.6	0.5	0.4	0.1	1.1	0.5	0.6	1.8	0.5	0.3	1.0	0.6	0.1										
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188803-4226889	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA035599	Uncertain									"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0			0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.8			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"CAB012341: AB_2157155, HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.8	2.7	1.6	0.0	0.1	3.8	0.0	0.2	0.2	0.2	2.8	1.4	0.1	0.5	0.0	1.9	1.8	1.2	0.3	0.6	1.6	1.7	1.4	3.1	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.0	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.0	1.4	2.3	0.4	0.7	0.5	0.3	0.3	1.1	0.1	0.9	0.6	33.9	0.1	0.6	1.1	0.0	0.5	1.0	0.7	2.5	0.2	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4
OVOL3	HOVO3	ENSG00000105261	"Ovo like zinc finger 3"	O00110	19	36111151-36113711	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;skin 1: 3.0;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"U-266/84: 7.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																		"unprognostic (1.70e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.96e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.2	0.0			0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1		0.1	0.1	0.0	0.4	0.0		0.1	0.0		0.1	0.2	0.7	3.0	0.1	0.0	0.2	0.1	0.0	5.1			0.0		0.8	0.2	0.1	0.2	0.0	1.9	0.3	0.0	0.9	0.0	1.6	2.7	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.5	1.3	0.3	0.0	1.5	0.0	0.0	0.3	0.8	1.1	0.3	2.6	0.4	0.0	1.1	0.9	0.0	0.0	0.5	0.0	0.0	0.6	1.1	0.0	0.0	1.2	0.6	0.3	1.3	1.7	0.5	1.4	0.0	0.2	0.6	0.8	0.3	0.2	0.4	1.1	0.2	0.0	0.0	2.0	0.5	0.6	2.2	7.4	1.2	0.1	0.9	0.2	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0										
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.5;HaCaT: 22.5;hTCEpi: 13.8;SK-BR-3: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.6	0.0	0.2	0.1	0.0	0.0	4.3	0.0	0.1	0.6	0.4	14.5	2.0	0.1	2.3	0.0	22.5	3.2	4.8	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	13.8	0.2	3.2	0.0	1.1	0.2	0.0	3.1	0.0	0.3	0.4	2.0	0.2	0.1	1.8	1.1	5.9	5.2	1.3	1.8	7.6	0.2	0.8	7.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.3	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247546	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 21.1;hTCEpi: 19.7;RT4: 15.8;U-2 OS: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	2.9	2.2	3.1	4.0	3.1	0.8	8.8	2.0	4.3	15.1	5.0	3.1	8.2	2.1	9.5	6.1	17.3	6.7	4.5	3.0	4.3	4.1	5.5	3.5	2.6	10.4	2.8	2.4	8.9	3.1	2.1	3.7	5.7	3.7	8.8	2.5	4.0	7.0	6.6	2.0	37.0	2.9	8.2	2.6	2.4	2.5	2.4	1.8	6.9	20.7	14.1	11.2	8.4	10.7	0.5	0.5	2.5	0.4	0.6	1.0	0.1	1.6	2.4	10.2	7.7	0.3	0.4	7.4	1.9	0.4	1.7	0.2	0.7	0.7	0.0	0.8	0.8	7.6	3.6	10.9	1.6	0.3	3.2	0.1	1.9	5.8	0.5	2.1	21.1	3.4	19.7	0.2	1.0	0.8	0.7	0.5	2.4	2.8	1.9	0.2	3.1	2.9	0.0	6.7	0.8	0.3	15.8	4.3	4.4	2.3	1.3	10.8	1.5	1.9	0.6	3.4	17.0	1.2	0.9	0.5	0.6	0.1	1.1	0.5	6.3	2.5	0.2	0.4	0.3	0.2	0.2	0.3	0.3	1.0	0.2	0.5	0.4	0.5	1.2	0.6	0.4	0.5	0.1	0.1	3.1	3.1	2.0	4.3	4.3	4.1	2.8	2.4	3.7	1.8
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.2;hTCEpi: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022269	Enhanced									"HPA022269: AB_1855219"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.0	11.3	0.0	1.1	7.9	8.4	23.6	16.4	18.5	2.3	1.7	9.2	20.8	0.0	5.9	4.1	37.2	2.0	29.6	0.5	15.8	9.2	0.0	11.3	8.7	5.7	0.0	0.0	6.3	139.5	0.2	15.2	9.2	0.1	4.4	0.2	6.9	0.0	0.5	4.8	6.0	0.0	3.7	0.0	15.8	11.7	3.9	0.0	17.3	9.3	7.9	5.2	2.0	11.0	4.1	1.6	4.4	0.0	1.3	1.7	0.0	3.3	0.0	8.7	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.6;HDLM-2: 3.5;hTCEpi: 3.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219704-22232341	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.4;skin 1: 37.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.7;SH-SY5Y: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4"	HPA069318	Approved		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	5.4	18.6	25.0	2.3	71.8	1.3	3.5	58.9	89.4	3.2	2.1	3.0	0.0	2.2	6.0	3.4	7.1	9.8	6.2	2.9	31.2	12.3	2.2	1.4	1.8	1.4	7.3	40.3	2.3	2.2	1.3	5.5	3.0	21.1	3.6	1.7	0.0	1.4	5.9	1.7	37.9	2.4	7.2	3.5	3.6	1.6	5.8	10.4	0.0	2.0	0.0	1.4	7.8	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.3	0.8	1.1	0.3	1.2	0.4	0.4	0.1	1.9	0.0	2.1	0.6	3.7	0.0	0.6	0.1	0.0	0.2	0.0	3.9	1.4	1.6	0.0	0.0	0.9	0.0	0.8	0.0	2.5	0.2	1.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	12.7	0.0	0.0	4.3	4.9	2.9	0.0	3.3	0.0	0.3	1.1	0.0	2.1	1.5	0.7	1.0	0.2	0.0	2.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	71.8	58.9	82.9	31.2	12.3	7.3	40.3	21.1	10.4
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in some"	5	"HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		2700000	2700000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	44.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.0	1.0	25.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell line enriched"	"Detected in single"	67	"RT4: 54.8"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favourable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Group enriched"	"Detected in some"	5	"AF22: 13.9;AN3-CA: 14.0;NTERA-2: 7.1;SCLC-21H: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favourable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	14.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.9	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"																						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.6	1.7	0.2	0.4	2.1	1.0	4.1	1.0	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell line enriched"	"Detected in some"	4	"RT4: 13.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA042713: , HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	13.2	0.7	0.1	0.0	1.4	0.0	1.4	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 49.5;hTCEpi: 23.3;hTERT-HME1: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced									"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	6.9	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	13.9	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.7	5.6	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6466092-6520061	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;skin 1: 60.0"	"Cell line enhanced"	"Detected in many"		"TIME: 17.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2"	"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	10.6	9.7	8.7	2.9	6.3	0.7	4.1	59.8	11.6	3.9	3.0	1.2	2.5	3.3	3.8	4.5	7.1	3.9	6.5	5.4	7.7	2.9	2.3	0.8	3.6	2.7	1.8	6.7	2.6	3.1	4.0	15.2	7.6	4.4	3.4	2.8	4.9	4.2	5.3	3.4	60.0	4.3	2.7	1.8	16.9	2.6	2.6	1.4	0.0	2.4	6.5	4.8	2.3	4.4	0.5	0.6	2.1	0.5	0.3	1.0	0.4	3.9	1.1	8.0	4.7	0.8	2.7	1.4	5.4	3.0	1.7	1.0	2.3	7.9	0.1	12.4	1.7	13.6	0.9	11.9	0.8	7.8	1.5	0.0	5.5	1.4	1.2	0.0	0.7	2.9	6.4	5.8	6.8	12.1	0.0	1.0	0.4	3.4	0.1	15.4	2.5	12.0	0.0	1.0	1.0	4.3	1.3	5.2	14.7	0.6	4.1	0.3	5.3	0.1	17.3	4.1	3.0	0.0	3.3	0.1	0.0	0.9	4.5	0.0	0.3	1.8	0.5	0.3	0.4	0.4	1.0	0.2	0.8	0.7	0.1	0.5	0.5	0.6	2.1	0.3	0.2	0.6	0.2	0.4	8.7	6.3	59.8	11.6	7.7	2.9	1.8	6.7	4.4	1.4
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell line enhanced"	"Detected in many"		"A-431: 11.1;HaCaT: 19.5;SK-BR-3: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.1	1.2	0.0	0.7	0.0	0.5	1.9	5.2	1.3	3.4	0.8	1.5	8.6	0.0	2.5	2.1	19.5	0.2	3.2	0.5	3.8	0.8	0.0	3.4	2.2	0.4	0.2	0.1	0.1	2.7	2.2	1.2	0.3	0.2	3.1	0.2	6.5	0.0	0.2	0.3	9.0	0.0	0.0	4.1	3.6	3.4	0.1	0.1	5.8	13.3	0.7	2.5	0.0	2.3	4.2	1.8	0.4	3.4	2.5	0.1	0.1	5.1	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
PLET1	C11orf34	ENSG00000188771	"Placenta expressed transcript 1"	Q6UQ28	11	112248479-112260860	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 2.8"	"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040237	Uncertain									"HPA040237: AB_10793960"								"unprognostic (8.70e-2)"		"unprognostic (1.75e-1)"			"unprognostic (8.51e-3)"	"unprognostic (5.19e-2)"				0.2	0.7	0.0	0.2	0.0	1.1	0.2	0.3	0.1	0.5	0.2			0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.0		0.3	0.5	0.0	1.2	0.1		0.1	0.0		0.2	0.0	0.5	2.8	0.3	0.0	0.0	0.1	0.1	0.3			0.2		0.0	0.1	0.1	0.7	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.4	0.0	0.6	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.4	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.7	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0										
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36312229	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;skin 1: 25.1"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 28.5;eosinophil: 9.5"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	10	"cerebellum: 0.4"	HPA037853			Uncertain	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA037853: "	"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.8	0.2	0.1	0.5	0.1	3.6	0.5	0.1	0.5	0.3	1.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.5	1.0	1.0	5.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.2	25.1	7.4	0.1	0.8	3.7	1.4	0.8	0.1	0.9	0.1	0.1	0.1	0.1	0.5	0.0	0.9	28.5	1.9	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	20.5	0.0	28.5	1.9	9.5	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.1	0.0	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.6;epididymis: 6.2;skin 1: 4.6"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.9;RPMI-8226: 7.1;SCLC-21H: 2.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain									"HPA050409: AB_2681118, HPA054211: AB_2682418"				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.1	0.5	0.2	5.6	1.0	0.9	0.1	2.4	0.1	0.0			0.1	0.3	6.2	0.0	0.6	0.5	0.0	0.8	0.9	0.0	1.7	0.1	0.1	0.4		0.0	0.0	0.0	1.3	0.1		0.2	0.0		0.1	0.1	0.0	4.6	0.0	0.1	0.1	0.2	0.1	0.4			0.5		0.0	0.0	0.0	0.7	1.0	2.2	0.5	0.2	0.7	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.8	0.3	0.4	0.1	0.4	0.2	0.4	0.2	0.5	0.1	0.7	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.3	0.4	0.3	0.1	0.3	3.9	0.1	0.2	0.2	7.1	0.1	0.0	2.4	0.2	0.5	0.1	0.0	0.3	0.1	0.2	0.6	0.2	0.3	0.1	0.3	0.1	0.2	0.4	0.2	0.1	2.2	0.5	0.1	0.7	0.3	0.5	0.4	0.6	0.6	0.1	0.7	0.4	0.6	1.6	0.2	0.5	1.0	0.6	0.0										
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		430000	430000	"Golgi apparatus"	"Golgi apparatus"	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.7	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	11.3	5.8	1.6	0.0	11.5	2.5	0.1	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	1.9	0.0	4.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	38.6	0.0	0.0	0.0	2.9	0.0	1.2	0.5	0.1	0.0	0.0	0.1	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379634-45406349	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 78.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.1;hTCEpi: 51.3;hTERT-HME1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: "	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavourable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	6.7	6.6	2.5	3.6	4.1	0.6	14.5	3.5	3.4	13.2	6.2	2.4	8.5	2.9	5.8	8.2	51.6	3.6	4.7	37.2	4.0	1.2	8.0	5.7	8.5	1.6	3.9	2.5	4.4	12.4	6.6	6.6	38.7	3.9	11.5	3.8	5.1	17.8	15.7	3.8	78.3	7.1	3.8	3.3	2.5	4.4	1.6	6.1	2.7	10.6	24.4	25.6	13.2	22.9	0.6	0.7	0.0	1.5	0.0	2.3	0.2	20.8	2.9	1.2	1.0	1.2	0.8	18.2	3.8	0.6	4.7	6.5	6.0	19.5	2.4	1.7	3.0	28.0	1.0	35.1	4.3	6.4	1.5	0.3	9.6	2.2	2.7	0.2	0.9	1.1	51.3	7.4	35.6	8.8	2.1	0.9	0.3	17.1	0.4	0.4	1.4	4.9	1.9	1.4	0.4	6.1	25.1	0.6	2.1	19.3	18.6	0.4	16.3	0.5	13.4	6.0	18.4	0.4	18.4	10.5	10.7	1.6	0.9	0.7	1.4	0.0	0.0	0.0	1.5	0.4	0.7	0.6	2.3	0.4	0.2	0.2	0.1	0.7	0.0	0.0	1.5	0.7	1.3	0.2	2.5	4.1	3.5	3.4	4.0	1.2	3.9	2.5	3.9	6.1
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143076-150250357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;HBEC3-KT: 32.6;hTCEpi: 39.9;hTERT-HME1: 16.0;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.4	4.2	1.9	7.7	0.3	3.7	1.3	12.8	4.5	6.8	0.8	0.0	5.7	1.0	0.7	8.0	9.0	0.3	50.0	4.7	3.7	5.3	0.3	6.7	0.4	2.7	7.6	0.2	0.5	4.7	0.8	13.9	7.7	0.9	5.0	0.1	1.5	0.3	32.0	37.1	1.2	0.7	1.3	0.3	0.7	3.5	1.0	0.0	32.4	8.8	3.2	0.4	8.3	0.0	0.0	0.0	0.2	0.0	1.2	0.1	10.2	0.0	4.5	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.5	1.4	0.2	3.1	2.0	15.4	2.3	32.6	0.0	0.0	13.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	39.9	0.0	16.0	0.0	8.6	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	13.7	0.5	2.4	0.0	0.2	14.5	0.8	0.0	0.7	0.0	0.0	7.9	12.5	3.5	0.0	0.0	0.0	5.5	6.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.2	7.7	1.3	12.8	4.7	3.7	2.7	7.6	7.7	1.0
PROX2	FLJ36749	ENSG00000119608	"Prospero homeobox 2"	Q3B8N5	14	74852871-74871940	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 5.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;CACO-2: 3.8;U-698: 3.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045057	Uncertain									"HPA045057: AB_10960259"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.73e-4)"	0.6	0.3	0.4	1.6	1.6	4.1	0.6	1.8	1.2	1.9	0.5			0.6	0.9	2.1	0.6	1.2	0.3	0.4	0.5	0.9	0.5	0.2	0.8	2.4	0.8		2.9	0.6	0.8	1.4	0.6		1.3	1.0		0.9	1.1	0.5	5.8	1.0	0.2	1.0	2.0	0.4	0.7			1.7		1.5	0.6	1.2	0.8	1.0	4.2	0.7	3.5	0.7	0.3	0.2	0.5	5.1	1.9	1.5	0.6	1.5	0.4	0.0	0.0	0.3	3.8	0.5	0.3	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.2	1.8	1.7	1.0	0.5	0.1	2.4	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	2.2	0.2	0.8	0.3	0.5	1.2	0.9	0.1	0.0	1.0	1.4	0.6	0.2	0.4	0.0	0.5	1.7	0.3	1.3	0.5	0.4	0.3	0.8	0.4	3.6	0.1	1.6	0.0	0.2	0.7	3.0	0.5	0.6	0.7	0.8	0.2	0.4	0.4	0.5	0.4	0.6	4.2	3.5	0.5	1.0	0.0	0.3										
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061228	Enhanced				"Secreted in other tissues"					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
PYDC1	"ASC2, POP1"	ENSG00000169900	"Pyrin domain containing 1"	Q8WXC3	16	31215962-31217359	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;skin 1: 10.1"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 2.4;T-47d: 2.5;U-266/70: 1.3"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 8.0"					"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"																						"unprognostic (9.72e-3)"	"unprognostic (1.00e-2)"		"unprognostic (2.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-2)"		"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.60e-10)"	"unprognostic (3.62e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.47e-2)"	0.1	0.1	7.7	0.2	9.0	0.2	1.0	12.4	2.7	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.5	2.4	0.1	0.0	0.0	0.1	0.9		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.5	0.0	3.0	10.1	0.1	0.0	0.1	0.2	0.3	0.1			0.0		0.5	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0										
RAB7B	"MGC16212, MGC9726"	ENSG00000276600	"RAB7B, member RAS oncogene family"	Q96AH8	1	205976740-206003461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 21.3;skin 1: 23.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 11.4;HBEC3-KT: 14.9;HMC-1: 40.6;hTCEpi: 17.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"myeloid DC: 8.4"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.18e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.82e-3)"	21.3	0.0	0.5	1.9	1.3	0.0	4.5	0.0	2.0	6.6	0.6	4.0	3.6	0.6	3.3	4.7	7.7	0.9	6.5	1.7	0.5		0.0	0.5	6.1	2.6	0.5	0.0	1.7	0.0	0.0	0.0	5.8	3.0	2.5	0.9	1.5	1.9	3.2	0.6	23.7	0.5	4.2	1.3	1.0	2.5	1.6	0.8	3.4	3.0	13.3	4.4	3.3	0.3	0.0	8.4	0.0	1.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.9	6.8	1.6	2.9	3.6	1.3	1.1	0.4	1.0	0.0	1.0	11.4	2.9	0.0	14.9	0.4	0.1	0.0	0.0	0.0	0.3	0.0	9.4	40.6	2.3	17.4	2.4	0.0	0.0	0.1	0.0	0.8	0.1	0.0	5.8	0.1	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.4	0.0	1.9	1.0	3.3	0.0	0.8	2.0	0.8	0.2	0.0	0.0	0.0	5.5	4.0	1.4	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4										
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 87.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 38.2;hTCEpi: 19.2;T-47d: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA022895: "	"prognostic favourable (8.43e-4)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	1.5	1.3	15.9	2.7	17.2	1.8	4.1	8.2	22.7	8.9	19.5	1.8	0.9	18.8	1.6	4.3	37.7	2.9	5.9	1.1	11.2	6.2	0.6	1.7	1.6	1.1	2.8	20.2	0.8	1.6	0.8	2.7	1.2	5.5	3.4	17.7	1.3	5.7	3.2	4.6	87.1	15.5	2.0	1.9	1.4	12.6	2.4	2.9	0.2	0.9	13.3	10.7	6.5	19.4	0.1	0.9	2.9	0.4	0.0	0.6	0.0	2.1	1.0	5.7	4.2	0.6	1.4	2.7	0.8	0.6	1.1	1.3	2.4	3.1	1.7	0.8	1.1	38.2	1.1	1.3	1.6	3.1	2.8	1.0	1.2	2.3	0.7	2.0	3.5	1.6	19.2	1.1	0.5	1.7	0.7	1.1	0.8	5.8	1.9	2.5	1.7	1.0	3.5	0.6	1.0	0.7	11.2	11.0	2.2	1.3	13.0	0.5	33.4	1.5	3.2	1.4	2.9	1.4	1.2	1.9	1.8	1.4	3.3	1.2	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.1	0.2	2.9	0.0	0.4	0.2	0.0	0.0	15.9	17.2	8.2	22.7	11.2	6.2	2.8	20.2	5.5	2.9
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 49.4;skin 1: 52.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;MCF7: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 5.6;T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053883	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	4.8	5.0	2.7	7.0	3.6	1.3	10.8	6.3	3.8	26.8	6.3	1.8	7.3	1.0	14.6	6.0	49.4	10.6	8.6	6.9	3.0	1.4	3.7	1.9	7.4	6.7	2.4	2.3	12.6	2.7	4.2	2.8	4.4	1.6	11.3	3.4	10.3	9.5	10.6	2.6	52.1	3.0	9.7	1.5	4.7	6.0	3.9	1.7	2.3	7.3	30.6	26.8	10.9	19.8	1.8	5.6	1.5	2.5	1.7	17.0	2.9	7.2	8.0	1.8	16.9	18.8	16.2	0.5	7.6	16.6	10.0	7.8	2.7	33.2	0.1	4.1	30.5	24.4	6.1	14.6	2.5	1.9	3.1	1.0	6.1	2.3	7.9	0.0	3.0	11.9	21.4	9.5	2.1	4.2	0.2	3.2	3.9	35.0	0.4	0.3	5.4	14.1	2.3	0.6	5.8	2.9	12.0	1.5	7.6	15.4	16.7	10.1	14.5	0.4	4.5	12.0	5.6	7.9	0.4	1.5	0.8	0.5	14.7	1.2	16.9	1.5	2.5	0.7	6.6	0.8	17.0	1.8	5.7	4.8	5.6	0.6	4.8	4.1	0.0	1.7	0.0	0.4	1.5	2.9	2.7	3.6	6.3	3.8	3.0	1.4	2.4	2.3	1.6	1.7
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)"	Q96NR8	14	67701886-67734452	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.3"	"Cell line enhanced"	"Detected in some"		"K-562: 2.0;SK-MEL-30: 2.4;U-266/70: 1.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.0	1.9	0.0	0.0	0.5	0.0	1.2	0.3	0.5	4.9	0.0			0.0	0.0	5.3	9.9	0.1	10.6	0.0	0.1	0.3	7.7	1.9	0.0	0.0	1.3		0.0	1.7	0.0	0.1	0.0		0.0	0.0		0.6	0.0	0.0	29.3	0.0	0.0	0.0	0.0	6.9	0.0			0.4		0.6	0.0	9.7	0.2	0.6	0.0	0.9	0.5	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	1.6	0.0	0.7	0.2	0.6	0.0	0.0	0.6	0.4	0.0	1.0	0.2	0.0	0.2	0.0	1.1	0.1	0.2	0.7	2.0	0.7	0.1	0.7	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.4	1.3	0.0	0.0	1.1	2.4	0.8	0.1	0.0	0.3	1.4	0.4	0.0	1.7	0.7	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.6	0.1										
REELD1		ENSG00000250673	"Reeler domain containing 1"		4	146214515-146230878	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"breast: 1.3;epididymis: 1.5;skin 1: 1.7"	"Cell line enriched"	"Detected in single"	87	"HDLM-2: 14.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.1	0.0		0.9		0.4	1.3		0.2	0.4	0.0			0.0	0.0	1.5	0.0	0.2	0.0	0.0			0.1	0.7	0.2	0.2			0.0	0.4	0.0		0.0		0.3	0.0		0.0	0.0	0.5	1.7	0.0	0.0		1.0	0.0	0.1			0.0		0.7	0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2										
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874289	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 74.8;skin 1: 31.5;tongue: 29.2"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 82.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA053343	Enhanced									"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.2	0.0	0.4	0.4	0.4	0.0	7.8	0.8	0.9	8.8	0.9	0.2	0.5	0.1	0.6	4.8	74.8	1.2	0.6	0.2	0.4	0.3	1.9	0.2	1.9	0.2	0.2	0.5	0.2	7.4	0.4	0.7	7.3	1.2	4.2	1.1	0.2	12.6	1.1	0.2	31.5	0.5	0.7	0.3	0.3	0.3	0.8	0.3	2.0	0.2	29.2	27.9	5.2	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.0	0.9	1.1	0.0	0.6	0.0	19.3	1.1	0.1	0.0	2.5	3.1	0.1	2.7	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.1	0.0	6.5	0.1	0.5	0.4	0.9	0.9	0.1	0.4	1.2	8.4	1.0	0.2	1.9	82.5	0.0	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.8	0.9	0.4	0.3	0.2	0.5	1.2	0.3
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330242-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 31.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.2;U-2197: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.7;non-classical monocyte: 19.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 19.1"	"Group enriched"	"Detected in many"	6	"amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6"	"Group enriched"	"Detected in many"	6	"amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1"	HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.9	5.1	11.1	7.1	22.7	3.9	3.4	13.0	13.5	5.9	5.2	1.5	2.4	8.0	4.2	2.3	15.8	5.8	8.7	3.3	9.7	2.3	2.3	2.7	3.8	5.4	1.4	5.8	4.8	6.6	1.5	5.0	4.5	2.2	4.7	3.6	2.5	4.8	3.5	10.3	31.5	5.8	2.8	0.8	4.6	11.1	2.8	2.5	0.0	1.5	8.7	8.6	3.4	7.0	0.1	3.3	0.0	19.1	0.0	1.5	2.0	1.6	4.4	1.3	2.7	1.5	8.6	1.0	9.9	9.1	7.6	3.7	2.7	5.0	0.3	5.0	7.2	10.5	0.0	13.4	1.0	0.5	0.0	0.4	4.3	2.3	3.0	0.1	4.6	8.3	26.2	7.8	4.7	1.6	0.2	0.1	3.3	0.3	0.1	11.3	0.6	19.8	0.1	3.8	0.0	2.2	1.7	9.9	2.6	2.6	1.3	13.6	0.9	0.8	4.3	12.3	7.3	28.8	2.5	0.2	0.5	0.0	17.1	2.6	4.9	0.0	4.3	0.0	0.2	9.7	1.5	0.1	1.0	0.3	3.3	0.0	1.1	0.5	0.0	0.0	19.1	0.0	0.1	2.0	11.1	22.7	13.0	13.5	9.7	2.3	1.4	5.8	2.2	2.5
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	6	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"	"Vesicles, Plasma membrane, Centrosome"	"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.7	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.5	2.6	1.1	0.3	0.0	0.0	0.1	0.3	0.0	1.9	0.0	0.2	0.0	0.7	0.6	0.0	1.0	0.0	1.3	0.0	0.0	0.3	0.4	0.0	1.9	0.3	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.3	1.9	8.0	0.7	0.6	0.1	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229319	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 64.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.3;U-266/70: 19.7;U-266/84: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009861	Approved									"CAB009861: AB_2180141"	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.6	32.4	8.1	6.0	9.8	12.2	12.0	29.8	17.0	7.6	6.1	4.8	11.9	2.7	7.5	6.7	14.8	5.4	8.1	6.7	8.7	4.2	11.2	23.1	10.0	5.9	7.8	7.0	8.9	11.8	11.8	10.3	4.1	10.0	5.4	3.5	9.1	7.8	12.0	34.6	64.8	6.2	7.8	11.0	7.7	5.5	11.2	9.3	1.5	11.1	9.9	8.8	8.9	10.3	0.8	0.4	0.3	0.0	3.7	16.9	2.6	0.0	0.3	1.2	0.0	1.6	0.8	0.4	0.6	0.7	0.5	0.6	0.8	0.2	0.0	0.2	1.6	0.2	2.8	1.2	1.0	1.3	2.4	0.0	0.1	1.3	0.6	0.0	0.1	3.7	0.3	1.5	0.0	5.4	0.1	34.3	2.3	0.1	0.3	0.0	0.9	0.5	0.0	1.1	0.5	1.1	0.2	0.9	2.1	0.1	0.2	0.0	0.0	0.0	0.1	4.8	2.1	1.9	0.0	19.7	27.2	0.1	8.1	0.0	0.5	0.1	0.0	0.0	14.7	0.0	16.9	0.8	11.1	9.9	0.0	0.1	3.5	7.4	0.3	3.7	0.0	0.4	9.3	2.6	8.1	9.8	29.8	17.0	8.7	4.2	7.8	7.0	10.0	9.3
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.7"	"Cell line enhanced"	"Detected in many"		"A549: 33.4;HBEC3-KT: 17.8;HeLa: 21.7;U-2197: 19.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 8.9;monocytes: 6.9"					"Low region specificity"	"Detected in many"			"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		390000	390000	Cytosol	Cytosol	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	4.7	0.6	0.6	3.3	3.1	1.5	2.2	0.6	1.7	3.7	1.2	1.3	0.1	0.4	2.4	1.6	7.4	1.6	1.6	7.9	0.5	0.7	10.2	0.1	14.2	4.6	1.7	0.1	1.2	5.3	0.0	0.3	5.6	3.5	3.6	1.0	0.3	2.0	1.6	2.5	44.7	1.0	1.8	1.5	2.1	0.7	1.4	0.4	0.5	1.7	2.1	4.9	3.7	4.0	0.7	8.9	0.0	6.9	0.0	0.3	0.4	2.8	33.4	0.0	0.0	3.2	2.1	0.0	2.3	12.2	2.9	4.9	0.9	1.0	0.0	7.5	5.8	8.8	0.0	17.8	1.6	0.1	0.0	0.1	21.7	6.0	0.8	0.0	0.1	1.5	9.1	7.1	8.0	0.6	0.0	0.0	15.7	0.2	0.0	0.0	0.2	4.1	0.0	2.4	1.8	9.7	7.2	0.5	0.0	2.1	2.5	0.7	0.1	0.2	3.0	1.2	1.9	19.5	2.4	0.5	0.6	0.0	15.6	0.2	7.4	0.0	0.2	0.0	0.0	3.6	0.3	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.9	8.9	0.1	0.4	0.6	3.1	0.6	1.7	0.5	0.7	1.7	0.1	3.5	0.4
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;brain: 37.8;skin 1: 25.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.5;HBEC3-KT: 8.3;RT4: 14.0;T-47d: 8.9;U-2 OS: 8.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2"	"Lineage enriched"	"Detected in many"	8	"T-cells: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced									"HPA029683: AB_10603237"	"unprognostic (9.07e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.55e-4)"	"unprognostic (4.21e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.71e-7)"	"unprognostic (2.46e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-1)"	1.4	1.0	10.0	1.6	17.4	21.0	1.1	1.9	15.1	2.7	1.0	37.8	0.0	0.9	1.1	6.9	6.5	1.0	1.0	0.9	15.7	8.0	1.1	2.7	3.0	1.7	28.8	9.3	0.7	0.8	0.6	0.2	2.8	13.9	2.0	0.8	0.7	1.3	1.4	1.4	25.4	1.0	0.9	26.2	11.6	0.9	0.9	21.0	0.0	0.8	0.2	3.3	3.1	5.0	0.1	0.1	0.8	0.1	8.1	62.0	10.2	1.4	2.2	0.4	0.0	0.0	0.1	0.1	0.5	0.3	0.6	0.4	0.2	0.1	0.0	5.9	0.2	21.5	1.4	8.3	1.6	0.0	1.4	0.2	1.7	0.0	0.0	0.0	0.1	0.0	3.9	2.3	0.4	0.0	0.1	0.0	0.0	2.7	0.8	0.0	3.4	0.4	0.0	1.6	0.0	0.0	14.0	0.0	0.0	3.5	0.0	0.4	8.9	2.5	0.0	1.1	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.2	62.0	0.0	38.0	0.1	7.8	29.2	0.1	0.1	2.4	23.2	0.8	8.1	0.1	0.1	0.1	10.2	10.0	17.4	1.9	15.1	15.7	8.0	28.8	9.3	13.9	21.0
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071699			Approved	"Vesicles,Cell Junctions"				Vesicles	Vesicles	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.5	0.2	0.2	0.0	2.9	1.0	0.8	0.1	0.2	1.7	0.0	0.8	0.1	0.0	3.2	3.9	7.7	1.1	0.2	0.4	0.1	0.2	0.0	1.2	1.4	0.5	0.5	1.2	0.0	3.9	2.9	2.4	0.0	0.9	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.5	0.3	0.0	0.3	0.1	3.1	0.0	0.3	2.2	2.1	2.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.7;ASC TERT1: 34.4;HSkMC: 46.5;U-2197: 16.0;U-87 MG: 37.7"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	62000000	62000000	Vesicles	Vesicles	"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.7	34.4	0.0	1.5	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.5	2.5	9.3	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	5.8	1.2	16.0	0.4	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced									"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favourable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	9.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.4	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923154-56934405	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 31.4;tongue: 27.8"	"Group enriched"	"Detected in some"	6	"hTCEpi: 1.1;SK-BR-3: 4.3"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.1	9.6	0.1	0.1	0.1	0.0	0.7	0.1	8.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.1	2.0	0.1	0.5	31.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	0.1	27.8	9.9	0.1	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.3	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63556160-63567011	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 9.3;skin 1: 38.8;vagina: 16.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;CAPAN-2: 1.0;hTCEpi: 2.4;U-266/70: 2.9"	"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									8500000	8500000					"unprognostic (7.35e-2)"				"prognostic favourable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	9.3	0.0			0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.4	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.3			0.0		1.4	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	660000	660000	Vesicles	Vesicles	"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavourable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavourable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	143.8	0.0	47.4	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	99.9	0.0	25.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	10.5	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Cell line enhanced"	"Detected in some"		"BJ: 45.7;fHDF/TERT166: 32.2;HaCaT: 78.8;HBEC3-KT: 25.0;HBF TERT88: 43.8;hTERT-HME1: 25.5;U-138 MG: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.7	0.0	45.7	9.2	7.0	5.2	0.0	0.2	0.0	0.0	32.2	78.8	0.0	25.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.5	1.0	25.5	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	1.6	0.9	4.3	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63969925-64019779	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	12.4	7.4	2.9	9.3	4.2	16.0	6.1	1.3	5.5	7.7	7.4	7.1	0.0	3.7	4.1	4.3	20.6	3.7	13.7	4.5	3.1	3.3	7.1	23.7	8.2	10.1	4.7	4.0	8.1	4.2	1.1	5.0	9.5	7.4	4.2	6.1	3.4	8.1	2.1	4.5	36.6	8.7	4.4	6.0	9.8	4.2	2.9	3.5	4.2	5.0	17.5	11.3	9.6	11.0	5.1	25.3	5.9	20.5	2.1	4.2	5.0	7.4	1.5	1.3	9.2	4.6	6.5	0.6	24.3	23.6	15.4	15.4	0.3	3.4	0.1	8.9	14.5	12.2	0.2	15.4	22.1	10.3	0.3	0.0	2.8	0.8	10.5	37.3	3.2	6.2	13.4	20.8	6.8	16.4	0.2	4.3	10.6	0.6	0.6	4.1	0.5	7.5	0.5	3.4	0.6	6.9	8.5	0.7	0.7	4.8	0.7	8.9	0.3	14.0	25.4	23.6	5.0	2.8	9.7	1.9	0.3	0.0	24.2	21.7	20.3	1.1	20.5	0.8	3.8	16.1	3.4	3.6	3.1	2.3	25.3	5.1	1.7	2.6	5.9	2.1	8.0	13.7	4.2	5.0	2.9	4.2	1.3	5.5	3.1	3.3	4.7	4.0	7.4	3.5
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"	54000000	54000000	Cytosol	Cytosol	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.7	0.9	0.3	1.6	1.3	2.4	0.0	2.4	0.7	0.2	11.1	1.6	16.7	1.0	0.1	0.5	0.7	27.8	0.9	2.3	0.7	0.1	1.0	21.5	0.4	5.1	0.3	0.1	0.5	21.6	0.1	0.4	1.7	0.8	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	10.9	1.8	0.4	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.7	0.4	4.6	2.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849263	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.3;breast: 15.2;skin 1: 17.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;BJ: 4.8;BJ hTERT+: 3.9;HaCaT: 3.6;HBEC3-KT: 1.6;U-266/84: 2.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016662	Enhanced									"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	20.3	0.5	0.6	0.9	0.7	0.0	15.2	0.1	0.6	3.7	1.6	0.0	2.1	0.1	2.0	0.8	12.5	0.8	1.4	1.2	0.4	0.2	0.2	0.2	1.2	0.1	2.7	0.0	0.4	1.1	0.9	3.7	0.3	0.9	0.9	0.4	0.0	2.0	0.5	2.3	17.7	0.4	2.4	1.6	0.3	0.5	4.9	1.1	0.0	1.4	11.2	2.9	4.6	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.9	0.1	0.2	4.8	3.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	3.6	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	0.1	0.6	0.4	0.2	2.7	0.0	0.9	1.1
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8"	"Cell line enriched"	"Detected in single"	70	"HaCaT: 22.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"				"Plasma membrane"	"Plasma membrane"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	1.3	0.3	0.4	5.6	1.2	0.0	44.3	0.0	0.8	0.0	13.0	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.2	1.0	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.3	0.1	6.1	3.3	1.2	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	22.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.4	0.0	0.2	0.1	0.2	0.0
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.0"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved									"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.5;hTCEpi: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.2	5.4	2.7	6.9	4.3	1.4	6.1	5.8	15.6	9.4	11.7	1.8	2.8	0.1	0.6	15.9	23.5	4.1	4.6	1.9	0.0	0.7	6.4	12.8	2.1	19.8	1.4	0.3	4.4	41.1	4.6	11.0	0.2	4.9	18.5	0.4	4.0	1.0	0.0	2.0	7.2	0.8	0.0	8.2	0.9	0.8	1.7	1.6	2.9	13.4	2.6	3.5	3.8	0.1	1.0	4.4	0.9	3.0	20.4	14.0	1.6	3.5	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3
SOX21	SOX25	ENSG00000125285	"SRY-box 21"	Q9Y651	13	94709622-94712399	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.2;skin 1: 18.3;stomach 1: 38.7"	"Group enriched"	"Detected in some"	4	"AF22: 41.6;NTERA-2: 11.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA048337: AB_2732547, HPA064084: AB_2685187"	"unprognostic (3.33e-1)"	"prognostic favourable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favourable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	0.6	0.6	11.0	0.7	10.1	0.6	1.5	2.5	13.2	0.7	0.6	7.5	0.0	0.6	0.7	0.6	8.3	0.7	0.7	0.6	10.9	5.5	0.6	0.6	0.8	0.6	6.0	8.2	0.6	0.6	0.6	0.1	0.6	5.8	1.2	0.6	0.0	1.7	0.6	0.7	18.3	0.6	0.7	6.1	0.6	38.7	0.8	9.8	0.0	0.7	1.0	4.3	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	41.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	6.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.1	2.5	12.3	10.9	5.5	6.0	8.2	5.8	9.8
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334946-174338492	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 5.1;skin 1: 4.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.8;fHDF/TERT166: 6.7;HEK 293: 2.7;THP-1: 14.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 6.0;olfactory region: 14.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.3;olfactory region: 44.8"	HPA062616	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.7	0.3	4.6	0.3	12.4	0.3	1.1	0.0	6.1	0.6	0.3	0.4	0.0	0.3	0.4	0.3	0.3	5.1	0.3	0.3	2.3	2.2	0.3	0.3	0.3	0.4	1.1	4.3	0.3	0.3	0.3	0.0	1.1	1.0	0.3	0.3	0.0	0.4	0.3	0.6	4.5	0.3	0.3	0.5	0.3	0.3	2.0	1.4	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	8.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	6.7	0.1	0.2	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	12.4	0.0	6.1	2.3	2.2	1.1	4.3	1.0	1.4
SPDYE5		ENSG00000170092	"Speedy/RINGO cell cycle regulator family member E5"		7	75493625-75504304	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 4.1;skin 1: 3.8;testis: 5.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 5.9;RT4: 5.0"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA051750	Approved									"HPA051750: AB_2681590"	"unprognostic (2.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.10e-4)"	"unprognostic (1.51e-10)"	"unprognostic (4.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.08e-4)"	0.0	0.5		0.8		1.6	0.0		0.6	0.0	0.0			0.2	0.0	0.0	0.1	0.0	0.8	0.0			0.0	0.0	0.0	1.2			0.3	0.5	0.0		0.1		0.0	0.0		0.4	0.0	0.4	3.8	0.6	0.0		0.8	0.3	5.0			0.6		0.0	0.6		3.8	2.6	4.1	2.2	1.0	3.6	0.7	1.4	1.4	1.5	2.4	0.1	0.0	1.5	1.1	0.0	0.0	0.0	1.4	1.3	1.9	0.6	0.0	1.5	0.0	0.0	0.0	1.0	0.9	0.8	5.9	1.0	0.0	3.7	0.9	0.0	0.0	0.0	0.0	0.0	1.8	2.2	0.0	2.2	0.9	2.6	1.2	1.0	1.0	0.3	0.0	0.0	5.0	1.7	1.2	1.2	1.4	0.3	2.0	0.5	2.3	2.6	1.1	1.6	1.5	1.7	0.7	2.8	0.4	1.7	1.8	4.1	2.2	1.1	3.6	1.2	1.9	2.0	1.9	1.8	0.9	3.8	1.7	2.1	3.5	1.0	2.1	2.6	0.5	0.7										
SPDYE6		ENSG00000260097	"Speedy/RINGO cell cycle regulator family member E6"		7	102347206-102356444	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5;skin 1: 3.9;testis: 4.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051750	Approved									"HPA051750: AB_2681590"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.84e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.49e-2)"	"unprognostic (7.81e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	0.0	0.2		2.0		3.2	0.0		0.0	0.0	0.3			0.7	0.3	0.0	0.8	0.0	0.1	0.2			0.1	0.0	0.0	3.3			0.0	1.1	0.0		0.3		0.0	0.0		1.1	0.0	4.5	3.9	0.8	0.0		1.5	0.9	4.2			1.1		0.0	0.4		3.0	1.1	1.3	1.9	0.4	2.2	1.1	2.8	1.4	1.6	3.1	0.0	0.0	5.2	4.4	0.0	0.0	0.0	1.2	2.5	4.8	1.6	0.0	1.4	0.0	0.0	0.0	1.0	4.1	2.5	7.8	0.8	0.0	2.2	2.3	0.0	0.0	0.0	0.0	0.0	3.4	11.9	0.0	4.4	1.1	2.6	1.6	0.0	3.6	0.5	2.9	0.0	5.5	3.1	1.8	5.8	2.3	1.1	1.2	2.0	1.4	5.2	1.6	3.2	2.5	3.0	2.1	2.8	1.0	4.2	2.3	0.1	0.9	1.3	2.2	1.6	2.1	0.6	1.4	0.9	0.5	3.0	1.4	2.0	0.9	0.4	1.9	1.1	1.7	1.1										
SPRR2E		ENSG00000203785	"Small proline rich protein 2E"	P22531	1	153093135-153106184	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 210.2;skin 1: 94.0;tongue: 291.9"	"Cell line enriched"	"Detected in some"	11	"hTCEpi: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 612.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (2.27e-1)"				"unprognostic (3.86e-2)"		"unprognostic (5.04e-2)"	"unprognostic (3.40e-1)"								"prognostic unfavourable (9.47e-4)"	0.3	0.0	0.3	0.3	0.3	0.0	5.7	0.3	0.3	25.9	0.3	0.3	0.3	0.0	0.6	0.3	210.2	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	26.8	0.3	0.3	94.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.4	0.3	291.9	54.7	0.3	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Cell Junctions,Cytosol"		4800000	4800000	"Cell Junctions, Cytosol"	"Cell Junctions, Cytosol"	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: "	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.4	3.3	1.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.1	8.0	0.0	1.7	0.0	7.7	11.7	1.1	0.0	0.0	4.6	0.0	19.9	1.1	0.3	3.3	0.3	0.1	5.4	0.0	3.5	2.9	3.2	0.0	0.0	12.5	2.6	1.5	23.1	10.3	10.7	1.3	6.6	4.4	1.1	23.5	13.8	6.5	16.4	1.5	18.7	0.9	0.6	0.0	4.1	0.6	5.1	0.3	1.2	6.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2
SPTSSB	"ADMP, C3orf57, ssSPTb"	ENSG00000196542	"Serine palmitoyltransferase small subunit B"	Q8NFR3	3	161344792-161372880	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 68.6;skin 1: 27.5;stomach 1: 42.0"	"Group enriched"	"Detected in some"	11	"MCF7: 155.3;RT4: 41.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 24.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	12	"NK-cell: 68.6"	"Lineage enriched"	"Detected in many"	12	"NK-cells: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047712			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA047712: AB_2680127"	"unprognostic (2.09e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.37e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.08e-2)"	"unprognostic (5.37e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.51e-3)"	1.4	0.4	2.0	0.7	3.4	0.5	6.4	8.9	18.5	4.0	0.9	1.6	0.0	0.5	1.0	0.4	5.1	0.6	1.5	0.4	2.2	2.2	0.7	0.6	0.3	1.0	2.0	6.2	0.4	1.5	0.3	0.3	0.3	12.0	12.4	0.8	0.2	8.0	0.4	0.4	27.5	0.5	1.4	1.1	1.1	42.0	0.3	0.4	0.1	0.4	2.1	1.7	23.5	5.4	0.0	0.0	0.2	0.0	68.6	5.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	155.3	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	41.2	0.2	1.6	0.0	5.6	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.2	68.6	0.0	0.0	0.0	0.5	2.0	3.4	8.9	18.5	2.2	2.2	2.0	6.2	12.0	0.4
STRA8		ENSG00000146857	"Stimulated by retinoic acid 8"	Q7Z7C7	7	135231979-135258492	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.0;skin 1: 2.5;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;K-562: 1.1;SK-BR-3: 2.3;THP-1: 6.7;U-266/84: 2.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (2.84e-1)"		"unprognostic (4.86e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.67e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.55e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.69e-1)"			0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0			0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	1.2		0.0	0.0		0.1	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.1;hTCEpi: 43.2;T-47d: 11.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052700	Uncertain									"HPA052700: AB_2681920"	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.7	0.9	0.0	6.8	0.7	0.1	7.3	19.9	0.6	61.8	0.1	0.1	0.0	0.5	0.3	2.3	0.0	0.0	0.0	0.1	7.8	0.0	0.1	5.7	0.0	5.6	0.1	0.3	11.8	4.2	0.1	41.6	3.6	6.3	0.1	0.1	3.1	0.1	0.0	0.0	0.1	19.4	13.3	31.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	27.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.2	0.0	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.2	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TAS1R2	"GPR71, T1R2, TR2"	ENSG00000179002	"Taste 1 receptor member 2"	Q8TE23	1	18839599-18859682	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAS2R5	T2R5	ENSG00000127366	"Taste 2 receptor member 5"	Q9NYW4	7	141790217-141791367	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 10.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA053742			Approved	"Nucleoplasm,Nucleoli,Cytoplasmic bodies"				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA053742: "	"unprognostic (5.48e-3)"	"unprognostic (3.90e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.39e-2)"	1.0	1.0	0.4	1.4	1.1	0.2	3.2	4.9	0.7	2.5	0.9			0.8	2.8	6.1	1.1	3.0	0.8	0.8	0.6	0.7	1.0	0.5	1.1	1.2	0.4		4.6	1.5	0.1	2.9	1.0		1.7	1.2		1.6	1.0	2.6	8.8	1.7	1.2	1.2	1.9	0.7	1.4			1.7		1.2	1.3	2.4	1.0	0.6	0.5	0.2	0.4	1.4	0.1	0.5	0.2	1.4	0.6	0.9	2.7	1.7	0.6	0.6	0.5	0.9	2.0	0.4	1.1	0.9	0.2	0.3	1.5	0.8	0.3	0.6	1.7	0.3	1.2	2.7	0.9	1.7	1.3	2.3	10.4	1.2	2.8	1.0	2.6	0.3	0.1	1.7	0.6	3.9	1.3	0.3	0.2	0.1	2.8	0.4	0.7	2.0	1.2	0.3	0.4	0.2	0.1	0.4	0.3	0.9	0.6	0.6	1.2	1.9	0.4	1.4	0.8	0.8	0.5	0.5	0.2	0.0	1.0	0.0	0.0	0.9	0.3	0.4	0.0	1.0	0.9	1.4	0.0	0.4	0.0	0.6	1.3	0.1										
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 6.6;testis: 3.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.3;HeLa: 9.7;T-47d: 7.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	0.0	0.1		1.0		0.4	0.4		0.1	0.0	0.1			1.2	0.0	0.0	1.0	0.4	0.2	0.0			0.0	0.0	0.2	0.6			0.1	1.3	0.0		0.0		0.2	0.0		0.8	0.8	1.2	6.6	0.5	0.0		2.0	1.9	3.5			0.0		0.1	0.4		0.0	0.0	0.7	0.0	1.0	0.4	0.1	1.4	2.4	1.4	1.8	1.5	1.8	4.8	1.2	0.7	1.3	2.1	0.5	11.3	0.2	0.9	0.7	4.9	0.7	1.1	0.5	2.0	3.8	0.8	9.7	0.7	0.9	0.3	1.4	1.5	2.2	1.5	0.2	0.9	0.7	1.1	0.4	0.1	1.0	4.3	0.5	0.5	1.5	0.4	0.1	1.5	1.4	0.9	1.3	1.1	0.7	0.9	7.9	1.0	2.7	0.5	0.4	3.9	0.5	1.6	1.2	0.5	1.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1										
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.3;skin 1: 3.5;testis: 3.4"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 26.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.6		3.3	0.0		0.0	0.0	0.0			0.9	0.2	0.0	0.0	0.5	1.2	0.5			0.1	0.0	1.8	1.0			0.7	0.0	0.0		0.0		0.0	0.0		0.8	0.0	1.3	3.5	0.0	0.1		0.0	1.5	3.4			0.0		0.9	0.0		0.0	0.0	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.2	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.2	0.0	1.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0										
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 7.9;skin 1: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			2.0	1.1	0.0	0.0	0.0	0.0	0.9			0.0	0.0	0.4	0.2			0.0	0.0	0.0		0.8		1.5	0.8		0.0	0.0	0.8	4.2	7.9	0.0		0.0	0.0	2.6			0.0		0.5	0.0		0.0	0.0	0.7	0.2	0.0	0.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	2.1	9.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	4.9	0.0	5.5	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.9	1.0	0.0	3.4	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3I		ENSG00000274933	"TBC1 domain family member 3I"	A0A087WXS9	17	36253456-36264553	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"skin 1: 1.3;testis: 3.0"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 10.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.7			0.0	0.0	0.4		0.0		0.2	0.0		0.9	0.5	0.0	1.3	0.9	0.0		0.3	0.1	3.0			0.0		0.1	0.2		0.1	0.2	0.7	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.6	0.0	0.1	0.1	0.2	0.1	10.9	0.1	0.6	0.0	1.6	0.0	0.1	0.0	0.1	0.7	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.2	0.7	0.0										
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 10.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.9;NB-4: 22.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	0.5	2.4		1.8		0.6	1.8		1.3	0.2	1.2			2.4	0.0	2.9	2.4	1.2	0.8	0.0			0.0	0.6	1.0	1.8			0.5	0.3	0.1		0.3		1.4	1.1		3.3	1.3	4.1	10.8	1.0	0.2		2.7	1.8	0.9			0.0		0.3	1.2		0.6	0.3	3.8	0.8	1.0	1.0	0.4	7.4	9.8	4.0	6.0	7.5	6.9	23.9	3.4	2.3	3.1	3.6	5.4	0.1	2.5	0.1	4.3	12.2	3.6	3.2	2.0	7.3	9.3	0.0	15.9	2.3	5.4	1.0	9.3	5.8	8.0	4.0	2.3	4.1	1.9	8.8	5.0	4.0	4.4	22.1	3.8	2.2	2.9	4.6	0.0	9.7	10.2	5.5	7.6	0.0	4.0	4.4	5.8	1.5	9.4	0.0	5.4	4.1	4.6	6.2	2.7	0.0	6.2	3.1	3.5	0.0	0.8	0.9	0.3	0.6	0.0	0.1	0.3	0.9	0.1	0.6	0.6	1.0	3.8	1.0	0.8	0.3	0.3	0.4										
TEX52		ENSG00000283297	"Testis expressed 52"	A6NCN8	12	2849039-2857083	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.5;testis: 18.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.2;Karpas-707: 6.8"									"Cell type enriched"	"Detected in single"	8	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"																															0.2	0.0	0.2	1.1	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2		0.2	0.2	0.2	1.2	0.2	0.2	0.2	1.3	0.0	0.2	0.2	0.2	0.2	0.0	0.2	1.9	0.2	3.2	5.5	1.1	0.2	0.2	1.0	0.3	18.1	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.4	1.8	0.5	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.3	0.7	0.3	0.0	3.0	0.0	0.0	0.2	1.3	1.9	0.3	5.2	2.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.2	6.8	0.0	1.3	0.2	1.0	0.6	0.0	1.4	0.2	0.2	0.0	1.4	0.1	0.4	0.0	0.2	0.3	0.8	0.1	0.7	0.3	1.7	0.8	0.5	1.1	0.2	0.9	0.3	1.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	4.0	0.0	0.0	0.0	0.0										
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629302-56639283	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 53.9;skin 1: 32.5"	"Group enriched"	"Detected in many"	4	"BEWO: 44.7;MCF7: 37.9;SK-BR-3: 72.1;T-47d: 20.1;WM-115: 26.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory region: 2.9"	"Low region specificity"	"Detected in single"			"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	0.7	0.2	0.4	0.0	16.1	0.4	0.9	17.3	2.4	0.2	7.7	0.0	3.7	3.4	19.6	1.6	2.0	0.4	1.4	0.2	0.7	0.1	2.8	0.0	0.2	0.5	0.3	1.6	0.0	0.6	53.9	0.4	5.7	0.7	1.9	19.7	7.9	1.0	32.5	0.3	0.6	0.4	0.1	0.3	0.7	0.2	0.3	4.2	21.0	10.1	2.1	11.1	0.1	0.2	0.8	0.1	0.2	0.2	0.0	2.8	3.6	0.0	0.0	0.0	0.0	44.7	4.6	8.4	5.8	1.0	0.7	0.0	0.0	0.3	3.0	9.8	6.3	1.2	4.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	5.0	1.7	1.7	0.0	0.0	0.7	0.0	37.9	4.6	0.2	2.2	4.8	0.0	0.0	1.5	0.0	2.3	1.2	0.0	3.1	72.1	4.7	20.1	1.0	0.0	3.8	0.1	2.0	3.4	0.0	0.0	0.0	0.9	0.0	26.5	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.1	0.0	0.7	0.4	0.4	0.9	1.4	0.2	0.2	0.5	0.4	0.2
TFAP2E	AP2E	ENSG00000116819	"Transcription factor AP-2 epsilon"	Q6VUC0	1	35573370-35595328	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;skin 1: 11.4"	"Cell line enhanced"	"Detected in some"		"NB-4: 10.3;SK-MEL-30: 5.6;THP-1: 4.9;U-937: 8.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 22.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (7.06e-4)"	"unprognostic (1.96e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.27e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.67e-15)"	"unprognostic (2.03e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.40e-2)"	0.6	0.5	2.5	2.6	4.3	4.7	1.3	22.0	3.4	1.2	1.3	1.1	0.6	0.3	1.3	1.8	0.7	1.3	0.7	0.6	4.8	2.9	0.6	0.6	8.2	3.0	2.2	0.6	1.7	0.6	0.2	1.5	0.7	4.7	1.2	0.4	2.2	1.1	0.7	0.6	11.4	0.6	0.7	4.3	1.9	1.0	1.7	2.9	0.6	0.6	0.6	1.6	0.6	1.3	1.4	1.2	5.2	3.1	3.5	3.1	1.6	0.4	0.4	0.6	0.3	0.5	0.9	1.7	0.3	0.3	0.2	0.1	1.2	1.0	0.2	0.8	0.3	0.4	0.1	0.0	0.3	0.5	1.1	4.3	0.8	1.1	1.2	0.7	0.3	0.3	0.9	0.6	0.4	0.0	0.1	1.2	0.0	0.7	0.9	10.3	0.9	0.6	0.4	0.2	0.3	0.0	0.1	0.4	0.8	1.1	0.5	5.6	1.6	4.9	0.5	0.3	1.7	2.6	0.7	2.1	1.1	0.1	0.3	8.6	1.5	1.6	3.1	5.2	3.1	1.1	1.5	1.4	1.8	2.5	1.2	1.3	0.8	2.5	0.0	3.5	1.4	1.0	2.1	1.6	2.5	4.3	22.0	3.4	4.8	2.9	2.2	0.6	4.7	2.9
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell line enriched"	"Detected in some"	7	"HEL: 19.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"														"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMEM269		ENSG00000274386	"Transmembrane protein 269"	A0A1B0GVZ9	1	42785007-42816619	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;skin 1: 2.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 6.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.03e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-9)"	"unprognostic (2.23e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.77e-2)"	0.1	0.0		0.0		1.5	0.6		0.6	0.0	0.0			0.0	0.1	1.3	0.0	0.0	0.0	0.0			0.0	0.5	0.0	0.3			0.0	0.6	0.4		0.0		0.2	0.3		0.0	0.0	1.8	2.1	0.1	0.0		0.5	0.1	1.4			0.0		0.4	0.0		0.9	1.8	3.4	0.6	1.5	0.9	0.1	0.3	1.6	1.2	2.5	1.1	0.1	1.2	0.2	0.2	0.6	0.7	1.4	0.6	2.4	0.4	0.1	0.3	0.7	0.1	0.2	2.2	0.6	2.5	0.5	0.6	0.1	1.0	0.5	0.7	0.5	0.0	2.0	0.0	0.8	2.0	0.0	0.7	0.4	2.7	2.0	1.1	0.8	1.2	0.3	0.0	0.3	1.5	1.6	0.7	0.7	1.1	1.1	1.2	0.3	0.6	1.3	2.2	0.5	3.8	6.2	2.6	0.4	0.9	0.6	2.1	0.6	0.4	0.3	0.4	0.3	0.4	0.4	0.3	0.2	0.9	0.9	0.4	3.4	1.5	0.4	1.8	0.3	0.1										
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 118.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 92.2;ASC TERT1: 27.0;HSkMC: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3;myeloid DC: 2.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	5.3	5.2	1.6	3.0	7.3	0.6	12.5	0.3	1.9	8.6	2.7	1.9	2.5	1.0	8.5	5.7	4.4	5.2	5.7	5.7	1.3	0.9	1.4	45.2	5.8	5.2	4.4	0.7	6.4	20.2	0.3	25.1	20.2	2.1	5.9	1.8	3.1	23.9	2.2	2.4	118.9	1.7	6.6	2.2	2.2	2.0	5.4	4.4	0.0	6.5	3.7	12.2	7.7	18.5	0.5	2.9	0.9	3.3	0.0	0.5	2.0	6.0	0.4	0.5	2.1	92.2	27.0	0.0	14.5	13.5	2.0	19.0	0.5	0.1	0.0	7.2	9.5	6.9	0.5	2.8	5.2	1.5	1.8	5.0	2.2	1.7	5.8	0.0	0.3	28.4	1.6	3.7	5.6	0.7	0.1	0.7	4.9	0.0	0.0	0.1	0.7	3.6	0.0	5.1	0.0	0.1	0.2	0.6	4.3	3.5	1.8	1.5	0.1	2.8	2.0	14.1	9.9	0.1	3.2	11.9	6.8	0.0	11.1	0.4	9.3	0.0	3.3	0.9	0.3	0.0	0.0	0.5	0.2	0.3	2.9	0.0	0.1	0.5	0.4	0.0	0.5	1.6	0.0	2.0	1.6	7.3	0.3	1.9	1.3	0.9	4.4	0.7	2.1	4.4
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 47.5;skin 1: 35.7;tongue: 37.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.5;SK-BR-3: 17.8;T-47d: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	1.2	1.3	2.4	1.2	5.1	2.0	3.4	3.4	3.7	12.5	1.2	3.6	1.9	1.8	1.3	1.9	47.5	1.5	1.9	1.0	2.0	1.1	1.1	1.4	1.0	1.8	5.6	1.4	1.5	1.0	3.8	2.5	4.5	3.1	19.0	1.1	1.2	9.4	2.1	1.9	35.7	1.3	1.1	3.2	1.6	1.6	0.9	5.2	3.7	1.5	37.2	24.2	3.3	20.5	5.2	4.1	7.8	4.1	3.0	5.2	3.1	8.0	4.8	1.7	3.1	1.2	1.3	4.0	2.4	0.9	4.3	1.7	5.6	2.3	1.5	5.2	0.6	7.2	1.8	3.6	1.8	5.4	2.7	1.5	1.9	1.6	2.3	1.6	2.3	1.3	21.5	3.2	3.3	0.9	6.8	10.1	2.0	9.6	4.7	2.6	2.5	3.8	5.6	1.6	3.2	0.8	2.5	2.9	3.2	2.9	17.8	4.6	19.0	4.9	2.3	8.0	2.7	2.8	6.2	7.8	8.2	3.4	5.5	4.0	6.0	0.0	4.1	5.6	3.9	1.4	3.9	3.7	3.4	4.0	3.2	5.2	4.4	5.2	7.8	3.0	2.6	4.1	4.0	3.1	2.4	5.1	3.4	3.7	2.0	1.1	5.6	1.4	3.1	5.2
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Group enriched"	"Detected in some"	8	"HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026911	Uncertain									"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS13	"MSPL, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900643-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.1;salivary gland: 16.6;skin 1: 26.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;BEWO: 17.5;MCF7: 14.7;SK-BR-3: 25.3;T-47d: 25.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.2	0.3	0.2	0.6	0.2	0.3	6.2	0.2	0.2	5.8	0.2	0.2	0.2	0.2	0.9	0.7	14.8	0.1	0.2	0.2	0.4	0.0	0.7	0.2	4.0	0.7	0.2	0.2	0.3	5.7	0.0	0.5	22.1	0.2	0.9	0.2	0.6	16.6	0.2	0.2	26.0	0.5	0.2	0.2	1.0	0.1	0.3	0.2	0.4	9.5	13.7	10.6	0.3	5.6	1.0	2.6	1.0	0.7	1.9	1.2	0.8	7.3	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	5.6	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.4	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.2	0.0	0.0	25.3	0.3	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.6	0.0	0.9	0.7	0.0	1.0	0.1	1.2	1.8	0.5	0.4	0.1	0.0	1.9	0.5	2.6	0.7	0.8	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206691	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 46.6;skin 1: 28.9"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 61.2;SCLC-21H: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 46.6"	"Group enriched"	"Detected in many"	11	"NK-cells: 46.6;T-cells: 19.0"									HPA008025	Approved				"Secreted to blood"					"HPA008025: "	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favourable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favourable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.4	0.5	1.0	8.9	1.0	1.9	4.2	4.9	2.5	14.3	8.3	0.3	0.1	5.7	2.1	1.1	4.7	1.0	3.7	0.2	0.5	0.3	1.1	1.7	3.0	9.1	0.4	2.4	0.3	2.7	9.4	3.8	1.3	1.7	1.9	1.2	0.5	9.0	2.6	1.0	28.9	5.0	0.2	0.3	6.7	3.8	0.8	0.1	4.4	0.9	2.7	8.2	1.5	2.2	2.9	0.0	0.2	0.0	46.6	19.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.6	0.0	0.0	61.2	0.0	0.0	43.9	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.6	1.3	8.5	1.2	0.0	2.9	0.3	0.4	0.2	46.6	0.0	0.0	19.0	2.1	1.0	1.0	4.9	2.5	0.5	0.3	0.4	2.4	1.7	0.1
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA010135: "	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favourable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.1	0.0	1.6	16.1	1.1	1.2	26.3	0.6	0.9	7.6	0.0	0.0	0.0	20.0	0.0	1.0	0.9	1.2	0.0	0.9	0.2	0.8	27.3	0.7	0.0	0.3	7.7	0.2	7.6	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.7	1.6	0.0	4.5	0.0	2.7	0.1	10.5	1.8	0.0	0.0	45.6	0.0	0.1	0.0	3.8	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.4	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	"Plasma membrane, Actin filaments, Focal adhesion sites"	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.5	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.2	2.1	0.0	2.9	0.0	3.1	0.4	3.6	0.0	19.7	1.4	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.1	3.1	0.0	0.0	0.0	1.6	0.0	7.8	1.0	5.3	0.6	0.2	19.3	0.8	0.5	3.8	5.2	0.0	1.9	0.1	1.6	2.1	1.6	1.0	1.5	0.0	1.5	0.0	3.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8
TNS4	CTEN	ENSG00000131746	"Tensin 4"	Q8IZW8	17	40475828-40501597	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 76.9;salivary gland: 58.8;skin 1: 60.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.2;HBEC3-KT: 103.4;hTCEpi: 77.0;hTERT-HME1: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (4.16e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.68e-4)"	"unprognostic (7.88e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.08e-2)"	0.4	0.2	0.2	0.5	0.2	0.0	10.4	0.2	0.2	12.5	1.7	0.0	18.2	0.3	1.2	10.8	35.3	0.6	2.4	0.2	0.2	0.2	2.6	0.2	1.3	0.0	0.2	0.0	0.2	0.2	0.0	1.0	76.9	0.0	17.5	3.5	0.0	58.8	38.2	0.2	60.1	0.4	2.1	0.2	0.2	0.9	1.2	0.0	0.0	8.1	28.4	27.6	7.4	23.1	0.0	0.0	0.0	0.0	0.2	1.4	0.1	1.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.1	0.0	0.6	0.0	23.2	0.0	103.4	0.0	0.0	0.0	0.0	9.2	1.5	0.0	0.0	0.0	0.0	77.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	13.3	2.5	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5"	"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SK-BR-3: 2.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"									"HPA044300, HPA048797"	Uncertain									"HPA044300: AB_2678888, HPA048797: AB_2680524"	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	0.3	4.6	0.1	0.2	4.2	0.0	0.4	8.9	19.6	3.2	0.1	0.1	0.3	0.6	0.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	1.2	0.1	0.1	3.0	1.2	0.9	22.5	0.2	0.1	0.1	0.1	0.2	0.6	0.1	15.2	0.1	31.5	6.7	0.2	11.0	0.4	0.1	1.9	0.2	0.2	0.3	0.1	0.4	0.0	0.2	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.4	0.4	0.5	0.0	0.1	1.6	0.0	0.1	1.0	0.0	0.8	0.6	0.0	0.4	0.0	0.0	3.4	1.1	0.1	0.0	2.3	0.0	0.7	0.0	0.0	0.7	0.7	0.5	0.4	0.0	0.0	0.4	0.0	0.2	0.1	1.3	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	1.9	0.2	0.1	0.1	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.1	0.1	0.1
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 23.3;HBEC3-KT: 44.6;hTCEpi: 33.8;hTERT-HME1: 32.3;RT4: 49.0"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favourable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	23.3	0.0	44.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	33.8	0.0	32.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 39.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;U-698: 10.1;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 3.9;eosinophil: 5.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.7"	"Not detected"	"Not detected"							HPA054060	Uncertain									"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	3.2	1.5	2.1	3.4	3.0	1.9	2.1	1.1	3.6	4.3	2.6	1.9	15.5	1.4	2.5	2.2	4.5	2.6	2.2	3.5	1.6	1.2	2.8	4.6	2.4	3.1	2.4	2.4	2.1	2.2	1.5	1.7	2.6	2.7	2.5	1.4	1.4	4.5	7.4	2.0	39.6	2.3	1.9	1.2	4.3	1.7	2.1	1.9	5.8	3.3	6.2	4.7	2.2	5.2	0.4	0.3	5.7	0.1	0.2	0.4	0.2	2.8	3.5	0.3	1.3	0.5	0.7	0.3	0.9	0.8	0.7	2.0	1.0	0.7	0.3	1.8	0.8	3.1	1.2	2.0	0.0	3.1	7.4	0.3	0.7	0.4	0.3	0.8	1.9	0.8	1.8	0.8	0.7	0.3	0.4	3.5	0.2	3.3	2.0	2.2	1.1	2.4	4.8	1.0	2.2	0.3	1.0	0.8	0.4	0.3	0.3	1.0	0.5	0.9	0.0	1.3	2.3	2.8	1.0	3.9	2.7	10.1	0.3	9.4	1.5	3.9	0.0	5.7	0.3	0.0	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	2.1	3.0	1.1	3.6	1.6	1.2	2.4	2.4	2.7	1.9
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020053	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"	"Nucleoplasm, Intermediate filaments"	"HPA020053: AB_1858280"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.8	0.0	53.0	0.0	12.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	70.5	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.2	0.9	39.6	5.6	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0
TRIM48	RNF101	ENSG00000150244	"Tripartite motif containing 48"	Q8IWZ4	11	55262182-55271119	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.1;skin 1: 2.4"	"Cell line enriched"	"Detected in single"	5	"SK-MEL-30: 4.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"																												"unprognostic (8.04e-3)"									0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 54.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"cerebellum: 72.2"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	3.4	4.0	2.7	3.3	2.5	3.8	11.6	8.5	4.5	13.3	8.1	1.1	6.7	4.6	5.9	6.9	23.4	3.1	9.7	3.0	2.0	4.0	9.4	3.9	5.3	2.2	1.9	3.9	5.4	9.3	7.8	5.7	33.1	3.3	7.5	8.3	3.3	18.8	9.4	1.7	54.9	9.8	9.6	1.8	1.1	7.4	5.0	1.5	0.5	3.6	12.0	14.4	11.9	12.2	1.2	1.6	6.5	1.1	0.2	6.0	0.9	14.3	4.9	3.7	4.2	0.8	0.7	23.4	3.8	3.4	15.3	14.8	15.6	11.5	1.2	24.1	4.5	16.8	6.4	5.9	11.3	9.5	3.2	0.7	8.3	2.3	12.2	0.3	1.7	2.4	7.0	12.0	26.8	1.2	1.2	9.9	4.7	5.9	0.6	0.1	4.3	4.2	0.0	10.4	4.9	12.8	22.3	7.2	2.9	24.7	16.9	2.9	13.4	0.7	3.1	2.7	19.4	17.0	25.6	2.4	4.7	0.1	2.3	0.3	1.7	6.5	1.1	1.1	0.7	0.3	1.4	1.2	1.9	1.0	1.6	0.6	1.7	0.6	4.5	0.2	0.6	0.2	6.0	0.9	2.7	2.5	8.5	4.5	2.0	4.0	1.9	3.9	3.3	1.5
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.3;hTEC/SVTERT24-B: 12.1;SiHa: 10.5;U-251 MG: 11.2;WM-115: 31.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain				"Secreted to blood"					"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.4	5.3	6.7	3.3	2.5	0.0	0.0	0.0	0.2	1.2	1.0	0.0	6.4	1.8	4.9	0.1	0.1	8.7	0.7	1.1	0.0	0.3	0.7	15.3	12.1	2.4	0.0	0.0	0.1	0.5	0.0	0.0	0.9	0.4	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.5	0.0	7.9	0.1	0.2	0.0	1.5	1.0	0.1	11.2	0.0	0.1	0.0	5.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	5.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	4.0	0.0	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316019	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.8;liver: 17.4;skin 1: 18.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.7;Hep G2: 4.8;SCLC-21H: 5.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA035729	Uncertain									"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.5	1.4	0.1	0.1	9.2	0.1	0.5	5.9	1.0	1.6	0.1	0.1	0.0	2.5	17.4	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.5	0.1	0.1	18.8	9.8	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.1	3.9	2.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VANGL2	"KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1"	ENSG00000162738	"VANGL planar cell polarity protein 2"	Q9ULK5	1	160400586-160428678	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5"	"Cell line enhanced"	"Detected in some"		"AF22: 45.6;AN3-CA: 11.2;NTERA-2: 18.4;SH-SY5Y: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027043	Uncertain									"HPA027043: AB_10601709"	"unprognostic (4.32e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.84e-3)"	"unprognostic (9.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-2)"	1.4	2.1	7.5	2.9	6.9	0.6	6.6	18.4	12.6	10.6	6.0	13.5	9.9	5.9	8.1	7.5	11.2	7.1	3.8	4.5	11.7	8.8	3.7	0.7	4.9	5.0	9.5	4.3	10.9	5.6	6.8	4.3	6.8	10.9	10.0	6.4	13.0	11.3	9.8	2.2	39.5	6.8	4.6	11.9	2.5	4.6	2.8	11.8	5.3	9.6	5.4	7.6	7.8	11.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.5	0.6	45.6	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.2	0.0	5.8	0.0	2.6	7.5	0.4	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	3.4	0.0	0.2	0.0	2.9	0.1	18.4	0.0	5.9	2.4	0.0	0.0	0.0	4.2	12.4	0.0	0.0	4.0	0.0	0.6	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.5	6.9	18.4	7.5	11.7	8.8	9.5	4.3	10.9	11.8
VSIG10L2		ENSG00000283703	"V-set and immunoglobulin domain containing 10 like 2"	P0DP72	11	125946056-125958647	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.6;skin 1: 20.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.2;AN3-CA: 1.1;SH-SY5Y: 2.7;SK-BR-3: 1.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.8	0.0	0.0	20.4	0.2	0.6	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WFDC12	"C20orf122, dJ211D12.4, WAP2"	ENSG00000168703	"WAP four-disulfide core domain 12"	Q8WWY7	20	45123425-45124465	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 26.9;skin 1: 30.5"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"head and neck cancer: 18.9;melanoma: 14.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																"Secreted - unknown location"	20000	20000					"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-2)"		"unprognostic (5.42e-2)"		"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (8.70e-3)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (4.49e-2)"		"unprognostic (3.91e-1)"	"unprognostic (5.50e-3)"	0.1	0.0	0.1	0.1	0.1	0.5	1.9	0.1	0.1	1.5	0.1	0.1	26.9	0.2	0.1	1.2	6.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	3.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	1.3	0.0	0.1	1.8	4.1	0.2	30.5	0.1	0.1	0.1	0.1	0.0	1.0	0.1	2.2	0.1	6.4	0.9	0.1	10.0	0.8	0.3	0.9	0.4	0.0	1.1	0.0	0.8	0.6	0.3	0.5	3.4	0.4	1.3	0.3	1.7	0.2	1.6	0.6	0.4	0.8	0.3	0.4	0.6	0.3	0.9	2.3	1.5	0.0	0.0	1.1	1.2	1.3	0.0	1.3	0.0	0.3	1.4	0.9	1.0	0.9	1.2	1.1	0.4	0.4	1.3	1.6	0.4	0.3	1.9	0.4	2.1	0.5	0.0	0.2	0.0	1.0	0.0	0.6	2.5	0.0	0.2	0.4	1.2	1.2	1.3	1.3	1.3	0.9	3.2	0.6	0.1	0.4	0.9	0.1	0.4	1.1	0.3	0.1	0.2	0.1	0.8	0.4	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.1;HEK 293: 9.8;hTEC/SVTERT24-B: 2.9;U-2197: 4.7;U-266/70: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	125	"memory B-cell: 13.1;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	132	"B-cells: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.3	0.5	0.8	0.7	1.0	0.2	2.0	0.9	2.2	19.7	1.0	0.2	11.7	0.2	2.1	7.9	0.3	0.4	0.3	0.2	0.8	0.4	0.2	0.4	0.4	1.3	0.8	0.9	0.1	0.2	0.1	0.6	0.8	1.6	1.0	0.3	0.0	0.5	4.0	0.3	24.4	0.7	0.3	2.3	1.2	0.3	0.6	0.8	0.0	0.2	0.0	0.6	0.5	5.5	13.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.3	4.1	0.3	0.0	0.9	1.0	0.0	0.0	0.1	0.0	9.8	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.5	2.9	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	0.9	2.2	0.8	0.4	0.8	0.9	1.6	0.8
WNT3	"INT4, MGC131950, MGC138321, MGC138323"	ENSG00000108379	"Wnt family member 3"	P56703	17	46762506-46833154	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 7.8;skin 1: 17.2"	"Cell line enhanced"	"Detected in many"		"AF22: 10.1;U-698: 11.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 13.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066281			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA066281: AB_2685647"	"unprognostic (1.84e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.41e-4)"	"unprognostic (4.73e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.10e-8)"	"unprognostic (1.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	0.5	0.6	1.0	0.6	3.9	0.4	0.4	1.4	4.7	0.2	0.2	3.8	0.1	4.7	0.3	0.4	0.6	0.4	0.4	0.6	1.4	2.9	0.6	7.8	0.3	2.9	2.1	3.5	0.6	0.3	6.0	0.9	0.7	4.1	0.8	0.6	0.1	1.2	0.3	0.5	17.2	1.4	0.5	1.6	0.5	0.4	2.4	2.3	0.1	0.6	1.4	0.5	0.2	0.3	1.0	1.4	0.2	0.3	0.0	1.2	0.1	2.5	0.0	10.1	0.0	0.0	0.0	0.9	0.8	0.6	1.8	0.0	2.6	2.0	1.9	1.1	0.4	1.2	0.4	0.0	2.2	0.0	0.2	0.0	0.5	2.2	0.0	0.0	0.3	0.0	1.4	0.3	0.6	0.5	1.6	0.0	0.3	0.4	0.0	1.6	0.1	1.1	1.0	1.9	0.1	0.1	0.0	0.2	0.7	1.4	0.0	0.5	0.0	2.4	0.0	3.1	1.3	0.5	0.7	0.3	0.2	11.1	0.5	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.3	1.4	1.2	0.1	1.0	3.9	1.4	4.7	1.4	2.9	2.1	3.5	4.1	2.3
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.0;SCLC-21H: 12.2;SK-BR-3: 10.3;T-47d: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA011397: "	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.0	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	10.0	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	1.8	12.2	0.0	0.1	10.3	0.7	4.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8
WNT7B		ENSG00000188064	"Wnt family member 7B"	P56706	22	45920362-45977129	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 25.9"	"Cell line enhanced"	"Detected in some"		"A549: 39.8;HeLa: 35.4;RPTEC TERT1: 14.1;SK-BR-3: 17.4;U-87 MG: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (2.02e-3)"	"unprognostic (7.83e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.58e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.22e-2)"	0.5	0.4	9.6	0.5	4.7	0.5	2.3	2.4	7.6	4.2	0.4	1.2	0.7	0.5	0.6	2.0	10.8	2.2	10.9	0.4	6.4	5.4	2.4	0.6	4.9	0.4	2.0	2.2	0.5	2.1	0.4	0.3	1.1	1.3	4.4	0.4	0.0	2.0	3.5	0.5	25.9	0.4	0.7	0.7	0.4	0.5	0.9	1.4	0.1	0.8	4.9	5.3	10.0	10.0	1.4	0.8	1.3	0.4	0.2	0.5	0.0	7.5	39.8	0.1	0.0	0.0	0.0	5.2	0.1	0.4	0.0	0.0	0.1	5.2	0.0	1.2	0.0	8.6	0.3	5.1	0.0	0.0	0.3	0.0	35.4	0.1	0.0	0.0	0.0	0.0	3.5	0.0	1.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	7.5	0.0	0.0	0.4	14.1	11.2	1.4	0.0	3.4	17.4	0.0	2.9	4.5	0.0	0.7	0.6	0.0	0.3	0.0	0.0	0.0	32.3	0.0	0.0	0.6	0.4	0.3	0.4	0.3	0.5	0.7	0.5	0.3	0.2	1.4	0.5	0.5	1.3	0.2	0.2	0.8	0.3	0.0	9.6	4.7	2.4	7.6	6.4	5.4	2.0	2.2	1.3	1.4
XG	PBDX	ENSG00000124343	"Xg blood group"	P55808	X	2752048-2816500	"Blood group antigen proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8"	"Group enriched"	"Detected in some"	6	"ASC diff: 33.7;ASC TERT1: 25.0;fHDF/TERT166: 15.7;hTCEpi: 23.4;T-47d: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 2.1;naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.1"					"Low region specificity"	"Detected in all"														"prognostic unfavourable (4.25e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-6)"	"unprognostic (3.96e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.77e-3)"	8.9	0.0	0.3	0.3	0.6	0.8	9.1	0.5	0.6	22.8	0.3	0.3	0.3	0.0	2.6	0.3	7.1	0.6	3.0	1.2	1.4	0.0	1.3	0.3	0.3	0.3	0.6	0.3	1.1	0.3	0.0	0.3	18.4	1.9	0.5	0.0	0.3	4.1	0.4	1.4	25.8	0.3	0.3	4.2	0.3	0.1	0.3	0.3	0.3	0.9	0.3	2.4	1.2	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	25.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	23.4	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	1.7	12.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	1.4	0.0	0.6	0.3	1.9	0.3
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.0	1.6	1.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.0	0.0	0.0	2.5	0.1	2.0	0.3	1.1	0.2	1.1	0.0	0.4	0.0	2.3	0.0	0.3	0.0	0.0	1.9	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	5.4	3.3	8.1	15.1	7.3	22.0	5.4	11.3	8.0	5.5	5.8	6.5	4.6	5.4	6.4	5.1	8.5	6.1	5.3	4.4	6.9	2.6	4.1	3.8	6.0	11.1	7.3	5.4	7.0	7.8	2.1	4.4	5.6	6.8	7.7	6.2	5.3	11.1	2.9	8.9	30.3	7.0	2.3	5.3	13.5	6.8	10.1	5.0	17.6	5.6	6.7	14.2	5.3	9.0	4.5	2.0	3.0	3.3	2.5	3.9	3.6	12.6	23.1	12.7	15.8	1.1	3.3	23.1	14.0	4.6	19.8	21.4	12.8	20.3	20.1	12.1	2.9	20.2	13.9	20.8	12.2	12.4	14.4	19.6	11.3	11.8	2.0	17.6	12.8	2.5	2.1	17.4	11.1	8.1	12.1	12.4	10.2	27.6	30.4	13.9	11.0	16.5	24.8	18.4	7.9	4.4	17.4	12.6	10.4	16.5	8.9	5.7	14.1	13.7	6.9	10.3	12.1	32.7	15.3	10.6	9.6	25.0	6.4	14.6	15.8	2.6	1.6	3.0	3.8	3.3	3.9	4.5	3.3	3.2	2.0	4.0	3.3	2.2	1.2	2.5	2.5	1.4	2.5	3.6	8.1	7.3	11.3	8.0	6.9	2.6	7.3	5.4	6.8	5.0
ZNF385A	"DKFZp586G1122, Hzf, ZFP385, ZNF385"	ENSG00000161642	"Zinc finger protein 385A"	Q96PM9	12	54369133-54391298	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 81.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.8;HBEC3-KT: 27.4;HEL: 34.4;hTCEpi: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 16.6;monocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039799			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA039799: "	"unprognostic (8.56e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (6.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (9.75e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.07e-3)"	23.7	4.3	23.6	16.3	27.3	16.8	7.9	13.2	32.5	7.9	5.7	12.8	2.3	4.8	3.2	10.7	28.1	6.2	8.9	4.3	18.4	22.6	2.3	3.8	11.6	8.9	31.8	15.4	2.0	2.0	13.8	8.5	12.6	19.4	10.3	5.4	35.5	8.9	10.1	5.9	81.6	5.7	8.7	16.4	13.9	4.4	2.1	16.1	5.5	18.1	21.9	21.9	25.8	14.9	0.8	16.6	1.6	16.8	0.0	0.2	6.6	0.8	3.4	5.2	6.5	6.0	4.0	14.3	0.6	2.6	2.7	2.3	6.9	2.5	1.9	2.3	1.4	28.8	1.9	27.4	0.9	1.8	2.7	34.4	2.2	1.3	2.7	0.5	24.1	3.5	30.9	3.0	7.7	1.6	16.5	0.1	1.2	15.3	1.6	4.9	2.9	2.7	6.1	0.4	6.7	2.1	22.5	2.3	10.4	0.2	19.5	1.4	23.0	14.4	1.7	1.5	3.4	1.7	1.7	0.5	0.1	1.6	6.1	1.6	3.8	1.6	15.3	0.0	0.0	16.8	0.0	0.6	0.0	0.0	16.6	0.8	0.0	0.2	1.2	0.0	11.9	1.6	0.0	6.6	23.6	27.3	13.2	32.5	18.4	22.6	31.8	15.4	19.4	16.1
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell line enriched"	"Detected in single"	86	"NTERA-2: 35.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2
